
<html lang="en"     class="pb-page"  data-request-id="2d717c31-b80e-4997-950b-e12b7c17d144"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b00647;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors" /></meta><meta name="dc.Creator" content="Agnès  Joncour" /></meta><meta name="dc.Creator" content="Nicolas  Desroy" /></meta><meta name="dc.Creator" content="Christopher  Housseman" /></meta><meta name="dc.Creator" content="Xavier  Bock" /></meta><meta name="dc.Creator" content="Natacha  Bienvenu" /></meta><meta name="dc.Creator" content="Laëtitia  Cherel" /></meta><meta name="dc.Creator" content="Virginie  Labeguere" /></meta><meta name="dc.Creator" content="Christophe  Peixoto" /></meta><meta name="dc.Creator" content="Denis  Annoot" /></meta><meta name="dc.Creator" content="Luce  Lepissier" /></meta><meta name="dc.Creator" content="Jörg  Heiermann" /></meta><meta name="dc.Creator" content="Willem Jan  Hengeveld" /></meta><meta name="dc.Creator" content="Gregor  Pilzak" /></meta><meta name="dc.Creator" content="Alain  Monjardet" /></meta><meta name="dc.Creator" content="Emanuelle  Wakselman" /></meta><meta name="dc.Creator" content="Veronique  Roncoroni" /></meta><meta name="dc.Creator" content="Sandrine  Le Tallec" /></meta><meta name="dc.Creator" content="René  Galien" /></meta><meta name="dc.Creator" content="Christelle  David" /></meta><meta name="dc.Creator" content="Nele  Vandervoort" /></meta><meta name="dc.Creator" content="Thierry  Christophe" /></meta><meta name="dc.Creator" content="Katja  Conrath" /></meta><meta name="dc.Creator" content="Mia  Jans" /></meta><meta name="dc.Creator" content="Alexandre  Wohlkonig" /></meta><meta name="dc.Creator" content="Sameh  Soror" /></meta><meta name="dc.Creator" content="Jan  Steyaert" /></meta><meta name="dc.Creator" content="Robert  Touitou" /></meta><meta name="dc.Creator" content="Damien  Fleury" /></meta><meta name="dc.Creator" content="Lionel  Vercheval" /></meta><meta name="dc.Creator" content="Patrick  Mollat" /></meta><meta name="dc.Creator" content="Nicolas  Triballeau" /></meta><meta name="dc.Creator" content="Ellen  van der Aar" /></meta><meta name="dc.Creator" content="Reginald  Brys" /></meta><meta name="dc.Creator" content="Bertrand  Heckmann" /></meta><meta name="dc.Description" content="Autotaxin (ATX) is a secreted enzyme playing a major role in the production of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC). The ATX–LPA signaling axis ..." /></meta><meta name="Description" content="Autotaxin (ATX) is a secreted enzyme playing a major role in the production of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC). The ATX–LPA signaling axis ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 18, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00647" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00647" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00647" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00647" /></link>
        
    
    

<title>Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00647" /></meta><meta property="og:title" content="Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0022.jpeg" /></meta><meta property="og:description" content="Autotaxin (ATX) is a secreted enzyme playing a major role in the production of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC). The ATX–LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases, and inflammation, among others. An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high-throughput screening (HTS). A cocrystal structure with one of these compounds and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site. Exploration of the structure–activity relationship led to compounds displaying high activity in biochemical and plasma assays, exemplified by compound 40. Compound 40 was also able to decrease the plasma LPA levels upon oral administration to rats." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00647"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00647">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00647&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00647&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00647&amp;href=/doi/10.1021/acs.jmedchem.7b00647" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7371-7392</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00632" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00696" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b00579"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-<i>a</i>]pyridine Series of Autotaxin Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agn%C3%A8s++Joncour">Agnès Joncour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Desroy">Nicolas Desroy</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4879-3439" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Housseman">Christopher Housseman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Bock">Xavier Bock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natacha++Bienvenu">Natacha Bienvenu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=La%C3%ABtitia++Cherel">Laëtitia Cherel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Virginie++Labeguere">Virginie Labeguere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Peixoto">Christophe Peixoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis++Annoot">Denis Annoot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luce++Lepissier">Luce Lepissier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Heiermann">Jörg Heiermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Willem+Jan++Hengeveld">Willem Jan Hengeveld</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor++Pilzak">Gregor Pilzak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alain++Monjardet">Alain Monjardet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emanuelle++Wakselman">Emanuelle Wakselman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veronique++Roncoroni">Veronique Roncoroni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Le+Tallec">Sandrine Le Tallec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ren%C3%A9++Galien">René Galien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christelle++David">Christelle David</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nele++Vandervoort">Nele Vandervoort</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Christophe">Thierry Christophe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katja++Conrath">Katja Conrath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mia++Jans">Mia Jans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++Wohlkonig">Alexandre Wohlkonig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sameh++Soror">Sameh Soror</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Steyaert">Jan Steyaert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Touitou">Robert Touitou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Fleury">Damien Fleury</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lionel++Vercheval">Lionel Vercheval</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Mollat">Patrick Mollat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Triballeau">Nicolas Triballeau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ellen++van+der+Aar">Ellen van der Aar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reginald++Brys">Reginald Brys</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bertrand++Heckmann">Bertrand Heckmann</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">○</span> <span class="aff-text">Mercachem, Kerkenbos 1013, 6546 Nijmegen, The Netherlands</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">VIB Structural Biology Research Center, Vrije Universiteit Brussel, 1050 Brussel, Belgium</span></div><div class="corresp-info"><strong>*</strong>(B.H.) Phone: +33-1-4942-4700. E-mail: <a href="/cdn-cgi/l/email-protection#f59790878187949b91db9d90969e98949b9bb592998592db969a98"><span class="__cf_email__" data-cfemail="f29097808680939c96dc9a9791999f939c9cb2959e8295dc919d9f">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(N.D.) Phone: +33-1-4942-4820. E-mail: <a href="/cdn-cgi/l/email-protection#a7c9cec4c8cbc6d489c3c2d4d5c8dee7c0cbd7c089c4c8ca"><span class="__cf_email__" data-cfemail="741a1d171b1815075a101107061b0d34131804135a171b19">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00647&amp;href=/doi/10.1021%2Facs.jmedchem.7b00647" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7371–7392</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2017</li><li><span class="item_label"><b>Published</b> online</span>18 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00647" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00647</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7371%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAgn%25C3%25A8s%2BJoncour%252C%2BNicolas%2BDesroy%252C%2BChristopher%2BHousseman%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00647%26title%3DDiscovery%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2Band%2BBinding%2BMode%2Bof%2Ban%2BImidazo%255B1%252C2-a%255Dpyridine%2BSeries%2Bof%2BAutotaxin%2BInhibitors%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7392%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00647"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3323</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00647" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Agnès&quot;,&quot;last_name&quot;:&quot;Joncour&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Desroy&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Housseman&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Bock&quot;},{&quot;first_name&quot;:&quot;Natacha&quot;,&quot;last_name&quot;:&quot;Bienvenu&quot;},{&quot;first_name&quot;:&quot;Laëtitia&quot;,&quot;last_name&quot;:&quot;Cherel&quot;},{&quot;first_name&quot;:&quot;Virginie&quot;,&quot;last_name&quot;:&quot;Labeguere&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Peixoto&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;Annoot&quot;},{&quot;first_name&quot;:&quot;Luce&quot;,&quot;last_name&quot;:&quot;Lepissier&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Heiermann&quot;},{&quot;first_name&quot;:&quot;Willem&quot;,&quot;last_name&quot;:&quot;Jan Hengeveld&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;Pilzak&quot;},{&quot;first_name&quot;:&quot;Alain&quot;,&quot;last_name&quot;:&quot;Monjardet&quot;},{&quot;first_name&quot;:&quot;Emanuelle&quot;,&quot;last_name&quot;:&quot;Wakselman&quot;},{&quot;first_name&quot;:&quot;Veronique&quot;,&quot;last_name&quot;:&quot;Roncoroni&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Le Tallec&quot;},{&quot;first_name&quot;:&quot;René&quot;,&quot;last_name&quot;:&quot;Galien&quot;},{&quot;first_name&quot;:&quot;Christelle&quot;,&quot;last_name&quot;:&quot;David&quot;},{&quot;first_name&quot;:&quot;Nele&quot;,&quot;last_name&quot;:&quot;Vandervoort&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Christophe&quot;},{&quot;first_name&quot;:&quot;Katja&quot;,&quot;last_name&quot;:&quot;Conrath&quot;},{&quot;first_name&quot;:&quot;Mia&quot;,&quot;last_name&quot;:&quot;Jans&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Wohlkonig&quot;},{&quot;first_name&quot;:&quot;Sameh&quot;,&quot;last_name&quot;:&quot;Soror&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Steyaert&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Touitou&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Fleury&quot;},{&quot;first_name&quot;:&quot;Lionel&quot;,&quot;last_name&quot;:&quot;Vercheval&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Mollat&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Triballeau&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;van der Aar&quot;},{&quot;first_name&quot;:&quot;Reginald&quot;,&quot;last_name&quot;:&quot;Brys&quot;},{&quot;first_name&quot;:&quot;Bertrand&quot;,&quot;last_name&quot;:&quot;Heckmann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7371-7392&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00647&quot;},&quot;abstract&quot;:&quot;Autotaxin (ATX) is a secreted enzyme playing a major role in the production of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC). The ATX–LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases, and inflammation, among others. An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high-throughput screening (HTS). A cocrystal structure with one of these compounds and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site. Exploration of the structure–activity relationship led to compounds displaying high activity in biochemical and plasma assays, exemplified by compound 40. Compound 40 was also able to decrease the plasma LPA levels upon oral administration to rats.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00647&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00647" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00647&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00647" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00647&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00647" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00647&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00647&amp;href=/doi/10.1021/acs.jmedchem.7b00647" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00647" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00647" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26pmid%3D28731719%26genre%3Darticle%26aulast%3DJoncour%26date%3D2017%26atitle%3DDiscovery%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2Band%2BBinding%2BMode%2Bof%2Ban%2BImidazo%255B1%252C2-a%255Dpyridine%2BSeries%2Bof%2BAutotaxin%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7371%26epage%3D7392%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Autotaxin (ATX) is a secreted enzyme playing a major role in the production of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC). The ATX–LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases, and inflammation, among others. An imidazo[1,2-<i>a</i>]pyridine series of ATX inhibitors was identified out of a high-throughput screening (HTS). A cocrystal structure with one of these compounds and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site. Exploration of the structure–activity relationship led to compounds displaying high activity in biochemical and plasma assays, exemplified by compound <b>40</b>. Compound <b>40</b> was also able to decrease the plasma LPA levels upon oral administration to rats.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autotaxin (ATX), also known as ENPP-2 (ectonucleotide pyrophosphatase/phosphodiesterase 2) or lysophospholipase D, is a secreted protein that belongs to the ENPP family of enzymes, which is composed of seven members. ATX is the only enzyme of the ENPP family with lysophospholipase D (lysoPLD) activity and is responsible for the hydrolysis of lysophosphatidyl choline (LPC), an abundant plasma phospholipid, into lysophosphatidic acid (LPA).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> LPA represents a family of bioactive lipids of varying fatty acyl chain length that signals through at least six LPA receptors (LPA<sub>1–6</sub>) to control a broad range of cellular events (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) ATX-mediated conversion of LPC into LPA and summary of cellular events triggered by LPA receptor activation. (B) Examples of abundant LPA species in plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In recent years, numerous ATX inhibitors were described in the literature and patented with possible application in the treatment of diverse pathologies such as cancer, fibrotic diseases, inflammation, pain, and angiogenesis, among others.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> At Galapagos, an ATX drug discovery program was initiated using a classical screening approach, aiming at developing novel therapeutics for fibrotic diseases. The monitoring of ATX-mediated cleavage of LPC requires either LC–MS/MS detection methods for LPA determination or a cascade of biochemical transformations to measure the amount of choline released (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). As both techniques were not deemed suitable for high-throughput screening (HTS) purposes, the use of an alternative fluorogenic substrate was envisaged. A screening campaign was performed on a diverse set of approximately 100,000 compounds using a biochemical assay with the FS-3 fluorogenic substrate as LPC surrogate.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Cleavage of FS-3 by ATX leads to the release of a fluorophore, inhibition of which can be directly measured by fluorescence detection. Several chemical series of ATX inhibitors were identified out of the screening campaign. Optimization and structure–activity relationships (SAR) of an imidazo[1,2-<i>a</i>]pyridine series to identify lead compound <b>40</b> and discussion of the binding modes of ATX inhibitors will be described in this article. Structural modifications of compound <b>40</b> leading to the discovery of clinical candidate GLPG1690 (<b>55</b>) have recently been disclosed.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Methods to assess ATX activity <i>in vitro</i> and in plasma samples.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structure–Activity Relationship</h3><div class="NLM_p">Out of HTS efforts, a <i>N</i>-benzyl-2-ethyl-<i>N</i>-methyl-imidazo[1,2-<i>a</i>]pyridin-3-amine series hit series was identified with the best compounds displaying an IC<sub>50</sub> around 30 nM with the FS-3 substrate based assay (FS-3 assay) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Since plasma naturally contains ATX and LPC but not membrane-bound lipid phosphate phosphatases responsible for LPA degradation, incubation of plasma at 37 °C leads to the production of LPA that can be measured by LC–MS/MS. Monitoring the inhibition of LPA production by compounds in this plasma assay allowed to evaluate their inhibitory activity and the impact of plasma proteins on this activity. The best <i>N</i>-benzyl-2-ethyl-<i>N</i>-methyl-imidazo[1,2-<i>a</i>]pyridin-3-amine derivatives were able to show roughly 50% reduction of LPA production at 10 μM. Those compounds suffered from poor metabolic stability, which precluded their use in vivo. Compound <b>1</b> with improved pharmacokinetic properties was identified as an early lead compound: <b>1</b> had a biochemical IC<sub>50</sub> of 122 nM (FS-3 assay) and displayed 39% bioavailability in rat and low clearance (0.15 L h<sup>–1</sup> kg<sup>–1</sup>). However, this compound only weakly inhibited the production of LPA in rat plasma, probably due to an insufficient potency.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hit series and compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Exploration of the substitution in position 6 of the imidazo[1,2-<i>a</i>]pyridine led to the identification of very potent inhibitors <b>2</b>–<b>6</b> of ATX mediated FS-3 cleavage (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Despite nanomolar activity in the FS-3 assay, those compounds displayed only micromolar activity in the biochemical assay using natural substrate LPC. These results clearly indicated divergence in the structure–activity relationships with the natural substrate LPC or with the artificial substrate FS-3. In order to assess the biological relevance of the data returned by biochemical assays, the inhibition of LPA production in plasma was evaluated. Compounds from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> appeared weakly active in this plasma assay, which illustrates the strong disconnect with the results obtained in the biochemical FS-3 assay. In contrast, a better correlation with little to no shift was observed when the potency of compounds for inhibiting the conversion of LPC <i>in vitro</i> was compared to the potency in the plasma assay. At this point, we hypothesized that the probe substrate used in the FS-3 assay, although mimicking LPC as a substrate might bind differently to the enzyme owing to the steric bulk associated with the fluorophore and quencher groups. A different binding mode of the substrates used in the different ATX assays might result in differences in the ability of ATX inhibitors to compete with these, possibly explaining discrepancies between the outcome of the FS-3 assay and phenotypic assays.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As a consequence, further explorations were carried out using LPC as substrate to assess the activity of compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activity of Compounds <b>1</b>–<b>6</b> in Biochemical and Plasma Assays<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">ATX FS-3 and ATX LPC activities were measured using FS-3 and LPC 16:0 as substrate, respectively. Plasma activity was evaluated by incubating rat plasma at 37 °C for 2 h and comparing LPA 18:2 production in the presence or absence of compound.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Standard deviations indicated when IC<sub>50</sub> determination was replicated at least twice.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Compounds evaluated at concentrations of 0.5, 5, and 50 μM (<i>n</i> = 3). Compounds with IC<sub>50</sub> of >50,000 nM showed less than 50% reduction of LPA production after incubation at all concentrations.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">7% reduction of LPA production at 0.5 μM, 67% at 5 μM, and 100% at 50 μM.</p></div></div><div></div></div><div class="NLM_p">The better potencies in the LPC assay of compounds <b>5</b> and <b>6</b> versus <b>2</b> and <b>4</b>, respectively, suggested that a basic amine and an extended substituent at position 6 bearing an H-bond accepting or donating group could impart ATX inhibitory activity. As depicted in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, imidazo[1,2-<i>a</i>]pyridine derivatives <b>7</b>–<b>22</b> bearing a substituted piperidine or piperazine at position 6 were explored. Compound <b>8</b> was identified as a submicromolar inhibitor of ATX, the methyl sulfonamide in compound <b>8</b> provided approximately a 2-fold gain of activity versus acetamide group in compound <b>7</b>. Compound <b>8</b> was also active in rat plasma with an IC<sub>50</sub> of 1033 nM. Side-chain extension with a basic group as in compound <b>9</b> further improved activity. Alternatively N-substitution with an ethyl acetate group on the piperidine or the piperazine ring provided compounds <b>10</b> and <b>11</b>, which displayed notable biochemical potencies. These data suggested that a substituent bearing a basic nitrogen atom and a distal H-bond accepting group was preferred at position 6. However, the latter compounds were weakly active in plasma due to plasma instability arising probably from ester cleavage and parent carboxylic acid derivative <b>12</b> being poorly active. Investigation of heteroaromatic rings as replacement of the ester function in compounds <b>13</b>–<b>16</b> led to a loss of activity in most cases. Only compound <b>16</b> retained interesting biochemical potency, but the compound had low activity in plasma (IC<sub>50</sub> = 4100 nM). Interestingly, whereas unsubstituted and monosubstituted amides were detrimental for activity (compounds <b>17</b> and <b>18</b>), replacement of the ester function by a disubstituted amide as in compounds <b>19</b>–<b>22</b> afforded potent compounds in the biochemical and plasma assays. Compounds <b>19</b> and <b>20</b> displayed IC<sub>50</sub> of 476 and 115 nM, respectively, in plasma.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR in Position 6 of the Imidazo[1,2-<i>a</i>]pyridine Ring<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">ATX LPC activities were measured using LPC 16:0 as substrate.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Standard deviations indicated when IC<sub>50</sub> determination was replicated at least twice.</p></div></div><div></div></div><div class="NLM_p">In parallel, exploration was carried out on the substituent in position 3 of the imidazo[1,2-<i>a</i>]pyridine scaffold. Early investigations showed that the thiazole ring was important for activity: replacing the thiazole ring by either a phenyl ring or heteroaromatic rings such as 1,2,4-oxadiazole or 1,3,4-oxadiazole rings led to significant loss of activity (data not shown). Therefore, investigations focused on the substitution of the thiazole ring as in compounds <b>23</b>–<b>39</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Compound <b>23</b> illustrates the loss of activity when the phenyl and thiazole rings were fused. Cyclohexyl replacing 4-fluorophenyl ring in compound <b>24</b> maintained activity, albeit with a slight loss of potency. The 4-fluorophenyl ring could also be replaced by a 4-chloro-3-pyridine moiety without any loss of activity in compound <b>25</b>. Replacing the <i>para</i>-fluorine substituent on the phenyl ring by other halogens, a trifluoromethyl group (<b>26</b>) or a methoxy substituent (<b>27</b>) was tolerated. However, bulky substituents such as <i>tert</i>-butyl group (<b>28</b>) had a detrimental impact on activity. Dihalogenated compounds <b>29</b> and <b>30</b> were less potent than the parent compound <b>8</b>. The importance of the <i>para</i> substitution was well established by the significant loss in potency with the <i>meta</i>, <i>meta</i>-difluoro compound <b>31</b>. Interestingly compound <b>32</b> bearing an <i>ortho</i>-methyl substituent displayed similar potency compared to analogue <b>8</b>. This good result inspired the preparation of rigidified tricyclic analogues <b>33</b> and <b>34</b>; however, the latter compounds only maintained similar level of activity and were not pursued any further. When the <i>ortho</i>-methyl substituent of <b>32</b> was replaced by a nitrile group in compound <b>35</b>, a remarkable improvement of activity was obtained. Although introduction of a methyl group in position 5 of the thiazole decreased potency (<b>36</b> versus <b>8</b>), introduction of a nitrile group in <b>37</b> afforded a very potent compound. Replacing the nitrile group by a carboxamide (<b>38</b>) or a carboxylic acid (<b>39</b>) resulted in a drop of potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR on the Thiazole Ring<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0020.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0021.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">ATX LPC activities were measured using LPC 16:0 as substrate.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Standard deviations indicated when IC<sub>50</sub> determination was replicated at least twice.</p></div></div><div></div></div><div class="NLM_p">Taken together these data indicated that a <i>para</i>-substituted 4-phenylthiazole substituent was preferred at position 3 and the introduction of a nitrile group on the <i>ortho</i> position of the phenyl ring or on the thiazole ring afforded a significant improvement of activity; our hypothesis to explain this gain of activity will be discussed later in this article. Structural modifications in positions 3 and 6 of the imidazo[1,2-<i>a</i>]pyridine scaffold were combined, and compound <b>40</b>, displaying potencies of 27 and 22 nM in the biochemical and rat plasma assays, respectively, was identified as the lead compound in the series (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of compound <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cocrystal Structure and Binding Mode Discussion</h3><div class="NLM_p">The first experimental structures of ATX (rat ortholog) were concurrently published by two different groups in 2011 revealing important structural features that explain the uncommon biochemical properties of this enzyme within the ENPP family as well as the binding mode of different LPA ligands and inhibitors.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Based on sequence and structural homology, ATX is composed of two somatomedin B-like domains followed by the catalytic ENPP domain and a nuclease-like domain maintained in close contact with the catalytic domain thanks to a peptide linker (or “lasso”) and a disulfide bridge. The catalytic domain reveals three pockets arranged in a T-shaped groove: a catalytic pocket that exhibits a nucleophilic threonine residue (Thr<sup>210</sup> in the human ortholog) and two adjacent zinc ions, a hydrophobic pocket that accommodates the hydrophobic tail of a variety of LPC substrates, and a so-called hydrophobic channel (or “tunnel”), which is proposed to play an important role in the transport and local delivery of LPA products and other hydrophobic substances.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> In order to resolve the binding mode of compound <b>9</b>, a dedicated construct of human ATX was produced and purified in house providing a batch of protein suitable for crystallography (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Cocrystals were obtained and diffracted with a maximum resolution of 2.7 Å, enabling the construction of an experimental model useful to assist and verify drug design hypothesis. Compound <b>9</b> binds to the catalytic domain with its imidazo[1,2-<i>a</i>]pyridine core occupying a pivotal spot in the center of the T-shaped groove, orienting each of its three substituents toward each of the three pockets (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). The ethyl group in position 2 points in the direction of the catalytic pocket, while substituents in positions 3 and 6 occupy the hydrophobic pocket and hydrophobic channel, respectively. In addition to van der Waals contacts essentially driven here by hydrophobic effects, <b>9</b> displays a hydrogen bond between a sulfonamide oxygen and the indole NH of Trp<sup>261</sup> and potentially a second one, albeit not certain given the electron density, between the basic nitrogen of the C6 substituent and the backbone carbonyl groups of Trp<sup>255</sup>and Gly<sup>257</sup>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Overall structure of ATX with compound <b>9</b> shown in CPK with green carbon atoms. Somatomedin B-like, catalytic, and nuclease-like domains are shown in blue, green, and pink, respectively. Disulfide bridges are depicted as yellow bars, and the two zinc ions of the catalytic site are shown as magenta spheres. The arrow indicates the viewing angle of panel B and the dashed line the clipping plane for the site surface. (B) Focus on the binding pocket showing details of the binding mode of <b>9</b>. The surface delineating the site is colored by hydrophobicity using in a blue–white–brown spectrum (blue for hydrophilic, brown for hydrophobic). For clarity, the surface was clipped vertically (see panel A). Dashed lines highlight interactions between compound <b>9</b> and ATX, hydrophobic contacts in pink, and hydrogen bonding in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the publication of the first structures of ATX, a variety of endogenous ligands and synthetic inhibitors has been described, examples of which are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. Interestingly, they exhibit a diversity of binding modes, which, at this stage, can be classified into four types illustrated in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of ATX inhibitors. PDB codes of cocrystal structures with ATX are indicated in brackets (note: reported PDB code for compound <b>64</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5mom">5mom</a>) does not match the intended structure).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic representation of the autotaxin binding pocket and the different inhibitor binding modes reported to date. Type I, II, III, and IV inhibitors are represented in green, purple, cyan, and orange, respectively, on the schema with matching colors for carbon atoms on the exemplified structures. The gray dotted lines represent secondary ligands modeled next to the inhibitor as shown with gray carbons on the illustrations. Some structures lack secondary ligand models but exhibit a positive electron density in the same region (Fo-Fc map at 3 sigma in green, 2Fo-Fc map at 1 sigma in blue). Zinc ions are depicted in magenta. (A) Binding mode of type I inhibitors LPA 22:6 (a), <b>56</b> (b), <b>58</b> (c). (B) Binding mode of type II inhibitors <b>60</b> (d), <b>59</b> (e), and <b>61</b> (f). (C) Binding mode of type III inhibitors <b>63</b> (g) and <b>62</b> (h). (D) Binding mode of type IV inhibitors <b>55</b> (i) and compound <b>9</b> (j).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Type I inhibitors (such as LPA species, HA-155 (<b>56</b>), PF-8380 (<b>57</b>), or “compound 2” (<b>58</b>) in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) mimic the binding mode of LPC substrate and occupy the catalytic site.<a onclick="showRef(event, 'ref13 ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref19">(13, 14, 19)</a> They generally have a zinc binding group and a hydrophobic tail lodged in the hydrophobic pocket (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). Such inhibitors leave the hydrophobic channel unoccupied, which explains why many structures categorized as type I inhibitors have a secondary compound occupying the channel, generally a substance from the solution with amphiphilic properties such as LPA or cholesterol derivatives. In fact, all crystallographic structures with type I inhibitors published so far exhibit an electronic density in the channel, but not all have a modeled compound in this area, probably because of partial occupancy. Type II inhibitors occupy the hydrophobic pocket by largely exploiting its intrinsic plasticity (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Indeed, in most cases this induced fit significantly restructures the binding pocket involving side-chain conformation variations of residues such as Phe<sup>214</sup>, Leu<sup>217</sup>, Phe<sup>274</sup>, Phe<sup>275</sup>, and Tyr<sup>307</sup>. Interestingly, type II inhibitors jam the bottleneck between the hydrophobic channel and the catalytic site but do not fully occupy any of them. PAT-078 (<b>59</b>), PAT-494 (<b>60</b>), and, to a certain extent, CRT0273750 (<b>61</b>) represent such type II inhibitors.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> As for type I inhibitors, the remaining pockets left vacant allow binding of an LPA molecule. By contrast, type III inhibitors bind to the hydrophobic channel leaving the hydrophobic pocket and catalytic site unoccupied (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). They comprise PAT-347 (<b>63</b>), PAT-505 (<b>65</b>), PAT-048 (<b>66</b>), and the steroids 7α-hydroxycholesterol and tauroursodeoxycholic acid (TUDCA, <b>62</b>).<a onclick="showRef(event, 'ref18 ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref22">(18, 20, 22)</a> The binding modes of compounds <b>55</b> and <b>9</b> differ from that of other inhibitors and can therefore be categorized as type IV inhibitors (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D). Indeed, by occupying both the hydrophobic pocket and the hydrophobic channel, the two sites enabling the binding of LPC, the type IV inhibitors preclude the binding of LPA and bile acid derivatives to ATX and avoid any interactions of substrates with the zinc atoms. Recently another type IV inhibitor (<b>64</b>) has been designed by grafting a “tail” fragment extracted from a type I inhibitor (<b>57</b>) on a type III inhibitor (<b>62</b>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Such diversity of binding modes might impact the properties of ATX inhibitors: recently, on top of LPA formation, a role for LPA transport and delivery to its cognate receptors has been suggested for ATX.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Whereas all types of ATX inhibitors block the formation of LPA, type IV and possibly some type II inhibitors such as compound <b>61</b> could also prevent LPA transport and delivery to LPA receptors through ATX channel occupancy. Consequently, ATX inhibitors could display various modes of action and subsequently different therapeutic effects depending on their binding mode, with some inhibitors allowing while others blocking the binding of fatty acids (LPA and derivatives).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">The reported SAR of the series confirms the binding mode determined experimentally. In particular, whereas position 6 of the imidazo[1,2-<i>a</i>]pyridine scaffold tolerates a broad range of substituents without significant change of potency, slight structural modification of the substituent at position 3 has a strong impact on activity. Indeed, the former appears to occupy the hydrophobic channel with access to the bulk solvent in contrast to the latter, which is lodged in an enclosed hydrophobic pocket within the structure of the enzyme. An interesting modification that boosted the potency is worth mentioning: by adding a nitrile group on the substituent in position 3, either on the thiazole or on the terminal fluorophenyl moiety, the potency could be systematically increased by a factor 7 on average (matched-molecular pair analysis, data not shown). This effect could be well-explained by analyzing the role of water before and after the binding event using WaterMap.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This tool simulates the dynamic behavior of water molecules enabling, among others, the identification of hydration sites that are energetically unfavorable. When the calculation is run without compound <b>9</b> in the ATX crystal structure (apo map, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A), WaterMap locates a high energy water molecule (+7.5 kcal/mol) close to the positions occupied by the hydrogen atoms of the thiazole moiety and the phenyl group of the bound ligand. This indicates that the overall energy of the system should benefit from the binding of a ligand that displaces the otherwise constrained water molecule. Although compounds that lack the cyano group (such as compound <b>9</b>) do not seem to allow for a water molecule to occupy the same site (holo map, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B), a high energy “vacuum bubble” is created instead, penalizing the global free energy of the system. By adding a nitrile group either on the phenyl moiety (compound <b>35</b>) or on the thiazole moiety (compounds <b>37</b>, <b>40</b>), not only is the high energy water molecule released into the bulk solvent but also the pocket is fully occupied by the ligand.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. WaterMap results in the hydrophobic pocket. (A) Apo map showing the high energy water molecule highlighted by a dashed circle. Water molecules are colored based on their calculated free energy using a blue (negative, stable)–green (neutral)–red (positive, unstable) spectrum. Albeit absent during the calculation, the ligand is shown in sticks with white carbon atoms. (B) Holo map highlighting the high energy vacuum bubble (crosses circled in black) left by compounds (balls and sticks with orange carbon atoms). (C) Model of a compound with a nitrile group on the thiazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vivo Reduction of LPA Production by Compound <b>40</b></h3><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, compound <b>40</b> displays low to moderate clearance in rodents and low oral bioavailability. As conversion of LPC into LPA by ATX is the major source of circulating LPA in blood,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> in vivo inhibition of this process can be evaluated by quantification of LPA levels in plasma. Compound <b>40</b> and other compounds within the chemical series generally displayed little to no potency shift between the biochemical and plasma assays despite a plasma protein binding greater than 99%. The high potency of compound <b>40</b> in plasma could therefore compensate for its low oral bioavailability. In order to evaluate in vivo ATX inhibitory activity of compound <b>40</b>, reduction of plasma LPA levels upon compound <b>40</b> administration to rats was monitored. Rats received a single dose of compound <b>40</b> (5 mg/kg), and blood was sampled at 0.5, 1, and 3 h postdosing for the determination of plasma levels of both compound <b>40</b> and LPA 18:2. Percentage of LPA reduction was calculated by comparing LPA 18:2 levels in animals treated with compound <b>40</b> or with vehicle at each time point. As seen in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, compound <b>40</b> was able to cause a more than 70% reduction of LPA 18:2 levels over 3 h, in line with the high potency of the compound in the rat plasma assay (IC<sub>50</sub> = 22 nM), which is approximately covered by the observed plasma levels for compound <b>40</b>. The higher reduction of LPA 18:2 level at 3 h compared to vehicle-treated animals could be due to the presence of an active metabolite, which was not investigated at this stage. This result clearly demonstrated in vivo target engagement with compound <b>40</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo Pharmacokinetic Properties for Compound <b>40</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse iv Cl (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse iv <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse iv <i>V</i><sub><b>ss</b></sub> (L kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse po <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv Cl (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">3.1 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.1 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv <i>V</i><sub>ss</sub> (L kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">8.3 (11)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat po <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">15 (22)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data determined from 5 mg/kg po and 1 mg/kg iv doses (<i>n</i> = 3). Between brackets is the coefficient of variation in percentage, CV%. No CV% is available for mice data because of composite blood sampling on a group of six mice.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Reduction of Plasma LPA 18:2 Levels in Rats after a Single po Dose of Compound <b>40</b> at 5 mg/kg<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time point (h)</th><th class="colsep0 rowsep0" align="center" char="±">compound <b>40</b> plasma concentration (nM)</th><th class="colsep0 rowsep0" align="center" char="±">% reduction of plasma LPA 18:2 level</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char="±">67 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">74 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">58 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">97 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Rats were dosed orally at 5 mg/kg with compound <b>40</b> under fasted conditions. Values for plasma concentration and LPA reduction are mean values of three animals. Percentage of reduction of LPA 18:2 level was calculated by comparing levels of LPA 18:2 in animals treated with compound <b>40</b> or vehicle at each time point.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">The general synthesis of imidazo[1,2-<i>a</i>]pyridine-3-yl-4-aryl-thiazol-2-amines is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 3-Formylamino-imidazo[1,2-<i>a</i>]pyridine derivatives <b>42a</b>–<b>c</b> were prepared by the three-component Groebke–Blackburn–Bienaymé reaction<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> of 5-substituted 2-aminopyridine compounds <b>41a</b>–<b>c</b> with propanal and Walborsky’s reagent<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (1,1,3,3-tetramethylbutyl isocyanide) in the presence of MgCl<sub>2</sub>. Alkylation and acidic deformylation with methanolic HCl of compounds <b>42a</b>–<b>c</b> afforded the 3-alkylamino-imidazo[1,2-<i>a</i>]pyridine derivatives <b>43a</b>–<b>c</b>. Aminothiazole derivatives <b>44a</b>–<b>h</b> were accessed from <b>43a</b>–<b>c</b> via the formation of the thiourea intermediate using Fmoc-NCS and piperidine and subsequent reaction with corresponding bromo- or chloro-acetophenones.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of (2-Ethylimidazo[1,2-<i>a</i>]pyridine-3-yl)-4-aryl-<i>N</i>-alkylthiazol-2-amine Derivatives <b>44a</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) 1,1,3,3-tetramethylbutyl isocyanide, EtCHO, MgCl<sub>2</sub>, <i>n</i>-BuOH, 130 °C, (2) HCOOH 80 °C, 56–78% over 2 steps; (b) (1) MeI, NaH, DMF, rt, (2) HCl, MeOH, rt-reflux, 37–80% over 2 steps; (c) (1) Fmoc-NCS, TEA, DCM, rt then piperidine, rt, (2) bromo- or chloroacetophenone, EtOH, reflux, 27–74% over 2 steps.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>1</b>–<b>6</b> is represented in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Intermediate <b>44a</b> was saponified with NaOH or LiOH and subjected to an EDCI-mediated coupling with the corresponding amines to give compounds <b>1</b> and <b>2</b>. Compound <b>5</b> was obtained from <b>44a</b> by reduction of the ester to alcohol with LAH followed by a one-pot mesylation/displacement of the mesylate with 4-amino-piperidine-1-carboxylic acid ethyl ester. Buchwald coupling of <b>44b</b> and <b>44c</b> with morpholine and 2-piperazin-1-yl-ethanol afforded compounds <b>4</b> and <b>6</b>, respectively. Compound <b>44b</b> also reacted in a Suzuki coupling with 3-pyridylboronic acid to give <b>3</b>.</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) NaOH, MeOH/H<sub>2</sub>O or LiOH, THF/H<sub>2</sub>O, rt, (2) amine, EDC.HCl, TEA, HOBt, DMF, rt, 15–74% over 2 steps (for <b>1</b> and <b>2</b>); (b) (1) LiAlH<sub>4</sub>, THF, rt, (2) MsCl, TEA, DCM, rt, then amine, rt, 25% over 2 steps (for <b>5</b>); (c) pyridine-3-boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 90 °C, 53% (for <b>3</b>); (d) amine, <i>t</i>-BuONa, Pd<sub>2</sub>dba<sub>3</sub>, Xantphos or DavePhos, toluene or dioxane, 90–120 °C, 7–16% (for <b>4</b> and <b>6</b>).</p></p></figure><div class="NLM_p">The syntheses of substituted piperidine derivatives <b>7</b>–<b>10</b>, <b>17</b>–<b>20</b>, and <b>22</b> from intermediate <b>44c</b> are depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Suzuki coupling on <b>44c</b> with the <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester followed by Boc deprotection afforded intermediate <b>45</b>. Acylation of <b>45</b> with acetyl chloride and subsequent reduction of the tetrahydropyridine double bond allowed the synthesis of <b>7</b>. Intermediate <b>46</b> was synthesized with good yield from <b>44c</b> via a Suzuki coupling with <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester, reduction of the tetrahydropyridine double bond using H<sub>2</sub>/Pd(OH)<sub>2</sub> system, and final Boc deprotection using HCl in MeOH. Intermediate <b>46</b> could then react with a wide range of alkylating agents in the presence of strong or weak bases to afford ester compound <b>10</b> and amides <b>17</b>–<b>20</b> and <b>22</b>. Chloro acetamide alkylating agents were typically prepared by reaction of chloroacetyl chloride with the corresponding amine as described for the synthesis of intermediate <b>47</b>. Reaction of methane sulfonyl chloride with <b>46</b> afforded sulfonamide <b>8</b>. Compound <b>9</b> was obtained from <b>46</b> by sulfonylation with 3-chloropropane-1-sulfonyl chloride followed by chlorine displacement with dimethylamine in the presence of NaI.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>7</b>–<b>10</b>, <b>17</b>–<b>20</b>, and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C, quant.; (b) HCl, THF/H<sub>2</sub>O or dioxane/MeOH or MeOH, 0 °C–rt, 71–100%; (c) (1) acetyl chloride, TEA, DCM, rt, 91%, (2) H<sub>2</sub>, Pd/C, EtOH, 60 °C, 34% (for <b>7</b>); (d) H<sub>2</sub>, Pd(OH)<sub>2</sub>, DCM/EtOH, rt, 79%; (e) ethyl 2-bromoacetate, NaH, DMF, rt, 56% (for <b>10</b>); (f) MsCl, TEA, DCM, 0 °C–rt, 17% (for <b>8</b>); (g) R<sub>2</sub>X, K<sub>2</sub>CO<sub>3</sub>, MeCN, 70–100 °C, 40–100% (for <b>17, 18, 19, 22</b>); (h) 2-chloro-1-pyrrolidin-1-yl-ethanone, TEA, MeCN, 190 °C (microwave irradiation), 45% (for <b>20</b>); (i) (1) 3-chloropropane-1-sulfonyl chloride, TEA, DCM, rt, 99%, (2) dimethylamine, NaI, THF, 150 °C (microwave irradiation), 59% over 2 steps (for <b>9</b>); (j) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DCM, 0 °C–rt, 70%.</p></p></figure><div class="NLM_p">Variation of the piperazine substitution (compounds <b>11</b>–<b>16</b> and <b>21</b>) was achieved from intermediate <b>48</b>, which was obtained from <b>44b</b> by a Buchwald coupling with <i>N</i>-Boc-piperazine using DavePhos as ligand followed by Boc cleavage with HCl (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Intermediate <b>48</b> could be alkylated with ethyl chloroacetate to give compound <b>11</b>, and subsequent ester hydrolysis with LiOH afforded carboxylic acid <b>12</b>. Syntheses of compounds <b>13</b>, <b>14</b>, and <b>21</b> were performed by alkylation of intermediate <b>48</b> with corresponding alkyl chloride reagents. Whereas <b>13</b> and <b>14</b> could be obtained at room temperature in the presence of TEA, heating at 160 °C under microwave irradiation was required to obtain <b>21</b> in a moderate yield. Finally, intermediate <b>48</b> underwent reductive amination with the corresponding aldehydes to provide compounds <b>15</b> and <b>16</b>.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Piperazine Derivatives <b>11</b>–<b>16</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) <i>N</i>-Boc-piperazine, <i>t-</i>BuONa, Pd<sub>2</sub>dba<sub>3</sub>, DavePhos, toluene, 105 °C, (2) HCl, dioxane, rt, 79% over 2 steps; (b) R<sub>1</sub>Cl, TEA, DCM, rt, 22–24% (for <b>13</b>, <b>14</b>); (c) R<sub>1</sub>CHO, NaBH<sub>3</sub>CN, TEA, MeOH, rt, 29–49% (for <b>16</b>, <b>15</b>); (d) ethyl chloroacetate, TEA, MeCN, 0–45 °C, 71% (for <b>11</b>); (e) LiOH, THF/H<sub>2</sub>O, rt, 33% (for <b>12</b>); (f) <b>49</b>, TEA, MeCN, 160 °C (microwave irradiation), 26%; (g) morpholine, TEA, DCM, 0 °C, quant.</p></p></figure><div class="NLM_p">Exploration of thiazole substitution could be performed from intermediate <b>51</b>, obtained in four steps from intermediate <b>42b</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Compound <b>42b</b> was <i>N</i>-methylated and reacted in a Suzuki coupling with 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine to give compound <b>50</b>. The tetrahydropyridine double bond was then reduced with H<sub>2</sub>/PtO<sub>2</sub>, and the obtained intermediate was deformylated to afford <b>51</b>. The latter intermediate was converted into thiourea derivative using the FmocNCS/piperidine procedure and then cyclized with the corresponding bromoacetophenone reagents to yield compounds <b>23</b>–<b>25</b>, <b>30</b>, <b>32</b>–<b>34</b>, <b>36</b>, <b>52</b>, and <b>53</b>. Compound <b>52</b> was then transformed into compound <b>35</b> by a cyanation reaction using CuCN under microwave irradiation. Carboxylic acid <b>39</b> was obtained from ester <b>53</b> by saponification with LiOH.</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>23</b>–<b>25</b>, <b>30</b>, <b>32</b>–<b>36</b>, and <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) MeI, NaH, DMF, rt, (2) 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 85 °C, 80% over 2 steps; (b) (1) H<sub>2</sub>, PtO<sub>2</sub>, THF/MeOH, rt, (2) HCl, dioxane/MeOH, rt, 47% over 2 steps; (c) (1) FmocNCS, TEA, DCM, rt then piperidine, rt, (2) bromoacetophenone derivative, EtOH, reflux, 17–64% over 2 steps (for <b>24</b>, <b>25</b>, <b>30</b>, <b>32</b>–<b>34</b>, <b>36</b>, <b>52</b>, <b>53</b>); (d) 2-bromobenzo[<i>d</i>]thiazole, Pd(OAc)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, 36% (for <b>23</b>); (e) CuCN, pyridine, 150 °C (microwave irradiation), 41% (for <b>35</b>); (f) LiOH, THF/H<sub>2</sub>O, rt to 50 °C, 18% (for <b>39</b>).</p></p></figure><div class="NLM_p">Other variations of the phenyl part of the molecule were done by functionalization of <b>44d</b>–<b>h</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Iodo compound <b>44d</b> bearing 4-<i>t</i>Bu substituent on the phenyl moiety reacted with 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine and the obtained intermediate was hydrogenated over PtO<sub>2</sub> to give compound <b>28</b>. Compounds <b>44e</b>–<b>h</b> reacted in Suzuki coupling with <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester and cleavage of the Boc group with HCl afforded intermediates <b>54e</b>–<b>h</b> respectively. The latter intermediates were then submitted to a mesylation/reduction sequence to obtain compounds <b>26</b>, <b>27</b>, <b>29</b>, and <b>31</b>.</div><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>26</b>–<b>29</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C, 79–94%, (2) HCl, dioxane/MeOH, rt, 90–100%, (b) (1) MsCl, TEA, DCM, rt, 39–88%, (2) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 35–65% (for <b>26, 27, 29</b>); (c) (1) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 70%, (2) MsCl, TEA, DCM, rt, 40% (for <b>31</b>); (d) (1) 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 100 °C, 99%, (2) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 27% for 2 steps.</p></p></figure><div class="NLM_p">Finally, as depicted in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>, bromination of <b>8</b> and <b>22</b> on the thiazole ring using polymer-supported bromine reagent, followed by cyanation with CuCN afforded compounds <b>37</b> and <b>40</b>, respectively, in low to moderate yields. Compound <b>37</b> could react further with concentrated sulfuric acid to provide carboxamide <b>38</b>.</div><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>37</b>, <b>38</b>, and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) bromine on polymer support, DCM, rt, quant., (2) CuCN, pyridine, 125 °C (microwave irradiation), 9–41%; (b) conc. H<sub>2</sub>SO<sub>4</sub>, rt, 29%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel imidazo[1,2-<i>a</i>]pyridine series of ATX inhibitors was identified out of HTS efforts run with FS-3 as a substrate. Discrepancies in the SAR generated through assays using artificial FS-3 or natural LPC substrates prompted to change the primary assay in order to better correlate with physiological conditions. The cocrystal structure of compound <b>9</b> in ATX revealed a novel binding mode in which the compound occupies the hydrophobic pocket, which normally accommodates the LPA acyl side chain and the hydrophobic channel thought to play a role in LPA transport and delivery to receptors, but does not bind to any of the zinc atoms of the catalytic site. Considering the possible roles of ATX, such binding mode might offer an advantage over other ATX inhibitors. Indeed, in view of the short half-life of LPA in blood, the hypothesis has been formulated that activation of LPA receptors might require local delivery of newly synthesized LPA. The ATX hydrophobic channel might play a role as local LPA delivery route. Optimization of ATX inhibitory activity of the series led to compound <b>40</b> displaying high potency in biochemical and plasma assays. Compound <b>40</b> was also able to decrease LPA levels in rat plasma after oral administration, confirming in vivo target engagement. Further profiling indicated that compound <b>40</b> inhibited the hERG channel with an IC<sub>50</sub> of 2.9 μM and showed time-dependent CYP3A4 inhibition in a human liver microsome assay. Improvement of these ADMET properties as well as pharmacokinetics properties leading to the identification of clinical candidate <b>55</b> has recently been described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were of commercial grade and were used as received without further purification, unless otherwise stated. Commercially available anhydrous solvents were used for reactions conducted under inert atmosphere. Reagent grade solvents were used in all other cases, unless otherwise specified. Column chromatography was performed on silica gel 60 (35–70 μm). Thin layer chromatography was carried out using precoated silica gel F-254 plates (thickness 0.25 mm). Microwave heating was performed with a Biotage Initiator apparatus. Celpure P65 is a filtration aid, commercial product (CAS number 61790-53-2). <sup>1</sup>H NMR spectra were recorded on a Bruker DPX 400 NMR spectrometer (400 MHz) or a Bruker Advance 300 NMR spectrometer (300 MHz). Chemical shifts (δ) for <sup>1</sup>H NMR spectra are reported in parts per million (ppm) relative to tetramethylsilane (δ 0.00) or the appropriate residual solvent peak, i.e., CHCl<sub>3</sub> (δ 7.27), as internal reference. Multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), quintuplet (quin), multiplet (m), and broad (br). Waters Acquity UPLC with Waters Acquity PDA detector and SQD mass spectrometer was used to generate UV and MS chromatograms as well as MS spectra. Columns used: UPLC BEH C18 1.7 μm 2.1 × 5 mm VanGuard Precolumn with Acquity UPLC BEH C18 1.7 μm 2.1 × 30 mm column or Acquity UPLC BEH C18 1.7 μm 2.1 × 50 mm column. LC–MS analyses were conducted using the following two methods. Method 1: solvent A, H<sub>2</sub>O–0.05% NH<sub>4</sub>OH; solvent B, MeCN–0.05% NH<sub>4</sub>OH; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. Method 2: solvent A, H<sub>2</sub>O–0.1% HCO<sub>2</sub>H; solvent B, MeCN–0.1% HCO<sub>2</sub>H; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. All final compounds reported were analyzed using one of these analytical methods and were at least 95% pure. Autopurification system from Waters was used for LC–MS purification. LC–MS columns used: Waters XBridge Prep OBD C18 5 μm 30 × 100 mm (preparative column) and Waters XBridge BEH C18 5 μm 4.6 × 100 mm (analytical column). All the methods used MeCN/H<sub>2</sub>O gradients. MeCN and H<sub>2</sub>O contained either 0.1% formic acid or 0.1% diethylamine. API5500 QTRAP mass spectrometer from ABSciex was used for the detection and quantification of compound and LPA in plasma.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure A for the Synthesis of Amide Derivatives</h3><div class="NLM_p last">To a solution of ester <b>44a</b> (1 equiv) in a mixture of MeOH/water or a mixture of THF/water is added an excess of a 1 N aqueous NaOH solution or LiOH (5 equiv). The reaction mixture is stirred at room temperature overnight, then concentrated in vacuo, and the residue is dissolved in a mixture of DCM and water. The aqueous layer is extracted with DCM twice. The combined organic layers are washed with a saturated NaHCO<sub>3</sub> solution and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is purified by chromatography on silica gel to afford the intermediate carboxylic acid. To a solution of carboxylic acid (1.1 equiv) in DCM are added HOBT (1.2 equiv) and EDC·HCl (1.2 equiv). The reaction mixture is stirred at room temperature for 45 min, then a prepared solution of amine (1 equiv) and TEA (3 equiv) in DCM is added. The reaction mixture is stirred at room temperature until completion and then quenched with water and a 1 N aqueous HCl solution. The aqueous layer is extracted with DCM. The organic layer is washed with a saturated Na<sub>2</sub>CO<sub>3</sub> solution and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is purified by chromatography on silica gel to afford the expected compound.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure B for Suzuki–Miyaura Coupling</h3><div class="NLM_p last">Under inert atmosphere, to a solution of the 6-halo-imidazo[1,2-<i>a</i>]pyridin-3-ylamine derivative (1 equiv) in a mixture of dioxane and water (9:1 or 4:1) under argon are successively added sodium carbonate (3 to 4 equiv), boronic acid or 4,4,5,5-tetramethyl-1,3,2-dioxaborolane reagent (1.4 to 1.5 equiv), and Pd(PPh<sub>3</sub>)<sub>4</sub> or PdCl<sub>2</sub>dppf (0.05 equiv). The mixture is heated at 85 to 100 °C until completion of the reaction. After cooling to room temperature, the reaction mixture is diluted with water and EtOAc, and layers are separated. The aqueous phase is extracted three times with EtOAc, then the combined organic layers are washed with brine and concentrated in vacuo. The residue is purified by chromatography on silica gel to afford the expected compound.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure C for Buchwald Coupling</h3><div class="NLM_p last">Under inert atmosphere, to a solution of the 6-halo-imidazo[1,2-<i>a</i>]pyridin-3-ylamine derivative (1 equiv) in toluene or dioxane under argon are successively added the corresponding amine (1.1 to 2 equiv), sodium <i>tert</i>-butoxide or potassium <i>tert</i>-butoxide (1.2 to 2 equiv), and then XantPhos or DavePhos (0.015 to 0.075 equiv) and Pd<sub>2</sub>(dba)<sub>3</sub> (0.007 to 0.05 equiv). The reaction mixture is heated at 85–120 °C until completion. After cooling to room temperature, the crude product is filtered on Celpure P65, the residue is washed with EtOAc, and the filtrate is concentrated in vacuo. The crude product is purified by chromatography on silica gel to afford the expected compound.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure D for the Sulfonylation of Amine or Alcohol Derivatives</h3><div class="NLM_p last">To a solution of the appropriate amine or alcohol (1 equiv) in DCM at 0 °C are added TEA or pyridine (3 to 5 equiv) and the corresponding sulfonyl chloride (1.3 to 2.5 equiv). The reaction mixture is stirred at room temperature until completion. The reaction is quenched with water and diluted with DCM, and the aqueous layer is extracted several times with DCM. The combined organic layers are washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is purified by chromatography on silica gel to afford the expected compound.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure E for Nucleophilic Substitution</h3><div class="NLM_p last">To a solution of nucleophilic reagent (1 to 3 equiv) dissolved in DCM, MeCN, or THF are successively added potassium carbonate (2 to 3 equiv) or TEA (4 to 5 equiv), and after a few minutes, the appropriate alkyl halide derivative (1 to 3 equiv). The reaction mixture is stirred at room temperature or heated at 70 to 100 °C until completion. Water is added, and the reaction mixture is extracted with EtOAc or DCM. The combined organic layers are washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is purified by chromatography on silica gel, preparative HPLC, or by trituration in acetone to afford the expected compound.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure F for Reductive Amination</h3><div class="NLM_p last">To compound <b>48</b> (1 equiv) dissolved in MeOH are added TEA (3 equiv) and the aldehyde reagent (2 equiv). The reaction mixture is stirred overnight at room temperature, and then sodium cyanoborohydride (3 equiv) is added. The reaction mixture is stirred at room temperature until completion, then water is added, and the mixture is extracted with DCM. The combined organic layers are washed with a saturated aqueous solution of NaHCO<sub>3</sub>, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is purified by chromatography on silica gel or preparative HPLC to afford the expected compound.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure G for the Synthesis of <i>N</i>-(2-Ethylimidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-alkyl-4-aryl-thiazol-2-amine Derivatives</h3><div class="NLM_p last">To a suspension of imidazo[1,2-<i>a</i>]pyridin-3-ylamine derivative (1 equiv) in DCM is added TEA (4.5 equiv), the mixture is stirred for 30 min at room temperature, and then Fmoc-isothiocyanate (1.3 equiv) is added. The resulting solution is stirred at room temperature for 3 h. Piperidine (3.2 equiv) is then introduced, and the reaction mixture is stirred at room temperature overnight. The reaction is quenched with water and the layers are separated. The aqueous layer is extracted with DCM/MeOH. The combined organic layers are washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The expected thiourea intermediate is obtained either by chromatography on silica gel or crystallization. The thiourea intermediate (1 equiv) is added to a solution of the corresponding bromo or chloro acetophenone reagent (1.3 equiv) in EtOH. The reaction mixture is stirred at reflux for 3 h, then concentrated in vacuo. The crude product is triturated in hot EtOAc, stirred for 30 min, and allowed to cool to room temperature. The solid is filtered off and rinsed with EtOAc to afford the expected compound.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure H for Alkene Reduction with PtO<sub>2</sub></h3><div class="NLM_p last">The alkene compound is dissolved in a 2:1 MeOH/THF mixture, and PtO<sub>2</sub> is added (10%). The mixture is degassed, saturated with H<sub>2</sub>, and stirred at room temperature under 1 atm H<sub>2</sub> until completion of the reaction (usually overnight). The mixture is filtered, rinsed with MeOH, and concentrated in vacuo. The residue is used as such or purified by chromatography on silica gel to afford the hydrogenated compound.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure I for α-Bromination of Ketones with Polymer-Supported Bromine</h3><div class="NLM_p last">The starting ketone (1 equiv) is dissolved in DCM, and bromine on polymer support (loading 1.2–1.8 mmol/g, 1 to 3 equiv) is added. The resulting suspension is shaken overnight, then the resin is filtered off and washed with DCM. The filtrate is evaporated to afford the expected brominated derivatives.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure J for the Synthesis of (2-Ethylimidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-formylamine Derivatives</h3><div class="NLM_p last">To a solution of 2-aminopyridine derivative (1 equiv) in <i>n</i>-BuOH under argon are added successively propionaldehyde (2.5 equiv), MgCl<sub>2</sub> (0.04 equiv), and 1,1,3,3-tetramethylbutyl isocyanide (1.15 equiv). The reaction mixture is heated at 130 °C for 3.5 h and then concentrated in vacuo. The residue is partitioned between heptane and water, stirred for 15 min, and filtered. The solid is collected and dissolved with DCM, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give 2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-amine intermediate. The latter amine (1 equiv) is dissolved in formic acid and heated at 80 °C for 1 h. The reaction mixture is concentrated in vacuo. The residue is then triturated in Et<sub>2</sub>O. The formed precipitate is filtered, rinsed with Et<sub>2</sub>O, and dried to afford the corresponding (2-ethylimidazo[1,2-<i>a</i>]pyridine-3-yl)-<i>N</i>-formylamine derivative.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure K for the Synthesis of (2-Ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-alkyl-amine Derivatives</h3><div class="NLM_p last">To a solution of imidazo[1,2-<i>a</i>]pyridin-3-ylamine derivative (1 equiv) in DMF is added NaH (1.5 equiv) portionwise, then alkyl iodide (1.4 equiv). The reaction mixture is stirred for 1 h at room temperature, then quenched with water and diluted with EtOAc. The aqueous layer is extracted with EtOAc. The combined organic layers are washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue is triturated with DIPE. The solid is filtered, rinsed with DIPE, and dried to give intermediate imidazo[1,2-<i>a</i>]pyridin-3-yl formamide derivative. A 4 N HCl solution in dioxane or 1.25 N HCl solution in MeOH (9 equiv) is added to a solution of imidazo[1,2-<i>a</i>]pyridin-3-yl formamide derivative (1 equiv) in MeOH. The reaction mixture is stirred at a room temperature or refluxed for 3 h. Additional 4 N HCl solution (1.5 equiv) is added, and stirring is continued until completion of the reaction. The reaction mixture is then concentrated in vacuo to afford the expected (2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-alkyl-amine derivatives as hydrochloride salt.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-{[4-(4-Chloro-phenyl)-thiazol-2-yl]-methylamino}-2-ethyl-imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (2-hydroxy-ethyl)-amide (<b>1</b>)</h3><div class="NLM_p last">Compound <b>44a</b> was treated with 2-aminoethanol in DMF according to general procedure A to afford the desired product <b>1</b> (60 mg, 36% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.50 (dd, <i>J</i> = 1.7, 1.0 Hz, 1 H), 7.81–7.75 (m, 2 H), 7.60–7.56 (m, 1 H), 7.53–7.49 (m, 1 H), 7.40–7.33 (m, 2 H), 6.83 (t, <i>J</i> = 5.4 Hz, 1 H), 6.73–6.71 (m, 1 H), 3.81 (t, <i>J</i> = 5.0 Hz, 2 H), 3.65–3.54 (m, 5 H), 2.76 (q, <i>J</i> = 7.6 Hz, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 456.0/458.0 [M + H].</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-[(3-{[4-(4-Chloro-phenyl)-thiazol-2-yl]-methylamino}-2-ethyl-imidazo[1,2-<i>a</i>]pyridine-6-carbonyl)-amino]-piperidine-1-carboxylic acid ethyl ester (<b>2</b>)</h3><div class="NLM_p last">Compound <b>44a</b> was treated with 4-amino-piperidine-1-carboxylic acid ethyl ester in DMF according to general procedure A to afford the desired product <b>2</b> (50 mg, 15% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.53 (d, <i>J</i> = 1.5 Hz, 1 H), 7.83–7.73 (m, 2 H), 7.66–7.55 (m, 2 H), 7.40–7.35 (m, 2 H), 6.77–6.66 (m, 1 H), 6.39 (d, <i>J</i> = 7.8 Hz, 1 H), 4.21–4.11 (m, 3 H), 4.08 (q, <i>J</i> = 7.3 Hz, 2 H), 3.62 (s, 3 H), 2.93–2.84 (m, 2 H), 2.77 (q, <i>J</i> = 7.6 Hz, 2 H), 2.05–1.96 (m, 2 H), 1.45–1.38 (m, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H), 1.23 (t, <i>J</i> = 7.3 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 567.0/569.1 [M + H].</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2-Ethyl-6-pyridin-3-yl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>3</b>)</h3><div class="NLM_p last">Compound <b>44b</b> was treated with pyridine-3-boronic acid according to general procedure B, using Pd(PPh<sub>3</sub>)<sub>4</sub>, to afford the expected compound <b>3</b> as an off-white powder (37 mg, 53%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.83 (d, <i>J</i> = 1.9 Hz, 1 H), 8.54 (dd, <i>J</i> = 5.0, 1.5 Hz, 1 H), 8.37 (s, 1 H), 8.13 (dt, <i>J</i> = 8.0, 2.0 Hz, 1 H), 7.92–7.86 (m, 2 H), 7.67–7.78 (m, 2 H), 7.52 (dd, <i>J</i> = 7.9, 4.8 Hz, 1 H), 7.14–7.06 (m, 2 H), 6.97 (s, 1 H), 3.67 (s, 3 H), 2.77 (q, <i>J</i> = 7.6 Hz, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 430.0 [M + H].</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2-Ethyl-6-morpholin-4-yl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>4</b>)</h3><div class="NLM_p last">Compound <b>44b</b> was treated with morpholine according to general procedure C, using Xantphos and sodium <i>tert</i>-butoxide in toluene, to afford the expected compound <b>4</b> as a green oil (10 mg, 7%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.90 (dd, <i>J</i> = 8.9, 5.4 Hz, 2 H), 7.47 (d, <i>J</i> = 1.0 Hz, 1 H), 7.42–7.29 (m, 2 H), 7.12 (t, <i>J</i> = 8.9 Hz, 2 H), 6.95 (s, 1 H), 3.84–3.78 (m, 4 H), 3.61 (s, 3 H), 3.12–2.94 (m, 4 H), 2.70 (q, <i>J</i> = 7.6 Hz, 2 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 438.0 [M + H].</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-[(3-{[4-(4-Chloro-phenyl)-thiazol-2-yl]-methylamino}-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-ylmethyl)-amino]-piperidine-1-carboxylic Acid Ethyl Ester (<b>5</b>)</h3><div class="NLM_p last">To a solution of compound <b>44a</b> (800 mg, 1.87 mmol) in THF (5 mL) under N<sub>2</sub> was added a solution of lithium aluminum hydride in THF (1 M, 3.75 mL, 3.75 mmol). The reaction mixture was allowed to stir at room temperature for 1 h. The reaction mixture was poured in water and extracted with EtOAc. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to [3-[[4-(4-chlorophenyl)thiazol-2-yl]-methylamino]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-yl]methanol. The latter compound was treated according to general procedure D, followed by the addition of 4-amino-piperidine-1-carboxylic acid ethyl ester to afford the desired product <b>5</b> (37 mg, 25% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.84–7.79 (m, 2 H), 7.76 (s, 1 H), 7.57 (d, <i>J</i> = 9.3 Hz, 1 H), 7.40–7.35 (m, 2 H), 7.29–7.23 (m, 1 H), 6.73 (s, 1 H), 4.11 (q, <i>J</i> = 7.1 Hz, 2 H), 4.04 (br. s, 2 H), 3.81 (s, 2 H), 3.62 (s, 3 H), 2.86–2.70 (m, 4 H), 2.64 (tt, <i>J</i> = 10.2, 3.8 Hz, 1 H), 1.83 (br. s, 2 H), 1.62 (br. s, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H), 1.25 (t, <i>J</i> = 7.1 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 553.0/555.1 [M + H].</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperazin-1-yl]-ethanol (<b>6</b>)</h3><div class="NLM_p last">Compound <b>44c</b> was treated with 2-piperazin-1-yl-ethanol according to general procedure C, using Davephos and potassium <i>tert</i>-butoxide in toluene, to afford the expected compound <b>6</b> (161 mg, 16%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.88–7.83 (m, 2 H), 7.50 (d, <i>J</i> = 9.7 Hz, 1 H), 7.18 (s, 1 H), 7.17–7.06 (m, 3 H), 6.67 (s, 1 H), 3.67–3.62 (t, <i>J</i> = 5.3 Hz, 2 H), 3.61 (s, 3 H), 3.09–3.05 (m, 4 H), 2.72 (q, <i>J</i> = 7.6 Hz, 2 H), 2.70–2.66 (m, 4 H), 2.61 (t, <i>J</i> = 5.3 Hz, 2 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 481.3 [M + H].</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-propan-1-one (<b>7</b>)</h3><div class="NLM_p last">To compound <b>45</b> (100 mg, 0.21 mmol) dissolved in DCM (2 mL) and TEA (89 μL, 0.64 mmol) was added propionyl chloride (22 μL, 0.26 mmol). After 15 min of stirring at room temperature, the reaction mixture was quenched with water and extracted with DCM. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was purified by chromatography on silica gel to afford the expected amide as a yellow oil. The latter intermediate (55 mg, 0.11 mmol) was dissolved in EtOH (2 mL) and reacted in a continuous-flow hydrogenation reactor (55 °C, 50 bar hydrogen pressure) using a 10% Pd/C cartridge. The reaction mixture was then concentrated to dryness and purified by chromatography on silica gel to afford the expected compound <b>7</b> as a colorless oil (16 mg, 24% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.93–7.78 (m, 3 H), 7.52 (d, <i>J</i> = 9.3 Hz, 1 H), 7.38 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.17–7.05 (m, 2 H), 6.94 (s, 1 H), 4.66 (d, 1 H, <i>J</i> = 13.2 Hz), 4.05 (d, <i>J</i> = 12.6 Hz, 1 H), 3.62 (s, 3 H), 3.17 (t, <i>J</i> = 12.4 Hz, 1 H), 2.89 (tt, <i>J</i> = 12.2, 3.4 Hz, 1 H), 2.78–2.63 (m, 3 H), 2.42 (q, <i>J</i> = 7.6 Hz, 2 H), 1.95–1.82 (m, 2 H), 1.77–1.51 (m, 2 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H), 1.11 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 492.6 [M + H].</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>8</b>)</h3><div class="NLM_p last">Compound <b>46</b> was treated with methane sulfonyl chloride according to general procedure D to afford the expected compound <b>8</b> as a colorless oil (11 mg, 17%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.93–7.86 (m, 3 H), 7.53 (d, <i>J</i> = 9.3 Hz, 1 H), 7.41 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.15–7.09 (m, 2 H), 6.95 (s, 1 H), 3.86–3.79 (m, 2 H), 3.63 (s, 3 H), 2.87–2.61 (m, 8 H), 1.97–1.90 (m, 2 H), 1.87–1.74 (m, 2 H), 1.32 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 514.0 [M + H].</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> {6-[1-(3-Dimethylamino-propane-1-sulfonyl)-piperidin-4-yl]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl}-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>9</b>)</h3><div class="NLM_p last">Compound <b>46</b> was treated with 3-chloropropanesulfonyl chloride according to general procedure D to afford the expected sulfonamide as a yellow foam (50 mg, 99%). The latter intermediate was treated with a 2 M solution of dimethylamine in THF according to general procedure E to afford compound <b>9</b> as a colorless oil (30 mg, 59%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.93–7.85 (m, 3 H), 7.53 (d, <i>J</i> = 9.3 Hz, 1 H), 7.39 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.11 (t, <i>J</i> = 8.9 Hz, 2 H), 6.93 (s, 1 H), 3.84 (d, <i>J</i> = 12.0 Hz, 2 H), 3.62 (s, 3 H), 3.09–3.01 (m, 2 H), 2.94–2.88 (m, 2 H), 2.81–2.73 (m, 1 H), 2.72 (q, <i>J</i> = 7.6 Hz, 2 H), 2.47–2.41 (m, 2 H), 2.24 (s, 6 H), 1.98–1.87 (m, 4 H), 1.82–1.69 (m, 2 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 585.1 [M + H].</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> [4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-acetic Acid Ethyl Ester (<b>10</b>)</h3><div class="NLM_p last">To compound <b>46</b> (200 mg, 0.46 mmol) dissolved in DMF (3 mL) was added NaH (60% in oil, 28 mg, 0.69 mmol), and the mixture was stirred at room temperature for 1.3 h. Ethyl bromoacetate (61 μL, 0.55 mmol) was added, and the reaction mixture was stirred at room temperature for 1 h. The reaction was quenched with AcOH (3 drops), diluted with EtOAc and water, then basified with a saturated aqueous solution of Na<sub>2</sub>CO<sub>3</sub> and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>10</b> as a yellow oil (134 mg, 56%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.98–7.92 (m, 2 H), 7.90 (s, 1 H), 7.58 (dd, <i>J</i> = 9.3, 0.7 Hz, 1 H), 7.46 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.20–7.14 (m, 2 H), 6.99 (s, 1 H), 4.24 (q, <i>J</i> = 7.3 Hz, 2 H), 3.68 (s, 3 H), 3.31 (s, 2 H), 3.12–3.08 (m, 2 H), 2.78 (q, <i>J</i> = 7.6 Hz, 2 H), 2.73–2.63 (m, 1 H), 2.41–2.32 (m, 2 H), 1.92–1.85 (m, 4 H), 1.38 (t, <i>J</i> = 7.6 Hz, 3 H), 1.32 (t, <i>J</i> = 7.3 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 522.2 [M + H].</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> [4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperazin-1-yl]-acetic Acid Ethyl Ester (<b>11</b>)</h3><div class="NLM_p last">To compound <b>48</b> (127 mg, 0.29 mmol) dissolved in MeCN (2 mL) were slowly added ethyl chloroacetate (47 μL, 0.44 mmol) and TEA (160 μL, 1.17 mmol). The reaction mixture was allowed to stir at 45 °C for 18 h, then quenched with a saturated aqueous solution of NH<sub>4</sub>Cl and extracted with Et<sub>2</sub>O and EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>11</b> as a viscous oil (108 mg, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.89–7.84 (m, 2 H), 7.50 (d, <i>J</i> = 9.7 Hz, 1 H), 7.20–7.04 (m, 4 H), 6.67 (s, 1 H), 4.19 (q, <i>J</i> = 7.3 Hz, 2 H), 3.61 (s, 3 H), 3.27 (s, 2 H), 3.12–3.07 (m, 4 H), 2.79–2.68 (m, 6 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H), 1.28 (t, <i>J</i> = 7.3 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 523.0 [M + H].</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> [4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperazin-1-yl]-acetic Acid (<b>12</b>)</h3><div class="NLM_p last">Compound <b>11</b> (104 mg, 0.12 mmol) and LiOH (24 mg, 0.995 mmol) were stirred in a mixture of THF (1 mL) and water (1 mL) at room temperature for 48 h. A 1 N aqueous solution of HCl was added, and the reaction mixture was extracted twice with DCM. The aqueous phase was concentrated in vacuo, and the expected compound <b>12</b> (33 mg, 33%) was obtained after LC–MS purification of the residue. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.93–7.86 (m, 2 H), 7.45 (dd, <i>J</i> = 9.4, 1.2 Hz, 1 H), 7.41–7.35 (m, 2 H), 7.11 (t, <i>J</i> = 8.9 Hz, 2 H), 6.95 (s, 1 H), 3.61 (s, 3 H), 3.25–3.13 (m, 6 H), 2.95–2.90 (m, 4 H), 2.70 (q, <i>J</i> = 7.6 Hz, 2 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 495.0 [M + H].</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> [2-Ethyl-6-(4-oxazol-2-ylmethyl-piperazin-1-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>13</b>)</h3><div class="NLM_p last">Compound <b>48</b> was treated with 2-chloromethyl-oxazole according to general procedure E to afford compound <b>13</b> as a yellow oil (17 mg, 22%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.92–7.85 (m, 3 H), 7.44 (dd, <i>J</i> = 9.6, 0.8 Hz, 1 H), 7.38–7.29 (m, 2 H), 7.15 (d, <i>J</i> = 0.8 Hz, 1 H), 7.11 (t, <i>J</i> = 8.9 Hz, 2 H), 6.93 (s, 1 H), 3.77 (s, 2 H), 3.59 (s, 3 H), 3.16–3.02 (m, 4 H), 2.73–2.63 (m, 6 H), 1.30 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 518.1 [M + H].</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> [2-Ethyl-6-(4-[1,2,4]oxadiazol-3-ylmethyl-piperazin-1-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>14</b>)</h3><div class="NLM_p last">Compound <b>48</b> was treated with 3-chloromethyl-[1,2,4]oxadiazole according to general procedure E to afford compound <b>14</b> (13 mg, 24%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.70 (br. s, 1 H), 7.86–7.81 (m, 2 H), 7.67 (d, <i>J</i> = 9.8 Hz, 1 H), 7.23 (dd, <i>J</i> = 9.8, 2.0 Hz, 1 H), 7.17 (d, <i>J</i> = 1.7 Hz, 1 H), 7.10 (t, <i>J</i> = 8.7 Hz, 2 H), 6.69 (s, 1 H), 3.83 (s, 2 H), 3.59 (s, 3 H), 3.15–3.10 (m, 4 H), 2.79–2.71 (6 H, m), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 519.1 [M + H].</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> {2-Ethyl-6-[4-(1<i>H</i>-imidazol-2-ylmethyl)-piperazin-1-yl]-imidazo[1,2-<i>a</i>]pyridin-3-yl}-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>15</b>)</h3><div class="NLM_p last">Compound <b>48</b> was reacted with 1<i>H</i>-imidazole-2-carbaldehyde according to general procedure F to afford compound <b>15</b> (22 mg, 29%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.88–7.83 (m, 2 H), 7.49 (d, <i>J</i> = 9.7 Hz, 1 H), 7.16 (d, <i>J</i> = 2.0 Hz, 1 H), 7.14–7.06 (m, 3 H), 7.01 (s, 2 H), 6.66 (s, 1 H), 3.72 (s, 2 H), 3.60 (s, 3 H), 3.08–3.01 (m, 4 H), 2.72 (q, <i>J</i> = 7.6 Hz, 2 H), 2.68–2.64 (m, 4 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 517.3 [M + H].</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> {2-Ethyl-6-[4-(3<i>H</i>-imidazol-4-ylmethyl)-piperazin-1-yl]-imidazo[1,2-<i>a</i>]pyridin-3-yl}-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>16</b>)</h3><div class="NLM_p last">Compound <b>48</b> was reacted with 3<i>H</i>-imidazole-4-carbaldehyde according to general procedure F to afford compound <b>16</b> (37 mg, 49%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.92–7.80 (m, 2 H), 7.64 (s, 1 H), 7.47 (d, <i>J</i> = 9.7 Hz, 1 H), 7.17 (s, 1 H), 7.13–7.05 (m, 3 H), 7.01 (s, 1 H), 6.66 (s, 1 H), 3.66 (s, 2 H), 3.59 (s, 3 H), 3.12–3.08 (m, 4 H), 2.77–2.65 (m, 6 H), 1.32 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 517.3 [M + H].</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-acetamide (<b>17</b>)</h3><div class="NLM_p last">Compound <b>46</b> was treated with 2-bromoacetamide according to general procedure E to afford compound <b>17</b> as a colorless oil (120 mg, quantitative yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.90–7.84 (m, 2 H), 7.62 (s, 1 H), 7.56 (d, <i>J</i> = 9.2 Hz, 1 H), 7.17 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.14–7.07 (m, 2 H), 7.08 (br. s, 1 H), 6.68 (s, 1 H), 5.42 (br. s, 1 H), 3.63 (s, 3 H), 3.06–2.96 (m, 4 H), 2.76 (q, <i>J</i> = 7.6 Hz, 2 H), 2.57–2.47 (m, 1 H), 2.31–2.25 (m, 2 H), 1.92–1.84 (m, 2 H), 1.81–1.69 (m, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 493.3 [M + H].</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-Cyclopropyl-2-[4-(2-ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-acetamide (<b>18</b>)</h3><div class="NLM_p last">Compound <b>46</b> was treated with 2-chloro-<i>N</i>-cyclopropyl-acetamide according to general procedure E to afford compound <b>18</b> as an orange foam (114 mg, 58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.87 (dd, <i>J</i> = 8.9, 5.4 Hz, 2 H), 7.62 (s, 1 H), 7.56 (d, <i>J</i> = 9.3 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.11 (t, <i>J</i> = 8.7 Hz, 2 H), 6.69 (s, 1 H), 3.63 (s, 3 H), 2.99 (s, 2 H), 2.94–2.88 (m, 2 H), 2.76 (q, <i>J</i> = 7.6 Hz, 2 H), 2.74–2.69 (m, 1 H), 2.57–2.45 (m, 1 H), 2.30–2.20 (m, 2 H), 1.91–1.81 (m, 2 H), 1.77–1.66 (m, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H), 0.85–0.74 (m, 2 H), 0.57–0.48 (m, 2 H). LC–MS: <i>m</i>/<i>z</i> = 533.3 [M + H].</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-<i>N</i>,<i>N</i>-dimethyl-acetamide (<b>19</b>)</h3><div class="NLM_p last">Compound <b>46</b> was treated with 2-chloro-<i>N</i>,<i>N</i>-dimethyl-acetamide according to general procedure E to afford compound <b>19</b> (82 mg, 40%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.87 (dd, <i>J</i> = 8.9, 5.5 Hz, 2 H), 7.61 (s, 1 H), 7.54 (d, <i>J</i> = 9.2 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.2, 1.6 Hz, 1 H), 7.10 (t, <i>J</i> = 8.7 Hz, 2 H), 6.67 (s, 1 H), 3.61 (s, 3 H), 3.19 (s, 2 H), 3.07 (s, 3 H), 3.05–2.99 (m, 2 H), 2.95 (s, 3 H), 2.74 (q, <i>J</i> = 7.6 Hz, 2 H), 2.57–2.42 (m, 1 H), 2.29–2.11 (m, 2 H), 1.87–1.74 (m, 4 H), 1.34 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 521.4 [M + H].</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-1-pyrrolidin-1-yl-ethanone (<b>20</b>)</h3><div class="NLM_p last">To a solution of compound <b>46</b> (30 mg, 0.069 mmol) in MeCN (2 mL) in a sealed-cap tube were added TEA (38 μL, 0.276 mmol) and 2-chloro-1-pyrrolidin-1-yl-ethanone (20 mg, 0.138 mmol). The vial was sealed, and the reaction mixture was heated at 190 °C under microwave irradiation for 20 min. The reaction was quenched with water, and the mixture was extracted with DCM. The aqueous phase was then made acidic with a 1 N aqueous HCl solution (2 mL) and extracted twice with DCM. The aqueous phase was made basic with a saturated aqueous solution of NaHCO<sub>3</sub> and extracted twice with DCM. The combined organic layers were washed with a saturated aqueous solution of NaHCO<sub>3</sub> and with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>20</b> as a colorless oil (17 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.87 (dd, <i>J</i> = 8.7, 5.5 Hz, 2 H), 7.61 (br. s, 1 H), 7.54 (d, <i>J</i> = 9.3 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.10 (t, <i>J</i> = 8.7 Hz, 2 H), 6.67 (s, 1 H), 3.61 (s, 3 H), 3.49 (q, <i>J</i> = 6.6 Hz, 4 H), 3.15 (s, 2 H), 3.10–3.05 (m, 2 H), 2.75 (q, <i>J</i> = 7.6 Hz, 2 H), 2.55–2.44 (m, 1 H), 2.28–2.17 (m, 2 H), 1.94 (q, <i>J</i> = 6.6 Hz, 2 H), 1.89–1.77 (m, 6 H), 1.34 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 547.4 [M + H].</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-[4-[2-Ethyl-3-[[4-(4-fluorophenyl)thiazol-2-yl]-methylamino]imidazo[1,2-<i>a</i>]pyridin-6-yl]piperazin-1-yl]-1-morpholino-ethanone (<b>21</b>)</h3><div class="NLM_p last">Compound <b>48</b> (150 mg, 0.32 mmol) was dissolved in MeCN (5 mL) and TEA (132 μL, 0.95 mmol) before addition of <b>49</b> (104 mg, 0.63 mmol). The reaction was heated under microwave irradiation at 160 °C for 40 min, then diluted with water and DCM, and the aqueous phase was extracted two times with DCM. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>21</b> (46 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.91–7.87 (m, 2 H), 7.57 (d, <i>J</i> = 9.7 Hz, 1 H), 7.21–7.11 (m, 4 H), 6.72 (s, 1 H), 3.70–3.63 (m, 11 H), 3.27 (s, 2 H), 3.13–3.06 (m, 4 H), 2.80–2.70 (m, 6H), 1.37 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 564.3 [M + H].</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-[4-(2-Ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-piperidin-1-yl]-1-(3-hydroxy-azetidin-1-yl)-ethanone (<b>22</b>)</h3><div class="NLM_p last">Compound <b>46</b> was reacted with <b>47</b> according to general procedure E to afford compound <b>22</b> as an off-white powder (1.85 g, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.86 (dd, <i>J</i> = 8.8, 5.4 Hz, 2 H), 7.61 (br. s, 1 H), 7.55 (d, <i>J</i> = 9.3 Hz, 1 H), 7.20 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 7.10 (t, <i>J</i> = 8.7 Hz, 2 H), 6.67 (s, 1 H), 4.72–4.65 (m, 1 H), 4.46 (dd, <i>J</i> = 9.2, 7.2 Hz, 1 H), 4.28 (dd, <i>J</i> = 10.4, 7.0 Hz, 1 H), 4.14–4.09 (m, 1 H), 3.90 (dd, <i>J</i> = 10.8, 4.4 Hz, 1 H), 3.61 (s, 3 H), 3.10–2.99 (m, 4 H), 2.73 (q, <i>J</i> = 7.6 Hz, 2 H), 2.56–2.45 (m, 1 H), 2.28–2.17 (m, 2 H), 1.94–1.76 (m, 4 H), 1.34 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 549.3 [M + H].</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Benzothiazol-2-yl-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>23</b>)</h3><div class="NLM_p last">Compound <b>51</b> (150 mg, 0.446 mmol), cesium carbonate (436 mg, 1.337 mmol), XantPhos (39 mg, 0.067 mmol), 2-bromobenzo[<i>d</i>]thiazole (105 mg, 0.490 mmol), and dioxane (6 mL) were stirred for 10 min with argon bubbling. Pd(OAc)<sub>2</sub> (20 mg, 0.089 mmol) was added, and the reaction mixture was refluxed overnight, then cooled to room temperature and diluted with EtOAc. The reaction mixture was filtered; the filtrate was diluted with water and extracted with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>23</b> (75 mg, 36%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.71 (d, <i>J</i> = 8.0 Hz, 1 H), 7.63–7.55 (m, 2 H), 7.50 (d, <i>J</i> = 7.2 Hz, 1 H), 7.36 (t, <i>J</i> = 7.2 Hz, 1 H), 7.21–7.08 (m, 2 H), 3.96–3.90 (m, 2 H), 3.65 (s, 3 H), 2.81 (s, 3 H), 2.80–2.65 (m, 4 H), 2.59 (t, <i>J</i> = 15.6 Hz, 1 H), 1.96–1.93 (m, 2 H), 1.91–1.58 (m, 2 H), 1.34 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 470.3 [M + H].</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (4-Cyclohexyl-thiazol-2-yl)-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>24</b>)</h3><div id="sec112" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step 1: 2-Bromo-1-cyclohexyl-ethanone</h4><div class="NLM_p last">To LDA (2 M in THF/heptane/ethylbenzene, 7.70 mmol) in THF (20 mL) at −78 °C was added dropwise cyclohexyl-ethanone (810 mg, 6.42 mmol) in THF (10 mL), and the mixture was stirred at −78 °C for 1 h. Then chlorotrimethylsilane (1.62 mL, 12.84 mmol) was added dropwise, and the reaction was stirred at −78 °C for 3.5 h. The mixture was poured into saturated aqueous NaHCO<sub>3</sub> solution, the aqueous layer was then extracted with Et<sub>2</sub>O twice and combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was taken up in THF (25 mL); at 0 °C, NBS (1.14 g, 6.42 mmol) and NaHCO<sub>3</sub> (809 mg, 9.63 mmol) were added, and the mixture was stirred at 0 °C for 10 min and then at rt for 1 h. The mixture was quenched with saturated aqueous NaHCO<sub>3</sub> solution. The aqueous phase was then extracted with Et<sub>2</sub>O twice, and combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford the expected compound (1.3 g, quantitative yield), which was used without further purification in the next step.</div></div><div id="sec113" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step 2: (4-Cyclohexyl-thiazol-2-yl)-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>24</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-1-cyclohexyl-ethanone according to general procedure G to afford the desired product <b>24</b> (28 mg, 20% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.60 (s, 1 H), 7.55 (d, <i>J</i> = 9.7 Hz, 1 H), 7.12 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 6.07 (d, <i>J</i> = 0.8 Hz, 1 H), 3.97–3.94 (m, 2 H), 3.52 (s, 3 H), 2.83 (s, 3 H), 2.81–2.56 (m, 6 H), 2.12–2.09 (m, 2 H), 1.99–1.92 (m, 2 H), 1.90–1.68 (m, 6 H), 1.45–1.35 (m, 4 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 502.4 [M + H].</div></div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> [4-(6-Chloro-pyridin-3-yl)-thiazol-2-yl]-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>25</b>)</h3><div id="sec110" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 1: 2-Bromo-1-(6-chloro-3-pyridyl)ethanone</h4><div class="NLM_p last">1-(6-Chloro-3-pyridyl)ethanone (150 mg, 0.96 mmol) was dissolved in THF (5 mL) and pyridinium tribromide (320 mg, 1.02 mmol), and the mixture was stirred at rt overnight. The reaction was quenched with saturated aqueous NaHCO<sub>3</sub> solution and the aqueous phase was then extracted with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude mixture was purified by chromatography on silica gel to obtain 2-bromo-1-(6-chloro-3-pyridyl)ethanone.</div></div><div id="sec111" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Step 2: [4-(6-Chloro-pyridin-3-yl)-thiazol-2-yl]-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>25</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-1-(6-chloro-pyridin-3-yl)-ethanone according to general procedure G to afford the desired product <b>25</b> (39 mg, 60% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.84–8.77 (m, 1 H), 8.36 (d, <i>J</i> = 9.3 Hz, 1 H), 8.03 (dd, <i>J</i> = 8.3, 2.4 Hz, 1 H), 7.83 (s, 1 H), 7.75 (dd, <i>J</i> = 9.3, 1.5 Hz, 1 H), 7.36 (d, <i>J</i> = 8.3 Hz, 1 H), 7.05–6.90 (m, 1 H), 4.00–3.96 (m, 2 H), 3.67 (s, 3 H), 3.05–2.91 (m, 2 H), 2.86–2.75 (m, 6 H), 2.07–1.96 (m, 2 H), 1.91–1.80 (m, 2 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 531.1/533.3 [M + H].</div></div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N-</i>methyl-4-[4-(trifluoromethyl)phenyl]thiazol-2-amine (<b>26</b>)</h3><div class="NLM_p last">Compound <b>54e</b> (95 mg, 0.16 mmol) was submitted to general procedure D using TEA and methane sulfonyl chloride to afford <i>N</i>-[2-ethyl-6-(1-methylsulfonyl-3,6-dihydro-2<i>H</i>-pyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-4-[4-(trifluoromethyl)phenyl]thiazol-2-amine as a colorless yellow oil (43 mg, 39%). The latter compound (35 mg, 0.067 mmol) was reduced following general procedure H, and compound <b>26</b> was obtained as a colorless oil after purification by chromatography on silica gel (15 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.03 (d, <i>J</i> = 8.1 Hz, 2 H), 7.71–7.61 (m, 4 H), 7.19 (dd, <i>J</i> = 9.3, 1.8 Hz, 1 H), 6.91 (s, 1 H), 4.01–3.96 (m, 2 H), 3.67 (s, 3 H), 2.84 (s, 3 H), 2.72–2.75 (m, 4 H), 2.70–2.62 (m, 1 H), 2.02–1.98 (m, 2 H), 1.92–1.82 (2 H, m), 1.43 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 564.1 [M + H].</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-methoxy-phenyl)-thiazol-2-yl]-methyl-amine (<b>27</b>)</h3><div class="NLM_p last">Compound <b>54f</b> (75 mg, 0.16 mmol) was treated with TEA and methane sulfonyl chloride according to general procedure B to afford <i>N</i>-[2-ethyl-6-(1-methylsulfonyl-3,6-dihydro-2<i>H</i>-pyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-4-(4-methoxyphenyl)-<i>N</i>-methyl-thiazol-2-amine as a yellow oil (72 mg, 88%). The latter intermediate (66 mg, 0.120 mmol) underwent hydrogenation following general procedure H to give compound <b>27</b> as a colorless oil after purification on silica gel (22 mg, 35%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.85–7.79 (m, 2 H), 7.63 (s, 1 H), 7.60 (d, <i>J</i> = 9.1 Hz, 1 H), 7.16 (dd, <i>J</i> = 9.1, 1.8 Hz, 1 H), 6.98–6.91 (m, 2 H), 6.62 (s, 1 H), 3.96–3.92 (m, 2 H), 3.86 (s, 3 H), 3.63 (s, 3 H), 2.84–2.69 (m, 7 H), 2.68–2.58 (m, 1 H), 2.02–1.92 (m, 2 H), 1.92–1.74 (m, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 526.3 [M + H].</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> [4-(4-<i>tert</i>-Butyl-phenyl)-thiazol-2-yl]-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>28</b>)</h3><div class="NLM_p last">Compound <b>44d</b> (70 mg, 0.14 mmol) was submitted to general procedure B with 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine to afford 4-(4-<i>tert</i>-butylphenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-3,6-dihydro-2<i>H</i>-pyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine as a yellow oil (74 mg, 99%). The latter compound (66 mg, 0.120 mmol) was submitted to general procedure H to afford compound <b>28</b> as a colorless oil (18 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.83–7.78 (m, 2 H), 7.63 (br. s, 1 H), 7.58 (d, <i>J</i> = 9.3 Hz, 1 H,), 7.46–7.41 (m, 2 H), 7.15 (dd, <i>J</i> = 9.3, 1.7 Hz, 1 H), 6.70 (s, 1 H), 3.99–3.90 (m, 2 H), 3.62 (s, 3 H), 2.81 (s, 3 H), 2.79–2.69 (m, 4 H), 2.66–2.55 (m, 1 H), 1.98–1.95 (m, 2 H), 1.90–1.75 (m, 2 H), 1.35 (s, 9 H), 1.26 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 552.4 [M + H].</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-(3,4-Difluorophenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>29</b>)</h3><div class="NLM_p last">Compound <b>54g</b> (105 mg, 0.20 mmol) reacted with methane sulfonyl chloride in the presence of TEA according general procedure D to give after LC–MS purification 4-(3,4-difluorophenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-3,6-dihydro-2<i>H</i>-pyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine as a yellow oil (58 mg, 55%). The latter compound (43 mg, 0.08 mmol) was submitted to general procedure H to afford <b>29</b> as a colorless oil (15 mg, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.79–7.73 (m, 1 H), 7.63–7.53 (m, 3 H), 7.24–7.11 (m, 2 H), 6.70 (s, 1 H), 3.97–3.93 (m, 2 H), 3.62 (s, 3 H), 2.81 (s, 3 H), 2.79–2.69 (m, 4 H), 2.68–2.56 (m, 1 H), 2.03–1.95 (m, 2 H), 1.92–1.81 (m, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 532.2 [M + H].</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-(2,4-difluorophenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>30</b>)</h3><div class="NLM_p last">Compound <b>51</b> was treated with 2-chloro-1-(2,4-difluorophenyl)ethanone according to general procedure G to afford <b>30</b> (42 mg, 48% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.29–8.18 (m, 1 H), 7.66–7.56 (m, 2 H), 7.19 (dd, <i>J</i> = 9.3, 1.8 Hz, 1 H), 7.03–6.95 (m, 2 H), 6.95–6.89 (m, 1 H), 4.00–3.96 (m, 2 H), 3.62 (s, 3 H), 2.82 (s, 3 H), 2.82–2.71 (m, 4 H), 2.66–2.57 (m, 1 H), 2.01–1.94 (m, 2 H), 1.88–1.81 (m, 2 H), 1.35 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 532.2 [M + H].</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-(3,5-Difluorophenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>31</b>)</h3><div class="NLM_p last">Compound <b>54h</b> (80 mg, 0.15 mmol) was submitted to general procedure H to afford 4-(3,5-difluorophenyl)-<i>N</i>-[2-ethyl-6-(4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (56 mg, 70%) that was used without purification in the next step. This amine was submitted to general procedure D with TEA to give after LC–MS purification compound <b>31</b> as a yellow oil (22 mg, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.64–7.61 (m, 2 H), 7.47–7.41 (m, 2 H), 7.19 (dd, <i>J</i> = 9.3, 1.8 Hz, 1 H), 6.83 (s, 1 H), 6.81–6.76 (m, 1 H), 4.00–3.96 (m, 2 H), 3.65 (s, 3 H), 2.85 (s, 3 H), 2.82–2.75 (m, 4 H), 2.69–2.61 (m, 1 H), 2.02–1.96 (m, 2 H), 1.92–1.81 (m, 2 H), 1.38 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 532.2 [M + H].</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-4-(4-fluoro-2-methyl-phenyl)-<i>N</i>-methyl-thiazol-2-amine (<b>32</b>)</h3><div id="sec108" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Step 1: 2-Bromo-1-(4-fluoro-2-methyl-phenyl)ethanone</h4><div class="NLM_p last">1-(4-Fluoro-2-methyl-phenyl)ethanone was submitted to general procedure I to obtain a mixture of expected product/dibrominated intermediate that was used as such in the next step.</div></div><div id="sec109" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Step 2: <i>N</i>-[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-4-(4-fluoro-2-methyl-phenyl)-<i>N</i>-methyl-thiazol-2-amine (<b>32</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-1-(4-fluoro-2-methyl-phenyl)ethanone according to general procedure G to afford <b>32</b> (43 mg, 48% over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.71–7.62 (m, 2 H), 7.58 (d, <i>J</i> = 9.3 Hz, 1 H), 7.15 (dd, <i>J</i> = 9.3, 1.9 Hz, 1 H), 7.01–6.91 (m, 2 H), 6.48 (s, 1 H), 3.99–3.95 (m, 2 H), 3.58 (s, 3 H), 2.83 (s, 3 H), 2.81–2.72 (m, 4 H), 2.72–2.61 (m, 1 H), 2.53 (s, 3 H), 2.04–1.94 (m, 2 H), 1.93–1.81 (m, 2 H), 1.39 (d, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 528.0 [M + H].</div></div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-(5-fluoro-8<i>H</i>-indeno[1,2<i>-d</i>]thiazol-2-yl)-methyl-amine (<b>33</b>)</h3><div id="sec106" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step 1: 2-Bromo-6-fluoro-indan-1-one</h4><div class="NLM_p last">6-Fluoro-indan-1-one was submitted to general procedure I to obtain a mixture of expected product/dibrominated intermediate that was used as such in the next step.</div></div><div id="sec107" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Step 2: [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-(5-fluoro-8<i>H</i>-indeno[1,2-<i>d</i>]thiazol-2-yl)-methyl-amine (<b>33</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-2,3-dihydro-6-fluoro-1<i>H</i>-inden-1-one according to general procedure G to afford the desired product <b>33</b> (41 mg, 64% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.66–7.57 (m, 2 H), 7.39 (dd, <i>J</i> = 8.9, 2.4 Hz, 1 H), 7.35 (dd, <i>J</i> = 8.2, 4.8 Hz, 1 H), 7.21–7.12 (m, 1 H), 6.89 (ddd, <i>J</i> = 9.3, 8.3, 2.6 Hz, 1 H), 3.96–3.92 (m, 2 H), 3.64 (s, 3 H), 3.62–3.60 (m, 2 H), 2.81 (s, 3 H), 2.80–2.70 (m, 4 H), 2.65–2.58 (m, 1 H), 2.00–1.92 (m, 2 H), 1.89–1.76 (m, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 526.3 [M + H].</div></div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-(6-fluoro-8<i>H</i>-indeno[1,2-<i>d</i>]thiazol-2-yl)-methyl-amine (<b>34</b>)</h3><div id="sec104" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step 1: 2-Bromo-5-fluoro-indan-1-one</h4><div class="NLM_p last">(a) 5-Fluoro-indan-1-one was submitted to general procedure I to obtain 2,2-dibromo-5-fluoro-indan-1-one (301 mg, 98%). (b) 2,2-Dibromo-5-fluoro-indan-1-one (255 mg, 0.83 mmol) was dissolved in THF (2 mL) and diethylphosphite (107 μL, 0.83 mmol) was added dropwise followed by a cooled solution of TEA (115 μL, 0.83 mmol) in THF (1 mL). The reaction was warmed to rt and stirred for 6 h, and solvents were concentrated in vacuo. The residue was taken up in water and EtOAc, layers were separated, and the aqueous layer was extracted twice with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude mixture was purified by chromatography on silica gel to obtain the desired compound (126 mg, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.90 (dd, <i>J</i> = 8.4, 5.3 Hz, 1 H,), 7.21–7.15 (m, 2 H), 4.70 (dd, <i>J</i> = 7.5, 3.2 Hz, 1 H,), 3.87 (dd, <i>J</i> = 18.4, 7.5 Hz, 1 H), 3.45 (dd, <i>J</i> = 18.4, 3.2 Hz, 1 H).</div></div><div id="sec105" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Step 2: [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-(6-fluoro-8<i>H</i>-indeno[1,2-<i>d</i>]thiazol-2-yl)-methyl-amine (<b>34</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-2,3-dihydro-5-fluoro-1<i>H</i>-inden-1-one according to general procedure G to afford the desired product <b>34</b> (11 mg, 48% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.63–7.56 (m, 3 H), 7.17 (td, <i>J</i> = 8.5, 2.0 Hz, 2 H), 7.12–7.03 (m, 1 H), 3.97–3.92 (m, 2 H), 3.68–3.57 (m, 5 H), 2.81 (s, 3 H), 2.80–2.70 (m, 4 H), 2.63–2.58 (m, 1 H), 2.00–1.92 (m, 2 H), 1.90–1.75 (m, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 526.3 [M + H].</div></div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-[2-[[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]thiazol-4-yl]-5-fluoro-benzonitrile (<b>35</b>)</h3><div class="NLM_p last">Compound <b>52</b> (50 mg, 0.08 mmol) was dissolved in pyridine (2.5 mL), CuCN (38 mg, 0.42 mmol) was added, and the mixture was irradiated under microwaves at 150 °C for 2 h. The reaction was quenched by the addition of water, and the aqueous phase was extracted with EtOAc three times. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford the expected compound <b>35</b> (18 mg, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.10 (dd, <i>J</i> = 8.9, 5.5 Hz, 1 H), 7.65 (br s, 1 H), 7.62 (d, <i>J</i> = 9.4 Hz, 1 H), 7.48 (1 H, dd, <i>J</i> = 8.1, 2.7 Hz), 7.43–7.38 (m, 1 H), 7.21–7.19 (m, 2H), 4.02–3.96 (m, 2 H), 3.66 (s, 3 H), 2.86 (s, 3 H), 2.83–2.77 (m, 4 H), 2.71–2.63 (m, 1 H), 2.04–1.97 (m, 2 H), 1.93–1.81 (m, 2 H), 1.39 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 539.3 [M + H].</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-fluoro-phenyl)-5-methyl-thiazol-2-yl]-methyl-amine (<b>36</b>)</h3><div class="NLM_p last">Compound <b>51</b> was treated with 2-chloro-1-(4-fluoro-phenyl)-propan-1-one according to general procedure G to afford the desired product <b>36</b> (23 mg, 21% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.71–7.65 (m, 2 H), 7.64 (s, 1 H), 7.57 (d, <i>J</i> = 9.3 Hz, 1 H), 7.18–7.05 (m, 3 H), 3.99–3.95 (m, 2 H), 3.54 (s, 3 H), 2.83 (s, 3 H), 2.79–2.73 (m, 4 H), 2.69–2.56 (m, 1 H), 2.32 (s, 3 H), 2.04–1.93 (m, 2 H), 1.92–1.77 (m, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 528.2 [M + H].</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-[[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>37</b>)</h3><div class="NLM_p last">Compound <b>8</b> (50 mg, 0.1 mmol) was dissolved in DCM (1 mL), and bromine on polymer support (loading 1.2–1.8 mmol/g, 59 mg, 0.1 mmol) was added. The suspension was shaken for 4 h at 0 °C. The resin was filtered and washed with DCM and MeOH, and the filtrate was evaporated to afford a brominated intermediate. This latter compound (50 mg, 0.08 mmol) was dissolved in pyridine (2.5 mL), CuCN was added (38 mg, 0.42 mmol), and the resulting suspension was heated under microwave irradiation at 150 °C for 2 h. The reaction medium was quenched with water and extracted twice with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel to afford compound <b>37</b> (18 mg, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.22–8.17 (m, 2 H), 7.70–7.62 (m, 2 H), 7.26–7.19 (m, 3 H), 4.02–3.97 (m, 2 H), 3.68 (s, 3 H), 2.86 (s, 3 H), 2.85–2.76 (m, 4 H), 2.73–2.65 (m, 1 H), 2.07–1.98 (m, 2 H), 1.94–1.82 (m, 2 H), 1.38 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 539.4 [M + H].</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-[[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Compound <b>37</b> (50 mg, 0.09 mmol) was dissolved in concentrated H<sub>2</sub>SO<sub>4</sub> (208 μL) and stirred at rt overnight. The reaction medium was diluted with water and basified with saturated aqueous NaHCO<sub>3</sub>. The precipitate was filtered off, washed with water, dried, and collected to afford compound <b>38</b> (15 mg, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.10 (s, 1 H), 7.77–7.74 (m, 2 H), 7.54 (d, <i>J</i> = 8.8 Hz, 1 H), 7.36 (d, <i>J</i> = 8.8 Hz, 1 H), 7.28–7.23 (m, 2 H), 3.72–3.65 (m, 2 H), 3.50 (s, 3 H), 3.30 (s, 2 H), 2.89 (s, 3 H), 2.82–2.71 (m, 3 H), 2.63 (q, <i>J</i> = 7.6 Hz, 2 H), 1.92–1.83 (m, 2 H), 1.81–1.71 (m, 2 H), 1.25 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 557.3 [M + H].</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-[[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carboxylic Acid (<b>39</b>)</h3><div class="NLM_p last">Compound <b>53</b> (95 mg, 0.16 mmol) was suspended in THF/water (1/1 mL), LiOH was added (20 mg, 0.48 mmol), and the mixture was stirred at rt for 2 h. Then LiOH (47 mg, 1.12 mmol) was added again, the reaction was stirred at rt overnight and at 50 °C for 2 h. Water (1 mL) was added and the mixture stirred at 50 °C for 12 h. After cooling down to rt, aqueous HCl (0.1 N, 3 mL) was added and the precipitate filtered. The filtrate was extracted with EtOAc, and the organic layer was concentrated in vacuo. The resulting residue and the former obtained precipitate were dissolved in DCM and combined, and solvent was evaporated to afford <b>39</b> as a white solid (16 mg, 18%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.02 (s, 1 H), 7.90–7.87 (m, 2 H), 7.62 (d, <i>J</i> = 9.3 Hz, 1 H), 7.51 (dd, <i>J</i> = 9.3, 1.5 Hz, 1 H), 7.19–7.14 (m, 2 H), 3.95–3.87 (m, 2 H), 3.65 (s, 3 H), 2.96–2.78 (m, 8 H), 2.05–1.99 (m, 2 H), 1.96–1.86 (m, 2 H), 1.41 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 558.0 [M + H].</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-[[2-Ethyl-6-[1-[2-(3-hydroxyazetidin-1-yl)-2-oxo-ethyl]-4-piperidyl]imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (<b>40</b>)</h3><div class="NLM_p last">Compound <b>22</b> (1.5 g, 2.73 mmol) was dissolved in DCM (60 mL), and bromine on polymer support (loading 1.2–1.8 mmol/g, 1.91 g, 2.87 mmol) was added. The suspension was shaken overnight. The resin was filtered and washed with DCM and MeOH, and the filtrate was evaporated. The residue was taken up in water and extracted with DCM twice. Then the combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford the expected brominated intermediate (1.6 g, 93%). This intermediate (1.34 g, 2.13 mmol) was dissolved in pyridine (10 mL), CuCN was added (953 mg, 10.64 mmol), and the resulting suspension was heated under microwave irradiation for 3.5 h at 125 °C. The reaction mixture was quenched with water and saturated aqueous Na<sub>2</sub>CO<sub>3</sub> and extracted twice with EtOAc. The aqueous phase was filtered to remove insoluble copper salts and was then extracted again with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. LC–MS purification of the residue afforded compound <b>40</b> (110 mg, 9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.22–8.12 (m, 2 H), 7.63–7.54 (m, 2 H), 7.28–7.19 (m, 3 H), 4.74–4.66 (m, 1 H), 4.49–4.42 (m, 1 H), 4.29 (dd, <i>J</i> = 10.4, 7.0 Hz, 1 H), 4.16–4.09 (m, 1 H), 3.90 (dd, <i>J</i> = 10.4, 7.0 Hz, 1 H), 3.64 (s, 3 H), 3.08–2.99 (m, 4 H), 2.75 (q, <i>J</i> = 7.6 Hz, 2 H), 2.70–2.51 (m, 2 H), 2.23–2.14 (m, 2 H), 1.89–1.77 (m, 4 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 574.4 [M + H].</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-Ethyl-3-formylamino-imidazo[1,2-<i>a</i>]pyridine-6-carboxylic Acid Methyl Ester (<b>42a</b>)</h3><div class="NLM_p last">6-Amino-nicotinic acid methyl ester was treated according to general procedure J to afford the desired product <b>42a</b> as a white solid (3.4 g, 64% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, presence of rotamers) δ (ppm) 8.73 (s, 1 H), 8.61–8.55 (m, 1 H), 8.22–8.15 (m, 1 H), 7.86–7.74 (m, 1 H), 7.57 (d, <i>J</i> = 9.3 Hz, 1 H), 3.97–3.95 (m, 3 H), 2.89–2.70 (m, 2 H), 1.42–1.29 (m, 3 H). LC–MS: <i>m</i>/<i>z</i> = 248.2 [M + H].</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(6-Bromo-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-formamide (<b>42b</b>)</h3><div class="NLM_p last">2-Amino-5-bromopyridine was treated according to general procedure J to afford the desired product <b>42b</b> as a yellow powder (39 g, 56% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.45 (s, 1 H), 8.22–8.20 (m, 1 H), 7.43–7.40 (m, 2 H), 2.70 (q, <i>J</i> = 7.6 Hz, 2 H), 1.28 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 267.9/269.9 [M + H].</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> N-(2-Ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-formamide (<b>42c</b>)</h3><div class="NLM_p last">2-Amino-5-iodopyridine was treated according to general procedure J to afford the desired product <b>42c</b> (20 g, 78% over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, presence of rotamers) δ ppm 10.04 (s, 1 H), 8.41–8.38 (m, 1 H), 8.36 (s, 1 H), 8.29–8.24 (m, 1 H), 8.10 (s, 1 H), 7.55–7.22 (m, 2 H), 2.63 (q, <i>J</i> = 7.6 Hz, 2 H), 2.58 (q, <i>J</i> = 7.6 Hz, 2 H), 1.31 (t, <i>J</i> = 7.6 Hz, 3 H), 1.28 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 316.0 [M + H].</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-Ethyl-3-methylamino-imidazo[1,2-<i>a</i>]pyridine-6-carboxylic Acid Methyl Ester (<b>43a</b>)</h3><div class="NLM_p last">Compound <b>42a</b> was treated with MeI according to general procedure K to afford the desired product <b>43a</b> as a yellow solid (5.4 g, 80% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.22 (s, 1 H), 8.22–8.19 (m, 2 H), 4.04 (s, 3 H), 3.11–3.01 (m, 2 H), 2.98 (s, 3 H), 1.56–1.44 (m, 3 H). LC–MS: <i>m</i>/<i>z</i> = 234.2 [M + H].</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (6-Bromo-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-methyl-amine (<b>43b</b>)</h3><div class="NLM_p last">Compound <b>42b</b> was treated with MeI according to general procedure K to afford the desired product <b>43b</b> as a yellow solid (19 g, 67% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 15.30 (s, 1 H), 8.96 (d, <i>J</i> = 1.6 Hz, 1 H), 7.92 (dd, <i>J</i> = 9.4, 1.6 Hz, 1 H), 7.80 (d, <i>J</i> = 9.4 Hz, 1 H), 7.41–6.54 (br. s, 1 H), 2.85 (q, <i>J</i> = 7.6 Hz, 2 H), 2.77 (s, 3 H), 1.30 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 254.0/256.0 [M + H].</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (2-Ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-methyl-amine (<b>43c</b>)</h3><div class="NLM_p last">Compound <b>42c</b> was treated with MeI according to general procedure K to afford the desired product <b>43c</b> (19 g, 37% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 15.19 (s, 1 H), 8.92–8.90 (m, 1 H), 7.98 (dd, <i>J</i> = 9.3, 1.5 Hz, 1 H), 7.65 (dd, <i>J</i> = 9.3, 0.9 Hz, 1 H), 2.83 (q, <i>J</i> = 7.6 Hz, 2 H), 2.76 (s, 3 H), 1.29 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 302.0 [M + H].</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 3-{[4-(4-Chloro-phenyl)-thiazol-2-yl]-methylamino}-2-ethyl-imidazo[1,2-<i>a</i>]pyridine-6-carboxylic Acid Methyl Ester (<b>44a</b>)</h3><div class="NLM_p last">Compound <b>43a</b> was treated with 2-bromo-1-(4-chloro-phenyl)-ethanone according to general procedure G to afford the desired product <b>44a</b> (1.4 g, 27% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.71–8.69 (m, 1 H), 7.96 (dd, <i>J</i> = 9.3, 1.3 Hz, 1 H), 7.91 (d, <i>J</i> = 8.8 Hz, 2 H), 7.68 (d, <i>J</i> = 9.3 Hz, 1 H), 7.44 (d, <i>J</i> = 8.7 Hz, 2 H), 7.12 (s, 1 H), 3.96 (s, 3 H), 3.70 (s, 3 H), 2.82 (q, <i>J</i> = 7.6 Hz, 2H,), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 427.0/429.0 [M + H].</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (6-Bromo-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>44b</b>)</h3><div class="NLM_p last">Compound <b>43b</b> was treated with 2-bromo-1-(4-fluoro-phenyl)-ethanone according to general procedure G to afford the desired product <b>44b</b> (7.4 g, 60% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.75 (d, <i>J</i> = 0.8 Hz, 1 H), 7.99 (dd, <i>J</i> = 9.4, 1.7 Hz, 1 H), 7.84–7.75 (m, 3 H), 7.13 (s, 1 H), 7.12–7.03 (m, 2 H), 3.64 (s, 3 H), 2.87 (q, <i>J</i> = 7.6 Hz, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 431.0/433.0 [M + H].</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (2-Ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>44c</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-(4-fluoro-phenyl)-ethanone according to general procedure G to afford the desired product <b>44c</b> (1.9 g 62% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.23 (s, 1 H), 8.00 (br, d, <i>J</i> = 7.1 Hz, 1 H), 7.81–7.77 (m, 3 H), 7.12–7.07 (m, 2 H), 6.81 (s, 1 H), 3.64 (s, 3 H), 2.91 (q, <i>J</i> = 7.6 Hz, 2 H), 1.46 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 479.0 [M + H].</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> ([4-(4-<i>tert</i>-Butyl-phenyl)-thiazol-2-yl]-(2-ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-methyl-amine (<b>44d</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)-ethanone according to general procedure G to afford the desired product <b>44d</b> (140 mg, 61% yield over 2 steps). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.88–7.85 (m, 1 H), 7.61–7.55 (m, 2 H), 7.24–7.16 (m, 4 H), 6.49 (s, 1 H), 3.39 (s, 3 H), 2.53 (q, <i>J</i> = 7.6 Hz, 2 H), 1.36 (t, <i>J</i> = 7.6 Hz, 3 H), 1.15 (s, 9 H). LC–MS: <i>m</i>/<i>z</i> = 517.3 [M + H].</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>N</i>-(2-Ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methyl-4-[4-(trifluoromethyl)phenyl]-thiazol-2-amine (<b>44e</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-[4-(trifluoro-methyl)phenyl]ethanone according to general procedure G to afford the desired product <b>44e</b> (254 mg, 74% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.39–8.35 (m, 2 H), 8.06 (dd, <i>J</i> = 9.2, 1.5 Hz, 1 H), 7.92 (d, <i>J</i> = 8.2 Hz, 2 H), 7.69 (d, <i>J</i> = 8.2 Hz, 2 H), 7.09 (s, 1 H), 3.85 (s, 3 H), 3.69 (s, 3 H), 3.02 (q, <i>J</i> = 7.6 Hz, 2 H), 1.56 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 529.0 [M + H].</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> (2-Ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-methoxy-phenyl)-thiazol-2-yl]-methyl-amine (<b>44f</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-(4-methoxy-phenyl)-ethanone according to general procedure G to afford the desired product <b>44f</b> as a white powder (298 mg, 62% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.36–8.31 (m, 2 H), 8.04–7.97 (m, 1 H), 7.71 (d, <i>J</i> = 8.8 Hz, 2 H), 6.93 (d, <i>J</i> = 8.8 Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 3.64 (s, 3 H), 2.98 (q, <i>J</i> = 7.6 Hz, 2 H), 1.42 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 491.0 [M + H].</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-(3,4-difluorophenyl)-<i>N</i>-(2-ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methyl-thiazol-2-amine (<b>44g</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-(3,4-difluoro-phenyl)-ethanone according to general procedure G to afford the desired product <b>44g</b> (120 mg, 40% yield over 2 steps). LC–MS: <i>m</i>/<i>z</i> = 497.0 [M + H].</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 4-(3,5-difluorophenyl)-<i>N</i>-(2-ethyl-6-iodo-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methyl-thiazol-2-amine (<b>44h</b>)</h3><div class="NLM_p last">Compound <b>43c</b> was treated with 2-bromo-1-(3,5-difluoro-phenyl)-ethanone according to general procedure G to afford the desired product <b>44h</b> (280 mg, 74% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.40–8.35 (m, 2 H), 8.07 (dd, <i>J</i> = 9.3, 1.4 Hz, 1 H), 7.37–7.32 (m, 2 H), 7.01 (s, 1 H), 6.84–6.79 (m, 1 H), 3.69 (s, 3 H), 3.01 (q, <i>J</i> = 7.6 Hz, 2 H), 1.46 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 497.0 [M + H].</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> [2-Ethyl-6-(1,2,3,6-tetrahydro-pyridin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine Hydrochloride (<b>45</b>)</h3><div class="NLM_p last">Compound <b>44b</b> reacted with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester according to general procedure B, using Pd(PPh<sub>3</sub>)<sub>4</sub>, to afford the 4-(2-ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic acid <i>tert</i>-butyl ester as a yellow foam. The latter (1.19 g, 2.23 mmol) was dissolved in a 1.25 N solution of HCl in MeOH (15 mL). The reaction mixture was stirred at room temperature for 16 h and concentrated to dryness to afford the expected compound <b>45</b> used as such in the next step (1.10 g, quantitative yield over 2 steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.51 (s, 1 H), 8.25 (d, <i>J</i> = 9.3 Hz, 1 H), 8.00 (d, <i>J</i> = 9.3 Hz, 1 H), 7.77 (dd, <i>J</i> = 8.7, 5.5 Hz, 2 H), 7.21 (s, 1 H), 7.09 (t, <i>J</i> = 8.7 Hz, 2 H), 6.41 (br, s, 1 H.), 3.90 (br, s, 2 H), 3.71 (s, 3 H), 3.50–3.46 (m, 2 H), 2.94 (q, <i>J</i> = 7.6 Hz, 2 H), 2.88–2.80 (m, 2 H), 1.40 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 434.0 [M + H].</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> (2-Ethyl-6-piperidin-4-yl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>46</b>)</h3><div class="NLM_p last">Compound <b>44b</b> was treated with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester according to general procedure B, using Pd(PPh<sub>3</sub>)<sub>4</sub>, to afford 4-(2-ethyl-3-{[4-(4-fluoro-phenyl)-thiazol-2-yl]-methylamino}-imidazo[1,2-<i>a</i>]pyridin-6-yl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic acid <i>tert</i>-butyl ester as a yellow foam. To the latter compound (905 mg, 1.70 mmol) in solution with DCM (20 mL) and EtOH (30 mL) was added palladium(II) hydroxide (181 mg), and the reaction mixture was stirred at 40 °C under H<sub>2</sub> atmosphere for 4 h and at room temperature overnight. The reaction mixture was filtered on Celpure P65, and the filtrate was concentrated to dryness. The residue was purified by column chromatography to give <i>tert</i>-butyl 4-[2-ethyl-3-[[4-(4-fluorophenyl)thiazol-2-yl]-methylamino]imidazo[1,2-<i>a</i>]pyridin-6-yl]piperidine-1-carboxylate (685 mg, 76% yield over 2 steps). This latter intermediate (280 mg, 0.52 mmol) was dissolved in a 1.25 N solution of HCl in MeOH (15 mL). The reaction mixture was stirred at room temperature for 16 h and concentrated to dryness to afford the expected compound <b>46</b> as a pale yellow foam (305 mg, quantitative yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.47 (s, 1 H), 8.12–8.07 (m, 1 H), 7.99 (d, <i>J</i> = 9.4 Hz, 1 H), 7.84–7.70 (m, 2 H), 7.20 (s, 1 H), 7.10 (t, <i>J</i> = 8.8 Hz, 2 H), 3.71 (s, 3 H), 3.59–3.45 (m, 2 H), 3.25–3.10 (m, 3 H), 2.90 (q, <i>J</i> = 7.6 Hz, 2 H), 2.18–1.98 (m, 4 H), 1.40 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 436.0 [M + H].</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 2-Chloro-1-(3-hydroxy-azetidin-1-yl)-ethanone (<b>47</b>)</h3><div class="NLM_p last">To a suspension of potassium carbonate (13.9 g, 100 mmol) in water (33.5 mL) was added hydroxyazetidine hydrochloride (5 g, 45.6 mmol). The reaction mixture was stirred at room temperature until complete dissolution. The obtained solution was diluted with 33.5 mL of DCM, and chloroacetyl chloride was introduced dropwise at 0 °C over 30 min. After 2 h of stirring at room temperature, the reaction mixture was filtered, and the layers were separated. The aqueous phase was extracted with a mixture of EtOAc/<i>n</i>-BuOH 1:1 (6 × 16 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was suspended in acetone (48 mL) and stirred vigorously for 20 min and filtered, and the filtrate was concentrated in vacuo to afford compound <b>47</b> as a white solid (4.74g, 70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 4.80–4.67 (m, 1 H), 4.56–4.46 (m, 1 H), 4.38–4.29 (m, 1 H), 4.16 (ddd, <i>J</i> = 9.5, 4.2, 1.1 Hz, 1 H), 3.95 (dd, <i>J</i> = 11.1, 3.6 Hz, 1 H), 3.91 (s, 2 H), 2.56 (d, <i>J</i> = 5.9 Hz, 1 H).</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> (2-Ethyl-6-piperazin-1-yl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-[4-(4-fluoro-phenyl)-thiazol-2-yl]-methyl-amine (<b>48</b>)</h3><div class="NLM_p last">Compound <b>44a</b> was treated with <i>N</i>-Boc-piperazine according to general procedure C, using Davephos and sodium <i>tert</i>-butoxide in toluene, to afford the expected Boc-protected amine as a yellow oil. To the latter intermediate (201 mg, 0.36 mmol) in solution in MeOH (0.5 mL) was added at 0 °C a 4 N solution of HCl in dioxane (1.5 mL). The reaction mixture was allowed to warm up to room temperature and was stirred at this temperature for 1 h. It was then concentrated to dryness and taken in Et<sub>2</sub>O. The pink precipitate was filtered, rinsed with Et<sub>2</sub>O and DCM, and dried under suction to afford the expected product <b>48</b> (180 mg, 79% yield over 2 steps). <sup>1</sup>H NMR (MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.04 (dd, <i>J</i> = 9.8, 2.3 Hz, 1 H), 7.93–7.87 (m, 2 H), 7.83–7.77 (m, 2 H), 7.19 (s, 1 H), 7.11 (t, <i>J</i> = 8.8 Hz, 2 H), 3.69 (s, 3 H), 3.60–3.47 (m, 4 H), 3.46–3.36 (m, 4 H), 2.90 (q, <i>J</i> = 7.6 Hz, 2 H), 1.38 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 437.0 [M + H].</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-Chloro-1-morpholino-ethanone (<b>49</b>)</h3><div class="NLM_p last">To a solution of morpholine (663 μL, 7.53 mmol) in DCM (25 mL) and TEA (1.75 mL, 12.55 mmol) at 0 °C was added chloroacetyl chloride (500 μL, 6.28 mmol). The reaction was stirred at 0 °C for 1 h, and then water and 1 N aqueous HCl were added. The solvents were concentrated in vacuo to afford <b>49</b>, which was used as such in the next step.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> <i>N</i>-[2-Ethyl-6-(1-methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-formamide (<b>50</b>)</h3><div class="NLM_p last">NaH 60% (6.41 g, 160 mmol) was washed twice with heptane and suspended in DMF (300 mL). A solution of compound <b>42b</b> (35.8 g, 134 mmol) in DMF (300 mL) was added dropwise. The reaction mixture was stirred at room temperature for 1 h, and methyl iodide (11.64 mL, 187 mmol) was added dropwise. The reaction mixture was allowed to stir at room temperature for 16 h, then was quenched with water and concentrated in vacuo. The residue was diluted with water and DCM. The aqueous layer was extracted twice with DCM and twice with EtOAc. The DCM and EtOAc layers were separately washed with water and brine, then combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The oily residue was triturated with DIPE, and the formed precipitate was filtered. The solid was rinsed with DIPE, water, DIPE again, and dried. The mother liquor was separated, the DIPE phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and submitted to a second crystallization process. The precipitates of the two crystallization processes were combined to afford <i>N</i>-(6-bromo-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>-methyl-formamide. A fraction of the latter intermediate was treated with 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine according to general procedure B, using Pd(PPh<sub>3</sub>)<sub>4</sub>, to afford the expected compound <b>50</b> (6.6 g, 80% yield over 2 steps). <sup>1</sup>H NMR (MHz, CDCl<sub>3</sub>) δ ppm 8.21 (s, 1 H), 7.68–7.65 (m, 1 H), 7.55 (d, <i>J</i> = 9.4 Hz, 1 H), 7.35 (dd, <i>J</i> = 9.4, 1.8 Hz, 1 H), 6.21–6.02 (m, 1 H), 4.02–3.98 (m, 2 H), 3.57–3.53 (m, 2 H), 3.26 (s, 3 H), 2.88 (s, 3 H), 2.72 (d, <i>J</i> = 7.6 Hz, 1 H), 2.66–2.62 (m, 2 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 363.3 [M + H].</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> [2-Ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-methyl-amine (<b>51</b>)</h3><div class="NLM_p last">Compound <b>50</b> (3.0 g, 8.28 mmol) was dissolved in MeOH (30 mL) and THF (30 mL), and platinum dioxide (113 mg, 0.414 mmol) was added. The mixture was degassed, saturated with H<sub>2</sub>, and stirred at room temperature under 1 atm H<sub>2</sub> for 18 h. Additional platinum dioxide (113 mg, 0.414 mmol) was added, and the mixture was stirred at room temperature under 1 atm H<sub>2</sub> for 40 h. The mixture was filtered over Celite and rinsed with MeOH and DCM, and the filtrate was concentrated in vacuo. The residue was purified by chromatography on silica gel to afford <i>N</i>-[2-ethyl-6-(1-methanesulfonyl-piperidin-4-yl)-imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-formamide. To the latter compound (1.96 g, 5.38 mmol), dissolved in MeOH (100 mL), was added a 4 N solution of HCl in dioxane (5.38 mL, 21.51 mmol). The reaction mixture was stirred at room temperature for 1 h. Additional 4 N solution of HCl in dioxane was added (5 mL), and the reaction mixture was stirred at room temperature until reaction completion. The solvents were evaporated in vacuo. The residue was triturated with chloroform, filtered, and dried to afford compound <b>51</b> as hydrochloride salt (2.0 g, 65% yield over 2 steps). LC–MS: <i>m</i>/<i>z</i> = 337.2 [M + H].</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 4-(2-Bromo-4-fluoro-phenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>52</b>)</h3><div id="sec102" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Step 1: 2-Bromo-1-(2-bromo-4-fluoro-phenyl)ethanone</h4><div class="NLM_p last">1-(2-Bromo-4-fluoro-phenyl)ethanone was submitted to general procedure I to obtain a mixture of starting material and monobrominated and dibrominated intermediate that was used as such in the next step.</div></div><div id="sec103" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Step 2: 4-(2-Bromo-4-fluoro-phenyl)-<i>N</i>-[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>52</b></h4><div class="NLM_p last">Compound <b>51</b> was treated with 2-bromo-1-(4-fluoro-2-bromo-phenyl)ethanone according to general procedure G to afford <b>52</b> (63 mg, 30% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.97 (dd, <i>J</i> = 8.8, 6.3 Hz, 1 H), 7.66 (br. s, 1 H), 7.62 (d, <i>J</i> = 8.8 Hz, 1 H), 7.45 (dd, <i>J</i> = 8.4, 2.6 Hz, 1 H), 7.20–7.13 (m, 2 H), 7.06 (s, 1 H), 4.02–3.97 (m, 2 H), 3.62 (s, 3 H), 2.86 (s, 3 H), 2.84–2.77 (m, 4 H), 2.71–2.63 (m, 1 H), 2.06–1.97 (m, 2 H), 1.93–1.83 (m, 2 H), 1.40 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 592.1/594.1 [M + H].</div></div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Methyl-2-[[2-ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carboxylate (<b>53</b>)</h3><div id="sec100" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Step 1: Methyl 2-Bromo-3-(4-fluorophenyl)-3-oxo-propanoate</h4><div class="NLM_p last">Methyl 3-(4-fluorophenyl)-3-oxo-propanoate was submitted to general procedure I to obtain the expected brominated intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.10–8.05 (2 H, m), 7.25–7.19 (2 H, m), 5.66 (1 H, s), 3.88 (3 H, s).</div></div><div id="sec101" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Step 2: Methyl 2-[[2-Ethyl-6-(1-methylsulfonyl-4-piperidyl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)thiazole-5-carboxylate (<b>53</b>)</h4><div class="NLM_p last">Compound <b>51</b> was treated with methyl 2-bromo-3-(4-fluorophenyl)-3-oxo-propanoate according to general procedure G to afford <b>53</b> (95 mg, 74% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.93–7.88 (m, 2 H), 7.76–7.68 (m, 1 H), 7.65 (s, 1 H), 7.29–7.25 (m, 1 H), 7.19–7.13 (m, 2 H), 4.03–3.99 (m, 2 H), 3.72 (s, 3 H), 3.63 (s, 3 H), 2.87 (s, 3 H), 2.84–2.77 (m, 4 H), 2.74–2.66 (m, 1 H), 2.07–1.98 (2 H, m), 1.94–1.84 (m, 2 H), 1.43 (t, <i>J</i> = 7.6 Hz, 3 H). LC–MS: <i>m</i>/<i>z</i> = 572.1 [M + H].</div></div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> <i>N</i>-[2-Ethyl-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-4-[4-(trifluoromethyl)phenyl]thiazol-2-amine (<b>54e</b>)</h3><div class="NLM_p last">Compound <b>44e</b> (100 mg, 0.19 mmol) reacted with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester according to general procedure B to afford <i>tert</i>-butyl 4-[3-[[4-(4-(trifluoromethyl)phenyl)thiazol-2-yl]-methylamino]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-yl]-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylate (95 mg, 86%). The latter intermediate was dissolved in MeOH (2 mL), and 4 N HCl in dioxane was added (3 mL). The mixture was stirred at rt for 4 h, and solvents were concentrated to dryness to obtain compound <b>54e</b> as hydrochloride salt used as such in the next step.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> <i>N</i>-[2-Ethyl-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-4-(4-methoxyphenyl)-<i>N</i>-methyl-thiazol-2-amine (<b>54f</b>)</h3><div class="NLM_p last">Compound <b>44f</b> (85 mg, 0.17 mmol) reacted with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester according to general procedure B to afford <i>tert</i>-butyl 4-[3-[[4-(4-methoxy)thiazol-2-yl]-methylamino]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-yl]-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylate as a yellow oil (86 mg, 91%). The latter compound (85 mg, 0.156 mmol) was dissolved in MeOH (2 mL), and a 4 N solution of HCl in dioxane (2 mL) was added. The reaction mixture was stirred at rt for 16 h and concentrated to dryness to afford the expected deprotected amine <b>54f</b> as hydrochloride salt used as such in the next step (76 mg, 94%).</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 4-(3,4-Difluorophenyl)-<i>N</i>-[2-ethyl-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>54g</b>)</h3><div class="NLM_p last">Compound <b>44g</b> (120 mg, 0.24 mmol) reacted with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester according general procedure B to afford <i>tert</i>-butyl 4-[3-[[4-(3,4-difluorophenyl)thiazol-2-yl]-methylamino]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-yl]-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylate (125 mg, 94%). The latter compound was dissolved in MeOH (2 mL), and 4 N HCl in dioxane was added (3 mL). The mixture was stirred at rt for 4 h, and solvents were concentrated to dryness to obtain compound <b>54g</b> as hydrochloride salt used as such in the next step (105 mg, 90%). LC–MS: <i>m</i>/<i>z</i> = 452.2 [M + H].</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 4-(3,5-Difluorophenyl)-<i>N</i>-[2-ethyl-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-<i>a</i>]pyridin-3-yl]-<i>N</i>-methyl-thiazol-2-amine (<b>54h</b>)</h3><div class="NLM_p last">Compound <b>44h</b> (150 mg, 0.30 mmol) was submitted to the general procedure B with <i>N</i>-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester to afford <i>tert</i>-butyl 4-[3-[[4-(3,5-difluorophenyl)thiazol-2-yl]-methylamino]-2-ethyl-imidazo[1,2-<i>a</i>]pyridin-6-yl]-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylate (132 mg, 79%). The latter compound was dissolved in MeOH (5 mL), and 4 N HCl in dioxane was added (3 mL). The mixture was stirred overnight at rt, and solvents were concentrated to dryness to obtain compound <b>54h</b> as hydrochloride salt (130 mg, quantitative yield).</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Biochemical Assay with FS-3 Substrate</h3><div class="NLM_p last">Starting from 20 μM highest concentration, 10 μL of a dilution series of compound, 1/5 dilution, was added to the wells. Glycosylated human ATX protein (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) was used at a final concentration of 0.4 or 0.64 μg/mL. The enzyme was diluted in 50 mM Tris-HCl (2-amino-2-(hydroxymethyl)-1,3-propanediol hydrochloride) pH 8.0, 250 mM NaCl, 5 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, and 0.1% fatty acid free BSA in a total volume of 20 μL. The enzyme mixture was added to compounds, and the resulting mixture was incubated for 30 min at room temperature under shaking. The reaction was started by the addition of 20 μL of 0.75 μM FS-3 diluted in the same buffer as described above. Fluorescence was read on an Envision apparatus (PerkinElmer) after 30 min incubation at room temperature (excitation 485 nm, emission 520 nM).</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Biochemical Assay with LPC 16:0 Substrate</h3><div class="NLM_p last">Starting from 20 μM highest concentration, 5 μL of a dilution series of compound (1/5 dilution) was added to the wells. Glycosylated human ATX protein (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) was used at a final concentration of 1 or 3 μg/mL. The enzyme was diluted in 50 mM Tris-HCl pH 8.5, 500 mM NaCl, 5 mM KCl, 10 mM CaCl<sub>2</sub>, and 0.1% fatty acid free BSA in a total volume of 10 μL. The reaction was started by the addition of 10 μL of 150 μM LPC 16:0 diluted in the same buffer as described above, and the mixture was incubated at 37 °C for 30 min. The reaction was terminated and choline quantified by the addition of a 25 μL mixture containing 0.6 U/mL of choline oxidase, 0.6 U/mL of horseradish peroxidase (HRP), 1.8 mM TOOS (<i>N</i>-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline, sodium salt dihydrate), 1.2 mM 4-aminoantipyrine, and 20 mM EGTA (ethylene glycol-bis(2-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid, stop-developer solution) diluted in the buffer described above. Luminescence was read on an Envision apparatus (PerkinElmer) after 30 min of incubation at room temperature (excitation 555 nm, excitation light = 70%).</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Rat Plasma Assay</h3><div class="NLM_p last">Rat plasma was thawed on ice and added into a plate containing a dose range of compound to be tested. After 2 h of incubation at 37 °C, plasma proteins from a 10 μL aliquot were precipitated with an excess of methanol containing LPA 17:0 as internal standard. After centrifugation, the corresponding supernatant was diluted and injected on a C18 column. Analytes were eluted out of the column under isocratic conditions. No calibration curve was prepared for LPA 18:2, and all quantifications were performed based on peak area ratios (LPA 18:2/LPA 17:0). For each concentration of compound, LPA data were expressed as percentage of reduction (% reduction) using the formula: 100 – [((LPA ratio)/(LPA ratio in control sample)) × 100].</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Rat PK/PD with Compound <b>40</b></h3><div class="NLM_p last">Male Sprague–Dawley rats were maintained in a controlled environment and dosed at 5 mg/kg with compound <b>40</b> formulated in 10% (2-hydroxypropyl)-β-cyclodextrin with pH adjusted to 3 with citric acid (1 mg/mL of <b>40</b>). Blood samples were collected at the jugular vein via a catheter according to protocols approved by the GALAPAGOS Ethical Committee for animal welfare with the agreement of the Ministère de l’Enseignement Supérieur et de la Recherche and the Direction Départementale de la Protection des Populations, at the following time points: 0.5, 1, and 3 h after dosing and placed into tubes containing Li-heparin as anticoagulant. LPA 18:2 plasma peak areas and compound <b>40</b> plasma concentrations were assayed by LC–MS/MS. Plasma concentrations of compound <b>40</b> were measured against a calibration curve consisting of eight levels with a 3-log amplitude. Back-calculated values of the QCs (three levels prepared in duplicate) were used for accepting or rejecting the whole batch. The lower limit of quantification was 4 ng/mL for compound <b>40</b>, using a plasma volume of 25 μL. Plasma proteins were precipitated with an excess of methanol containing the internal standard, and the corresponding supernatant was injected on a C18 column. Analytes were eluted out of the HPLC system by increasing the percentage of the organic mobile phase. Pharmacokinetic parameters were calculated after averaging individual plasma concentrations, by noncompartmental analysis using WinNonlin software (Pharsight, version 5.2). Plasma levels were compiled, and the average of plasma levels of three rats at each sampling time was used. For the analysis of LPA 18:2 plasma peak areas, plasma proteins from a 10 μL aliquot were precipitated with an excess of methanol containing the internal standard, LPA 17:0. After centrifugation, the corresponding supernatant was diluted and injected on a C18 column. Analytes were eluted out of the column under isocratic conditions. No calibration curve was prepared for LPA 18:2, and all quantifications were performed based on peak area ratios (LPA 18:2/LPA 17:0). LPA data were finally expressed as percentage of reduction (% reduction) using the formula: 100 – [((LPA value at time point <i>t</i>)/(mean of LPA value at the same time point <i>t</i>, in vehicle group)) × 100].</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00647">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56127" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56127" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00647" class="ext-link">10.1021/acs.jmedchem.7b00647</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Preparation, characterization of ATX protein, and cocrystallization protocol (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_001.pdf">jm7b00647_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_002.csv">jm7b00647_si_002.csv (4.7 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structure of compound <b>9</b> with ATX: PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M7M">5M7M</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00647" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Desroy</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4879-3439" title="Orcid link">http://orcid.org/0000-0002-4879-3439</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0c62656f63606d7f2268697f7e63754c6b607c6b226f6361"><span class="__cf_email__" data-cfemail="ddb3b4beb2b1bcaef3b9b8aeafb2a49dbab1adbaf3beb2b0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bertrand Heckmann</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3f5d5a4d4b4d5e515b11575a5c54525e51517f58534f58115c5052"><span class="__cf_email__" data-cfemail="791b1c0b0d0b18171d57111c1a1214181717391e15091e571a1614">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnès Joncour</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Housseman</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Bock</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natacha Bienvenu</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laëtitia Cherel</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Virginie Labeguere</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Peixoto</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis Annoot</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luce Lepissier</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Heiermann</span> - <span class="hlFld-Affiliation affiliation">Mercachem, Kerkenbos 1013, 6546 Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Willem Jan Hengeveld</span> - <span class="hlFld-Affiliation affiliation">Mercachem, Kerkenbos 1013, 6546 Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor Pilzak</span> - <span class="hlFld-Affiliation affiliation">Mercachem, Kerkenbos 1013, 6546 Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alain Monjardet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuelle Wakselman</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronique Roncoroni</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Le Tallec</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">René Galien</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christelle David</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nele Vandervoort</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Christophe</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katja Conrath</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mia Jans</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Wohlkonig</span> - <span class="hlFld-Affiliation affiliation">VIB
Structural Biology Research Center, Vrije
Universiteit Brussel, 1050 Brussel, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sameh Soror</span> - <span class="hlFld-Affiliation affiliation">VIB
Structural Biology Research Center, Vrije
Universiteit Brussel, 1050 Brussel, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Steyaert</span> - <span class="hlFld-Affiliation affiliation">VIB
Structural Biology Research Center, Vrije
Universiteit Brussel, 1050 Brussel, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Touitou</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Fleury</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lionel Vercheval</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Mollat</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Triballeau</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen van der Aar</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reginald Brys</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A. Joncour, N. Desroy, C. Housseman, X. Bock, N. Bienvenu, L. Cherel, V. Labeguere, C. Peixoto, D. Annoot, A. Monjardet, E. Wakselman, V. Roncoroni, S. Le Tallec, R. Galien, C. David, R. Touitou, L. Vercheval, P. Mollat, N. Triballeau, and B. Heckmann are employees of Galapagos SASU; N. Vandervoort, T. Christophe, K. Conrath, M. Jans, E. van der Aar, and R. Brys are employees of Galapagos NV, Belgium.<br /></br></div></li></ul></div><div class="ack" id="ACK-d375e6174-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Frank Ronald van Holst, Maria Cornelia Johanna Beens, Jasper Springer, and Peter Molenveld at Mercachem for their contribution to the synthesis of molecules on the ATX project. Part of this work was supported by a grant from the Flanders Innovation & Entrepreneurship (IWT080556) to Galapagos NV and VIB.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i120" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i120"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i121" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i121"> ABBREVIATIONS</h2><tr><td class="NLM_term">ATX</td><td class="NLM_def"><p class="first last">autotaxin</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Davephos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)biphenyl</p></td></tr><tr><td class="NLM_term">dba</td><td class="NLM_def"><p class="first last">dibenzylideneacetone</p></td></tr><tr><td class="NLM_term">DIPE</td><td class="NLM_def"><p class="first last">diisopropyl ether</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">JohnPhos</td><td class="NLM_def"><p class="first last">(2-biphenyl)di-<i>tert</i>-butylphosphine</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatidyl choline</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last"><i>per os</i></p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">xantphos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span> </span><span class="NLM_article-title">Autotaxin-an LPA producing enzyme with diverse functions</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin-an+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0ljLKAOpi1U7ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin-an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span><span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0li2Y33XnHXDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bandoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)01827-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2FS0014-5793%2800%2901827-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2000&pages=159-165&author=K.+Bandohauthor=J.+Aokiauthor=A.+Tairaauthor=M.+Tsujimotoauthor=H.+Araiauthor=K.+Inoue&title=Lysophosphatidic+acid+%28LPA%29+receptors+of+the+EDG+family+are+differentially+activated+by+LPA+species&doi=10.1016%2FS0014-5793%2800%2901827-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2901827-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252901827-5%26sid%3Dliteratum%253Aachs%26aulast%3DBandoh%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%2520of%2520the%2520EDG%2520family%2520are%2520differentially%2520activated%2520by%2520LPA%2520species%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D478%26spage%3D159%26epage%3D165%26doi%3D10.1016%2FS0014-5793%2800%2901827-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+Signaling+properties+and+disease+relevance&doi=10.1016%2Fj.prostaglandins.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0li2Y33XnHXDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520Signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D130%26epage%3D138%26doi%3D10.1016%2Fj.prostaglandins.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0li2Y33XnHXDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span> <span class="citation_source-journal">Biomol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0lgWX0vFffDySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="note"><p class="first last">Reviews:</p></div><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbayianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrioti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutevelis-Minakakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokotos, G.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1517/13543776.2013.796364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1517%2F13543776.2013.796364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=23641951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1123-1132&author=E.+Barbayianniauthor=V.+Magriotiauthor=P.+Moutevelis-Minakakisauthor=G.+Kokotos&title=Autotaxin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2013.796364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a patent review</span></div><div class="casAuthors">Barbayianni, Efrosini; Magrioti, Victoria; Moutevelis-Minakakis, Panagiota; Kokotos, George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Autotaxin (ATX) is a lysophospholipase D enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA) and choline.  LPA is a bioactive lipid mediator that activates several transduction pathways, and is involved in migration, proliferation and survival of various cells.  Thus, ATX is an attractive medicinal target.  Areas covered: The aim of this review is to summarize ATX inhibitors, reported in patents from 2006 up to now, describing their discovery and biol. evaluation.  Expert opinion: ATX has been implicated in various pathol. conditions, such as cancer, chronic inflammation, neuropathic pain, fibrotic diseases, etc.  Although there is an intensive effort on the discovery of potent and selective ATX inhibitors in order to identify novel medicinal agents, up to now, no ATX inhibitor has reached clin. trials.  However, the use of ATX inhibitors seems an attractive strategy for the development of novel medicinal agents, for example anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrIPRU28R5LVg90H21EOLACvtfcHk0lgWX0vFffDySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF&md5=517c590694d78587305229ce500e228a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.796364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.796364%26sid%3Dliteratum%253Aachs%26aulast%3DBarbayianni%26aufirst%3DE.%26aulast%3DMagrioti%26aufirst%3DV.%26aulast%3DMoutevelis-Minakakis%26aufirst%3DP.%26aulast%3DKokotos%26aufirst%3DG.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1123%26epage%3D1132%26doi%3D10.1517%2F13543776.2013.796364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0lgWX0vFffDySQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ferguson, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigman, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span><span class="refDoi"> DOI: 10.1021/ol060414i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol060414i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2023-2026&author=C.+G.+Fergusonauthor=C.+S.+Bigmanauthor=R.+D.+Richardsonauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=G.+D.+Prestwich&title=Fluorogenic+phospholipid+substrate+to+detect+lysophospholipase+D%2Fautotaxin+activity&doi=10.1021%2Fol060414i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fol060414i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060414i%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DC.%2BG.%26aulast%3DBigman%26aufirst%3DC.%2BS.%26aulast%3DRichardson%26aufirst%3DR.%2BD.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DFluorogenic%2520phospholipid%2520substrate%2520to%2520detect%2520lysophospholipase%2520D%252Fautotaxin%2520activity%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2023%26epage%3D2026%26doi%3D10.1021%2Fol060414i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Desroy, N.; Heckmann, B.; Brys, R. C. X.; Joncour, A.; Peixoto, C.; Bock, X.</span><span> </span><span class="NLM_article-title">Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders</span>. PCT Int. Appl. WO2014/139882A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Desroy&author=B.+Heckmann&author=R.+C.+X.+Brys&author=A.+Joncour&author=C.+Peixoto&author=X.+Bock&title=Compounds+and+Pharmaceutical+Compositions+Thereof+for+the+Treatment+of+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DCompounds%2520and%2520Pharmaceutical%2520Compositions%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Desroy, N.; Joncour, A.; Bock, X.; Housseman, C.; Peixoto, C.; Bienvenu, N.; Labeguere, V.; Cherel, L.; Annoot, D.; Christophe, T.; Conrath, K.; Triballeau, N.; Mollat, P.; Wohlkonig, A.; Blanque, R.; Cottereaux, C.; Hrvacic, B.; Borgonovi, M.; Monjardet, A.; Van der Aar, E.; Brys, R.; Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of GLPG1690: A first-in-class autotaxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis</span>. Abstracts of Papers, 251st ACS National Meeting & Exposition, San Diego, CA, United States, March 13–17,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-254</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Desroy&author=A.+Joncour&author=X.+Bock&author=C.+Housseman&author=C.+Peixoto&author=N.+Bienvenu&author=V.+Labeguere&author=L.+Cherel&author=D.+Annoot&author=T.+Christophe&author=K.+Conrath&author=N.+Triballeau&author=P.+Mollat&author=A.+Wohlkonig&author=R.+Blanque&author=C.+Cottereaux&author=B.+Hrvacic&author=M.+Borgonovi&author=A.+Monjardet&author=E.+Van+der+Aar&author=R.+Brys&author=B.+Heckmann&title=Discovery+of+GLPG1690%3A+A+first-in-class+autotaxin+inhibitor+in+clinical+development+for+the+treatment+of+idiopathic+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520GLPG1690%253A%2520A%2520first-in-class%2520autotaxin%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520251st%2520ACS%2520National%2520Meeting%2520%2526%2520Exposition%252C%2520San%2520Diego%252C%2520CA%252C%2520United%2520States%252C%2520March%252013%25E2%2580%259317%26date%3D2016%26spage%3DMEDI-254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Desroy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housseman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joncour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienvenu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labeguere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassot, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picolet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annoot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triballeau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjardet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakselman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncoroni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Tallec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanque, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottereaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandervoort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrvacic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oste, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Aar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brys, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxo-ethyl]piperazin-1-yl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-methyl-amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3580</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=A.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.-M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxo-ethyl%5Dpiperazin-1-yl%5D-8-methyl-imidazo%5B1%2C2-a%5Dpyridin-3-yl%5D-methyl-amino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DA.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.-M.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxo-ethyl%255Dpiperazin-1-yl%255D-8-methyl-imidazo%255B1%252C2-a%255Dpyridin-3-yl%255D-methyl-amino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">A similar observation where the activity of ATX inhibitors is influenced by the assay substrate was also observed by other groups:</p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potjewyd, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado-Polo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel García, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semaan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=722-748&author=L.+M.+Millerauthor=W.+J.+Keuneauthor=D.+Castagnaauthor=L.+C.+Youngauthor=E.+L.+Duffyauthor=F.+Potjewydauthor=F.+Salgado-Poloauthor=P.+Engel+Garc%C3%ADaauthor=D.+Semaanauthor=J.+M.+Pritchardauthor=A.+Perrakisauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Structure-activity+relationships+of+small+molecule+autotaxin+inhibitors+with+a+discrete+binding+mode&doi=10.1021%2Facs.jmedchem.6b01597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode</span></div><div class="casAuthors">Miller, Lisa M.; Keune, Willem-Jan; Castagna, Diana; Young, Louise C.; Duffy, Emma L.; Potjewyd, Frances; Salgado-Polo, Fernando; Engel Garcia, Paloma; Semaan, Dima; Pritchard, John M.; Perrakis, Anastassis; Macdonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">722-748</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline.  The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a no. of diseases including fibrotic diseases, cancer, and inflammation, amongst others.  Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small no. of inhibitors have been described that deviate from this common scaffold.  Herein, the authors report the structure-activity relationships (SAR) of a previously reported small mol. ATX inhibitor.  The authors show through enzyme kinetics studies that analogs of this chemotype are noncompetitive inhibitors, and using a crystal structure with ATX the authors confirm the discrete binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiaOETATMDbVg90H21EOLACvtfcHk0liOHJglETMk7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsrrO&md5=514df4aae4a6d362812d4461494c5c4a</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01597%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BM.%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DDuffy%26aufirst%3DE.%2BL.%26aulast%3DPotjewyd%26aufirst%3DF.%26aulast%3DSalgado-Polo%26aufirst%3DF.%26aulast%3DEngel%2BGarc%25C3%25ADa%26aufirst%3DP.%26aulast%3DSemaan%26aufirst%3DD.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520of%2520small%2520molecule%2520autotaxin%2520inhibitors%2520with%2520a%2520discrete%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D722%26epage%3D748%26doi%3D10.1021%2Facs.jmedchem.6b01597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also references <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a> and <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+also+references+18+and+20."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a discussion on substrate-specific kinetics of ATX, see:</p></div><span class="NLM_contrib-group">Saunders, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De La Cruz, E. M.</span><span> </span><span class="NLM_article-title">Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">30130</span><span class="NLM_x">–</span> <span class="NLM_lpage">30141</span><span class="refDoi"> DOI: 10.1074/jbc.M111.246884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1074%2Fjbc.M111.246884" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=30130-30141&author=L.+P.+Saundersauthor=W.+Caoauthor=W.+C.+Changauthor=R.+A.+Albrightauthor=D.+T.+Braddockauthor=E.+M.+De+La+Cruz&title=Kinetic+analysis+of+autotaxin+reveals+substrate-specific+catalytic+pathways+and+a+mechanism+for+lysophosphatidic+acid+distribution&doi=10.1074%2Fjbc.M111.246884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.246884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.246884%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DL.%2BP.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DW.%2BC.%26aulast%3DAlbright%26aufirst%3DR.%2BA.%26aulast%3DBraddock%26aufirst%3DD.%2BT.%26aulast%3DDe%2BLa%2BCruz%26aufirst%3DE.%2BM.%26atitle%3DKinetic%2520analysis%2520of%2520autotaxin%2520reveals%2520substrate-specific%2520catalytic%2520pathways%2520and%2520a%2520mechanism%2520for%2520lysophosphatidic%2520acid%2520distribution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D30130%26epage%3D30141%26doi%3D10.1074%2Fjbc.M111.246884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiosaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.</span><span> </span><span class="NLM_article-title">Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span><span class="refDoi"> DOI: 10.1016/S0040-4039(98)00653-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2FS0040-4039%2898%2900653-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlWrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3635-3638&author=C.+Blackburnauthor=B.+Guanauthor=P.+Flemingauthor=K.+Shiosakiauthor=S.+Tsai&title=Parallel+synthesis+of+3-aminoimidazo%5B1%2C2-a%5Dpyridines+and+pyrazines+by+a+new+three-component+condensation&doi=10.1016%2FS0040-4039%2898%2900653-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation</span></div><div class="casAuthors">Blackburn, Christopher; Guan, Bing; Fleming, Paul; Shiosaki, Kazumi; Tsai, Shirling</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3635-3638</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A three-component condensation reaction between 2-aminopyridine, an aldehyde and an isonitrile catalyzed by scandium triflate affords derivs. of 3-aminoimidazo[1,2-a]pyridine; aminopyrazine reacts similarly.  A library of heterocycles, prepd. in high yield by parallel synthesis and purifn. on an ion-exchange resin, was subjected to further reaction at the amino group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrndWK-azaOEbVg90H21EOLACvtfcHk0lhzQ7LRz9xsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlWrtLs%253D&md5=dfdddf23bcb1051d2ff6375f9f2616f5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900653-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900653-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DShiosaki%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DS.%26atitle%3DParallel%2520synthesis%2520of%25203-aminoimidazo%255B1%252C2-a%255Dpyridines%2520and%2520pyrazines%2520by%2520a%2520new%2520three-component%2520condensation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3635%26epage%3D3638%26doi%3D10.1016%2FS0040-4039%2898%2900653-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Groebke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlin, F.</span><span> </span><span class="NLM_article-title">Synthesis of imidazo[1,2-a] annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1055/s-1998-1721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1055%2Fs-1998-1721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1998&publication_year=1998&pages=661-663&author=K.+Groebkeauthor=L.+Weberauthor=F.+Mehlin&title=Synthesis+of+imidazo%5B1%2C2-a%5D+annulated+pyridines%2C+pyrazines+and+pyrimidines+by+a+novel+three-component+condensation&doi=10.1055%2Fs-1998-1721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-1721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-1721%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DL.%26aulast%3DMehlin%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520imidazo%255B1%252C2-a%255D%2520annulated%2520pyridines%252C%2520pyrazines%2520and%2520pyrimidines%2520by%2520a%2520novel%2520three-component%2520condensation%26jtitle%3DSynlett%26date%3D1998%26volume%3D1998%26spage%3D661%26epage%3D663%26doi%3D10.1055%2Fs-1998-1721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bienaymé, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzid, K.</span><span> </span><span class="NLM_article-title">A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2234</span><span class="NLM_x">–</span> <span class="NLM_lpage">2237</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1Crt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2234-2237&author=H.+Bienaym%C3%A9author=K.+Bouzid&title=A+new+heterocyclic+multicomponent+reaction+for+the+combinatorial+synthesis+of+fused+3-aminoimidazoles&doi=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles</span></div><div class="casAuthors">Bienayme, Hugues; Bouzid, Kamel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2234-2237</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Reaction of heteroarom. amidines, aldehydes, and isonitriles in the presence of a catalytic amt. of protic acids gave fused 3-aminoimidazoles.  E.g., HClO4-catalyzed reaction of 2-aminopyrimidine, PhCHO, and Me3CNC gave 82% imidazopyrimidine I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1LwDCSCFs_rVg90H21EOLACvtfcHk0lhzQ7LRz9xsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1Crt7Y%253D&md5=6c11f8f883d1699e9a3def969b5f3e04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819980904%252937%253A16%253C2234%253A%253AAID-ANIE2234%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DBienaym%25C3%25A9%26aufirst%3DH.%26aulast%3DBouzid%26aufirst%3DK.%26atitle%3DA%2520new%2520heterocyclic%2520multicomponent%2520reaction%2520for%2520the%2520combinatorial%2520synthesis%2520of%2520fused%25203-aminoimidazoles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2234%26epage%3D2237%26doi%3D10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, G. E.</span><span> </span><span class="NLM_article-title">Lithium Aldimines. A new synthetic intermediate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">7778</span><span class="NLM_x">–</span> <span class="NLM_lpage">7778</span><span class="refDoi"> DOI: 10.1021/ja50001a064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja50001a064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1969&pages=7778-7778&author=H.+M.+Walborskyauthor=G.+E.+Niznik&title=Lithium+Aldimines.+A+new+synthetic+intermediate&doi=10.1021%2Fja50001a064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fja50001a064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja50001a064%26sid%3Dliteratum%253Aachs%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26aulast%3DNiznik%26aufirst%3DG.%2BE.%26atitle%3DLithium%2520Aldimines.%2520A%2520new%2520synthetic%2520intermediate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1969%26volume%3D91%26spage%3D7778%26epage%3D7778%26doi%3D10.1021%2Fja50001a064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, G. E.</span><span> </span><span class="NLM_article-title">Synthesis of isonitriles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1021/jo00967a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00967a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1972&pages=187-191&author=H.+M.+Walborskyauthor=G.+E.+Niznik&title=Synthesis+of+isonitriles&doi=10.1021%2Fjo00967a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjo00967a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00967a005%26sid%3Dliteratum%253Aachs%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26aulast%3DNiznik%26aufirst%3DG.%2BE.%26atitle%3DSynthesis%2520of%2520isonitriles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1972%26volume%3D37%26spage%3D187%26epage%3D191%26doi%3D10.1021%2Fjo00967a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulkerson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeijl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Structural basis of substrate discrimination and integrin binding by autotaxin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nsmb.1980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21240271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=198-204&author=J.+Hausmannauthor=S.+Kamtekarauthor=E.+Christodoulouauthor=J.+E.+Dayauthor=T.+Wuauthor=Z.+Fulkersonauthor=H.+M.+Albersauthor=L.+A.+van+Meeterenauthor=A.+J.+Houbenauthor=L.+van+Zeijlauthor=S.+Jansenauthor=M.+Andriesauthor=T.+Hallauthor=L.+E.+Peggauthor=T.+E.+Bensonauthor=M.+Kasiemauthor=K.+Harlosauthor=C.+W.+Kooiauthor=S.+S.+Smythauthor=H.+Ovaaauthor=M.+Bollenauthor=A.+J.+Morrisauthor=W.+H.+Moolenaarauthor=A.+Perrakis&title=Structural+basis+of+substrate+discrimination+and+integrin+binding+by+autotaxin&doi=10.1038%2Fnsmb.1980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate discrimination and integrin binding by autotaxin</span></div><div class="casAuthors">Hausmann, Jens; Kamtekar, Satwik; Christodoulou, Evangelos; Day, Jacqueline E.; Wu, Tao; Fulkerson, Zachary; Albers, Harald M. H. G.; van Meeteren, Laurens A.; Houben, Anna J. S.; van Zeijl, Leonie; Jansen, Silvia; Andries, Maria; Hall, Troii; Pegg, Lyle E.; Benson, Timothy E.; Kasiem, Mobien; Harlos, Karl; Vander Kooi, Craig W.; Smyth, Susan S.; Ovaa, Huib; Bollen, Mathieu; Morris, Andrew J.; Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types.  ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation.  However, the mol. basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear.  Here, we present the crystal structure of ATX, alone and in complex with a small-mol. inhibitor.  We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates.  We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B-like domains, using an atypical mechanism.  Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-mol. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fkNlSRtsTbVg90H21EOLACvtfcHk0ljTcKOVwZYV0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D&md5=bc2ab613ace29ee008825cec69d65fce</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1980%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DFulkerson%26aufirst%3DZ.%26aulast%3DAlbers%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DHouben%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BZeijl%26aufirst%3DL.%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPegg%26aufirst%3DL.%2BE.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DKooi%26aufirst%3DC.%2BW.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520discrimination%2520and%2520integrin%2520binding%2520by%2520autotaxin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D198%26epage%3D204%26doi%3D10.1038%2Fnsmb.1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin an insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-213&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+an+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0ljTcKOVwZYV0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520an%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D213%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">A 3D view of autotaxin</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/j.tips.2011.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.tips.2011.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=22277299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=138-145&author=H.+Nishimasuauthor=R.+Ishitaniauthor=J.+Aokiauthor=O.+Nureki&title=A+3D+view+of+autotaxin&doi=10.1016%2Fj.tips.2011.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A 3D view of autotaxin</span></div><div class="casAuthors">Nishimasu, Hiroshi; Ishitani, Ryuichiro; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (Enpp2), is a secreted lysophospholipase D (lysoPLD) that generates the lipid mediator lysophosphatidic acid (LPA), which in turn activates G protein-coupled receptors to evoke various cellular responses.  ATX is essential for normal development, is implicated in various physiol. processes, and is also assocd. with pathol. conditions such as cancer, pain and fibrosis.  Despite its importance, the mol. mechanism of ATX-catalyzed LPA prodn. has long been elusive.  Recent structural analyses have provided new insights into the mechanisms of localized and regulated LPA prodn. by ATX.  This structural information will pave the way for further biochem., biol. and medical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxar9dg5wsrVg90H21EOLACvtfcHk0liuWif61Ie2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOgsLc%253D&md5=9bbf198e24aa8cb4f9e7da2525e1e60c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DA%25203D%2520view%2520of%2520autotaxin%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D138%26epage%3D145%26doi%3D10.1016%2Fj.tips.2011.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Insights into autotaxin: how to produce and present a lipid mediator</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1038/nrm3188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnrm3188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21915140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=674-679&author=W.+H.+Moolenaarauthor=A.+Perrakis&title=Insights+into+autotaxin%3A+how+to+produce+and+present+a+lipid+mediator&doi=10.1038%2Fnrm3188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into autotaxin: how to produce and present a lipid mediator</span></div><div class="casAuthors">Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA).  LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types.  ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumor progression.  However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved.  Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3UHhjy0QP7Vg90H21EOLACvtfcHk0liuWif61Ie2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ&md5=96ab96a9e7f6cd70f5dcc1be0363d298</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrm3188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3188%26sid%3Dliteratum%253Aachs%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DInsights%2520into%2520autotaxin%253A%2520how%2520to%2520produce%2520and%2520present%2520a%2520lipid%2520mediator%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D674%26epage%3D679%26doi%3D10.1038%2Fnrm3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tabchy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1038/nsmb0211-117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb0211-117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21289650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVynsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=117-118&author=A.+Tabchyauthor=G.+Tigyiauthor=G.+B.+Mills&title=Location%2C+location%2C+location%3A+a+crystal-clear+view+of+autotaxin+saturating+LPA+receptors&doi=10.1038%2Fnsmb0211-117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Location, location, location: A crystal-clear view of autotaxin saturating LPA receptors</span></div><div class="casAuthors">Tabchy, Adel; Tigyi, Gabor; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-118</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The interaction of autotaxin with its substrates leads to the prodn. of lysophosphatidic acids (LPA), bioactive lipids with an emerging prominent role in inflammation and cancer.  Two papers in this issue tell the previously unknown story of autotaxin, from substrate discrimination to highly efficient local delivery of LPA to target receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kKn6fh2B1LVg90H21EOLACvtfcHk0liuWif61Ie2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVynsr0%253D&md5=2518bc0067b00bd07d1872dbb83619fb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnsmb0211-117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb0211-117%26sid%3Dliteratum%253Aachs%26aulast%3DTabchy%26aufirst%3DA.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DLocation%252C%2520location%252C%2520location%253A%2520a%2520crystal-clear%2520view%2520of%2520autotaxin%2520saturating%2520LPA%2520receptors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D117%26epage%3D118%26doi%3D10.1038%2Fnsmb0211-117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolenaars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matas-Rico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11248</span><span class="refDoi"> DOI: 10.1038/ncomms11248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fncomms11248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27075612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11248&author=W.+J.+Keuneauthor=J.+Hausmannauthor=R.+Bolierauthor=D.+Tolenaarsauthor=A.+Kremerauthor=T.+Heidebrechtauthor=R.+P.+Joostenauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=E.+Matas-Ricoauthor=W.+H.+Moolenaarauthor=R.+P.+Oude+Elferinkauthor=A.+Perrakis&title=Steroid+binding+to+Autotaxin+links+bile+salts+and+lysophosphatidic+acid+signalling&doi=10.1038%2Fncomms11248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span></div><div class="casAuthors">Keune, Willem-Jan; Hausmann, Jens; Bolier, Ruth; Tolenaars, Dagmar; Kremer, Andreas; Heidebrecht, Tatjana; Joosten, Robbie P.; Sunkara, Manjula; Morris, Andrew J.; Matas-Rico, Elisa; Moolenaar, Wouter H.; Oude Elferink, Ronald P.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11248</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) generates the lipid mediator lysophosphatidic acid (LPA).  ATX-LPA signalling is involved in multiple biol. and pathophysiol. processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumor progression.  ATX has a tripartite active site, combining a hydrophilic groove, a hydrophobic lipid-binding pocket and a tunnel of unclear function.  We present crystal structures of rat ATX bound to 7α-hydroxycholesterol and the bile salt tauroursodeoxycholate (TUDCA), showing how the tunnel selectively binds steroids.  A structure of ATX simultaneously harbouring TUDCA in the tunnel and LPA in the pocket, together with kinetic anal., reveals that bile salts act as partial non-competitive inhibitors of ATX, thereby attenuating LPA receptor activation.  This unexpected interplay between ATX-LPA signalling and select steroids, notably natural bile salts, provides a mol. basis for the emerging assocn. of ATX with disorders assocd. with increased circulating levels of bile salts.  Furthermore, our findings suggest potential clin. implications in the use of steroid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3bO2RWT8ZrVg90H21EOLACvtfcHk0liuWif61Ie2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D&md5=29178b1c529c8c72ea6890fe32a66372</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncomms11248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11248%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DBolier%26aufirst%3DR.%26aulast%3DTolenaars%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMatas-Rico%26aufirst%3DE.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DSteroid%2520binding%2520to%2520Autotaxin%2520links%2520bile%2520salts%2520and%2520lysophosphatidic%2520acid%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11248%26doi%3D10.1038%2Fncomms11248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jones, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirunavukkarasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0lgy0mANHwA8_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1124/mol.115.100404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1124%2Fmol.115.100404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=26371182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=982-992&author=A.+J.+Steinauthor=G.+Bainauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=N.+M.+Stelzerauthor=R.+S.+Sidhuauthor=J.+Schaubauthor=L.+Gouletauthor=D.+Lonerganauthor=I.+Calderonauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Structural+basis+for+inhibition+of+human+autotaxin+by+four+potent+compounds+with+distinct+modes+of+binding&doi=10.1124%2Fmol.115.100404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span></div><div class="casAuthors">Stein, Adam J.; Bain, Gretchen; Prodanovich, Pat; Santini, Angelina M.; Darlington, Janice; Stelzer, Nina M. P.; Sidhu, Ranjinder S.; Schaub, Jeffrey; Goulet, Lance; Lonergan, Dave; Calderon, Imelda; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA).  LPA is a bioactive phospholipid that regulates diverse biol. processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of Gprotein-coupled receptors.  The ATXLPA pathway has been implicated in many pathol. conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain.  Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases.  Mouse and rat ATX have been crystd. previously with LPA or small-mol. inhibitors bound.  Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors.  We demonstrate that the mechanism of inhibition of each compd. reflects its unique interactions with human ATX.  Our studies may provide a basis for the rational design of novel ATX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8334n30PQrLVg90H21EOLACvtfcHk0lgy0mANHwA8_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D&md5=f847e18cf228207349d21c449abdb039</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100404%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DStelzer%26aufirst%3DN.%2BM.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26aulast%3DSchaub%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520human%2520autotaxin%2520by%2520four%2520potent%2520compounds%2520with%2520distinct%2520modes%2520of%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D982%26epage%3D992%26doi%3D10.1124%2Fmol.115.100404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheasty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farooq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeete, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of the lysophospholipase autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5410</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.bmcl.2016.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5403-5410&author=P.+Shahauthor=A.+Cheastyauthor=C.+Foxtonauthor=T.+Raynhamauthor=M.+Farooqauthor=I.+F.+Gutierrezauthor=A.+Lejeuneauthor=M.+Pritchardauthor=A.+Turnbullauthor=L.+Pangauthor=P.+Owenauthor=S.+Boydauthor=A.+Stowellauthor=A.+Jordanauthor=N.+M.+Hamiltonauthor=J.+R.+Hitchinauthor=M.+Stockleyauthor=E.+MacDonaldauthor=M.+J.+Quesadaauthor=E.+Trivierauthor=J.+Skeeteauthor=H.+Ovaaauthor=W.+H.+Moolenaarauthor=H.+Ryder&title=Discovery+of+potent+inhibitors+of+the+lysophospholipase+autotaxin&doi=10.1016%2Fj.bmcl.2016.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DCheasty%26aufirst%3DA.%26aulast%3DFoxton%26aufirst%3DC.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DFarooq%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DI.%2BF.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DPritchard%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DStowell%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DN.%2BM.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DTrivier%26aufirst%3DE.%26aulast%3DSkeete%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520lysophospholipase%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5403%26epage%3D5410%26doi%3D10.1016%2Fj.bmcl.2016.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1124/jpet.116.237156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1124%2Fjpet.116.237156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27754931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=1-13&author=G.+Bainauthor=K.+E.+Shannonauthor=F.+Huangauthor=J.+Darlingtonauthor=L.+Gouletauthor=P.+Prodanovichauthor=G.+L.+Maauthor=A.+M.+Santiniauthor=A.+J.+Steinauthor=D.+Lonerganauthor=C.+D.+Kingauthor=I.+Calderonauthor=A.+Laiauthor=J.+H.+Hutchinsonauthor=J.+F.+Evans&title=Selective+inhibition+of+autotaxin+is+efficacious+in+mouse+models+of+liver+fibrosis&doi=10.1124%2Fjpet.116.237156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis</span></div><div class="casAuthors">Bain Gretchen; Shannon Kristen E; Huang Fei; Darlington Janice; Goulet Lance; Prodanovich Patricia; Ma Gina L; Santini Angelina M; Stein Adam J; Lonergan Dave; King Christopher D; Calderon Imelda; Lai Andiliy; Hutchinson John H; Evans Jilly F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autotaxin (ATX) is a secreted glycoprotein that converts lysophosphatidylcholine (LPC) to the bioactive phospholipid lysophosphatidic acid (LPA) and is the major enzyme generating circulating LPA.  Inhibition of LPA signaling has profound antifibrotic effects in multiple organ systems, including lung, kidney, skin, and peritoneum.  However, other LPA-generating pathways exist, and the role of ATX in localized tissue LPA production and fibrosis remains unclear and controversial.  In this study, we describe the preclinical pharmacologic, pharmacokinetic, and pharmacodynamic properties of a novel small-molecule ATX inhibitor, PAT-505 [3-((6-chloro-2-cyclopropyl-1-(1-ethyl-1H-pyrazol-4-yl)-7-fluoro-1H-indol-3-yl) thio)-2-fluorobenzoic acid sodium salt].  PAT-505 is a potent, selective, noncompetitive inhibitor that displays significant inhibition of ATX activity in plasma and liver tissue after oral administration.  When dosed therapeutically in a Stelic Mouse Animal Model of nonalcoholic steatohepatitis (NASH), PAT-505 treatment resulted in a small but significant improvement in fibrosis with only minor improvements in hepatocellular ballooning and hepatic inflammation.  In a choline-deficient, high-fat diet model of NASH, therapeutic treatment with PAT-505 robustly reduced liver fibrosis with no significant effect on steatosis, hepatocellular ballooning, or inflammation.  These data demonstrate that inhibiting autotaxin is antifibrotic and may represent a novel therapeutic approach for the treatment of multiple fibrotic liver diseases, including NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL-FO7LhxeeTjk2McQZ6XmfW6udTcc2eavdl-IrU07TLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D&md5=0ecd238167807657b30f436c05180dce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237156%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DG.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DSelective%2520inhibition%2520of%2520autotaxin%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520liver%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D360%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.116.237156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potjewyd, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado-Polo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelvarajan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Latif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Rational design of autotaxin inhibitors by structural evolution of endogenous modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2017</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01743</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01743" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2006-2017&author=W.+J.+Keuneauthor=F.+Potjewydauthor=T.+Heidebrechtauthor=F.+Salgado-Poloauthor=S.+J.+Macdonaldauthor=L.+Chelvarajanauthor=A.+Abdel+Latifauthor=S.+Somanauthor=A.+J.+Morrisauthor=A.+J.+Watsonauthor=C.+Jamiesonauthor=A.+Perrakis&title=Rational+design+of+autotaxin+inhibitors+by+structural+evolution+of+endogenous+modulators&doi=10.1021%2Facs.jmedchem.6b01743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators</span></div><div class="casAuthors">Keune, Willem-Jan; Potjewyd, Frances; Heidebrecht, Tatjana; Salgado-Polo, Fernando; Macdonald, Simon J. F.; Chelvarajan, Lakshman; Abdel Latif, Ahmed; Soman, Sony; Morris, Andrew J.; Watson, Allan J. B.; Jamieson, Craig; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2006-2017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin produces the bioactive lipid lysophosphatidic acid (LPA), and is a drug target of considerable interest for numerous pathologies.  The authors report the expedient, structure-guided evolution of weak physiol. allosteric inhibitors (bile salts) into potent competitive Autotaxin inhibitors that do not interact with the catalytic site.  Functional data confirms that the authors' lead compd. attenuates LPA mediated signaling in cells, and reduces LPA synthesis in vivo, providing a promising natural product derived scaffold for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot4QXxEeWhtrVg90H21EOLACvtfcHk0ljqkHuvCy1UDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWgsrk%253D&md5=b6409fd76eda5042a983800a43723922</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01743%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DPotjewyd%26aufirst%3DF.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DSalgado-Polo%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DChelvarajan%26aufirst%3DL.%26aulast%3DAbdel%2BLatif%26aufirst%3DA.%26aulast%3DSoman%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DRational%2520design%2520of%2520autotaxin%2520inhibitors%2520by%2520structural%2520evolution%2520of%2520endogenous%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2006%26epage%3D2017%26doi%3D10.1021%2Facs.jmedchem.6b01743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">For example, the following articles describe the activity of ATX inhibitors in a bleomycin-induced pulmonary fibrosis mice model; differences in their pharmacological activity might be linked, in part, to differences in their binding modes:</p></div><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Structural basis for specific inhibition of autotaxin by a DNA aptamer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/nsmb.3200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.3200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27043297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=395-401&author=K.+Katoauthor=H.+Ikedaauthor=S.+Miyakawaauthor=S.+Futakawaauthor=Y.+Nonakaauthor=M.+Fujiwaraauthor=S.+Okudairaauthor=K.+Kanoauthor=J.+Aokiauthor=J.+Moritaauthor=R.+Ishitaniauthor=H.+Nishimasuauthor=Y.+Nakamuraauthor=O.+Nureki&title=Structural+basis+for+specific+inhibition+of+autotaxin+by+a+DNA+aptamer&doi=10.1038%2Fnsmb.3200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific inhibition of Autotaxin by a DNA aptamer</span></div><div class="casAuthors">Kato, Kazuki; Ikeda, Hisako; Miyakawa, Shin; Futakawa, Satoshi; Nonaka, Yosuke; Fujiwara, Masatoshi; Okudaira, Shinichi; Kano, Kuniyuki; Aoki, Junken; Morita, Junko; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nakamura, Yoshikazu; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATX is a plasma lysophospholipase D that hydrolyzes lysophosphatidylcholine (LPC) and produces lysophosphatidic acid.  To date, no ATX-inhibition-mediated treatment strategies for human diseases have been established.  Here, we report anti-ATX DNA aptamers that inhibit ATX with high specificity and efficacy.  We solved the crystal structure of ATX in complex with the anti-ATX aptamer RB011, at 2.0-Å resoln.  RB011 binds in the vicinity of the active site through base-specific interactions, thus preventing the access of the choline moiety of LPC substrates.  Using the structural information, we developed the modified anti-ATX DNA aptamer RB014, which exhibited in vivo efficacy in a bleomycin-induced pulmonary fibrosis mouse model.  Our findings reveal the structural basis for the specific inhibition of ATX by the anti-ATX aptamer and highlight the therapeutic potential of anti-ATX aptamers for the treatment of human diseases, such as pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NHdAXL4UqLVg90H21EOLACvtfcHk0ljqkHuvCy1UDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D&md5=aca4be211ddf67faad6a2decadd73a12</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3200%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DMiyakawa%26aufirst%3DS.%26aulast%3DFutakawa%26aufirst%3DS.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DKano%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DMorita%26aufirst%3DJ.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520basis%2520for%2520specific%2520inhibition%2520of%2520autotaxin%2520by%2520a%2520DNA%2520aptamer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D395%26epage%3D401%26doi%3D10.1038%2Fnsmb.3200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahluwalia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1096/fj.201500197R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1096%2Ffj.201500197R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2435-2450&author=K.+E.+Blackauthor=E.+Berdyshevauthor=G.+Bainauthor=F.+V.+Castelinoauthor=B.+S.+Sheaauthor=C.+K.+Probstauthor=B.+A.+Fontaineauthor=I.+Bronovaauthor=L.+Gouletauthor=D.+Lagaresauthor=N.+Ahluwaliaauthor=R.+S.+Knipeauthor=V.+Natarajanauthor=A.+M.+Tager&title=Autotaxin+activity+increases+locally+following+lung+injury%2C+but+is+not+required+for+pulmonary+lysophosphatidic+acid+production+or+fibrosis&doi=10.1096%2Ffj.201500197R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1096%2Ffj.201500197R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201500197R%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DFontaine%26aufirst%3DB.%2BA.%26aulast%3DBronova%26aufirst%3DI.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLagares%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DN.%26aulast%3DKnipe%26aufirst%3DR.%2BS.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAutotaxin%2520activity%2520increases%2520locally%2520following%2520lung%2520injury%252C%2520but%2520is%2520not%2520required%2520for%2520pulmonary%2520lysophosphatidic%2520acid%2520production%2520or%2520fibrosis%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D2435%26epage%3D2450%26doi%3D10.1096%2Ffj.201500197R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">WaterMap (Schrödinger, LLC, New York, NY, 2017).</p></div><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+molecular+recognition+exploiting+hydrophobic+enclosure+in+protein-ligand+binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0li1LLplFpeCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520molecular%2520recognition%2520exploiting%2520hydrophobic%2520enclosure%2520in%2520protein-ligand%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Role of the active-site solvent in the thermodynamics of factor Xa ligand binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+active-site+solvent+in+the+thermodynamics+of+factor+Xa+ligand+binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0li1LLplFpeCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520active-site%2520solvent%2520in%2520the%2520thermodynamics%2520of%2520factor%2520Xa%2520ligand%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Marcus Litchfield, Melinda Wuest, Daryl Glubrecht, Emmanuelle Briard, Yves P. Auberson, Todd P. W. McMullen, David N. Brindley, <span class="NLM_string-name hlFld-ContribAuthor">Frank Wuest</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [18F]PRIMATX. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.1c00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.1c00265%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252BAutotaxin%252Bin%252BThyroid%252Band%252BBreast%252BCancer%252BModels%252BUsing%252B%25255B18F%25255DPRIMATX%26aulast%3DLitchfield%26aufirst%3DMarcus%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04042021%26date%3D19072021%26date%3D17072021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Franck Brebion, Romain Gosmini, Pierre Deprez, Marie Varin, Christophe Peixoto, Luke Alvey, Hélène Jary, Natacha Bienvenu, Nicolas Triballeau, Roland Blanque, Céline Cottereaux, Thierry Christophe, Nele Vandervoort, Patrick Mollat, Robert Touitou, Philip Leonard, Frédéric De Ceuninck, Iuliana Botez, Alain Monjardet, Ellen van der Aar, <span class="NLM_string-name hlFld-ContribAuthor">David Amantini</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 2937-2952. <a href="https://doi.org/10.1021/acs.jmedchem.0c02008" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BGLPG1972%25252FS201086%25252C%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BADAMTS-5%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BOsteoarthritis%26aulast%3DBrebion%26aufirst%3DFranck%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19112020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D2937%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen, Lisa Dietz, Carsten Terjung, Michaela Bairlein, Clemens-Jeremias von Bühler, Sonja Anlauf, Chantal Fürstner, Timo Stellfeld, Dirk Schneider, Kersten M. Gericke, Thomas Buyck, Kai Lovis, Uwe Münster, Johanna Anlahr, Elisabeth Kersten, Guillaume Levilain, Virginia Marossek, <span class="NLM_string-name hlFld-ContribAuthor">Raimund Kast</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11639-11662. <a href="https://doi.org/10.1021/acs.jmedchem.0c00834" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSelective%252BHuman%252BProstaglandin%252BF%252B%252528FP%252529%252BReceptor%252BAntagonist%252B%252528BAY-6672%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%252B%252528IPF%252529%26aulast%3DBeck%26aufirst%3DHartmut%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16052020%26date%3D08102020%26date%3D24092020%26volume%3D63%26issue%3D20%26spage%3D11639%26epage%3D11662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Neetu Dayal, Modi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Herman O. Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">HSD1787, a Tetrahydro-3H-Pyrazolo[4,3-f]Quinoline Compound Synthesized via Povarov Reaction, Potently Inhibits Proliferation of Cancer Cell Lines at Nanomolar Concentrations. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (37)
                                     , 23799-23807. <a href="https://doi.org/10.1021/acsomega.0c03001" title="DOI URL">https://doi.org/10.1021/acsomega.0c03001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c03001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c03001%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DHSD1787%25252C%252Ba%252BTetrahydro-3H-Pyrazolo%25255B4%25252C3-f%25255DQuinoline%252BCompound%252BSynthesized%252Bvia%252BPovarov%252BReaction%25252C%252BPotently%252BInhibits%252BProliferation%252Bof%252BCancer%252BCell%252BLines%252Bat%252BNanomolar%252BConcentrations%26aulast%3DDayal%26aufirst%3DNeetu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D28082020%26date%3D11092020%26volume%3D5%26issue%3D37%26spage%3D23799%26epage%3D23807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongrui Lei, Ming Guo, Xiaopeng Li, Fang Jia, Changtao Li, Yu Yang, Meng Cao, Nan Jiang, Enlong Ma, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great In Vivo Efficacy in a Mouse Lung Fibrosis Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 7326-7346. <a href="https://doi.org/10.1021/acs.jmedchem.0c00506" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00506%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BIndole-Based%252BAllosteric%252BHighly%252BPotent%252BATX%252BInhibitors%252Bwith%252BGreat%252BIn%252BVivo%252BEfficacy%252Bin%252Ba%252BMouse%252BLung%252BFibrosis%252BModel%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27032020%26date%3D12062020%26date%3D01062020%26volume%3D63%26issue%3D13%26spage%3D7326%26epage%3D7346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongrui Lei, Yu Yang, Changtao Li, Fang Jia, Nan Jiang, Ping Gong, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Cyclization- and Curtius Rearrangement-Induced Functional Group Transformation: An Improved Synthetic Strategy of First-in-Class ATX Inhibitor Ziritaxestat (GLPG-1690). </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (6)
                                     , 997-1005. <a href="https://doi.org/10.1021/acs.oprd.9b00511" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00511%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCatalyst-Free%252BCyclization-%252Band%252BCurtius%252BRearrangement-Induced%252BFunctional%252BGroup%252BTransformation%25253A%252BAn%252BImproved%252BSynthetic%252BStrategy%252Bof%252BFirst-in-Class%252BATX%252BInhibitor%252BZiritaxestat%252B%252528GLPG-1690%252529%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D08052020%26date%3D23042020%26volume%3D24%26issue%3D6%26spage%3D997%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinsi Li, Xuerong Fang, <span class="NLM_string-name hlFld-ContribAuthor">Xin Ming</span>. </span><span class="cited-content_cbyCitation_article-title">Visibly Emitting Thiazolyl-Uridine Analogues as Promising Fluorescent Probes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (7)
                                     , 4602-4610. <a href="https://doi.org/10.1021/acs.joc.9b03208" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03208%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DVisibly%252BEmitting%252BThiazolyl-Uridine%252BAnalogues%252Bas%252BPromising%252BFluorescent%252BProbes%26aulast%3DLi%26aufirst%3DJinsi%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28112019%26date%3D19032020%26date%3D10032020%26volume%3D85%26issue%3D7%26spage%3D4602%26epage%3D4610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, Kotaro Hama, Kuniyuki Kano, Hiroshi Nishimasu, Hidehiko Nakagawa, Ryuichiro Ishitani, Hirotatsu Kojima, Osamu Nureki, Junken Aoki, <span class="NLM_string-name hlFld-ContribAuthor">Tetsuo Nagano</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potent In Vivo Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3188-3204. <a href="https://doi.org/10.1021/acs.jmedchem.9b01967" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252BIn%252BVivo%252BAutotaxin%252BInhibitors%252Bthat%252BBind%252Bto%252BBoth%252BHydrophobic%252BPockets%252Band%252BChannels%252Bin%252Bthe%252BCatalytic%252BDomain%26aulast%3DKawaguchi%26aufirst%3DMitsuyasu%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D13032020%26date%3D05032020%26volume%3D63%26issue%3D6%26spage%3D3188%26epage%3D3204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aikaterini Nikolaou, Ioanna Ninou, Maroula G. Kokotou, Eleanna Kaffe, Antreas Afantitis, Vassilis Aidinis, <span class="NLM_string-name hlFld-ContribAuthor">George Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3697-3711. <a href="https://doi.org/10.1021/acs.jmedchem.8b00232" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxamic%252BAcids%252BConstitute%252Ba%252BNovel%252BClass%252Bof%252BAutotaxin%252BInhibitors%252Bthat%252BExhibit%252Bin%252BVivo%252BEfficacy%252Bin%252Ba%252BPulmonary%252BFibrosis%252BModel%26aulast%3DNikolaou%26aufirst%3DAikaterini%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12022018%26date%3D18042018%26date%3D05042018%26volume%3D61%26issue%3D8%26spage%3D3697%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Denis Bucher, Pieter Stouten, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Triballeau</span>. </span><span class="cited-content_cbyCitation_article-title">Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (3)
                                     , 692-699. <a href="https://doi.org/10.1021/acs.jcim.7b00642" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DShedding%252BLight%252Bon%252BImportant%252BWaters%252Bfor%252BDrug%252BDesign%25253A%252BSimulations%252Bversus%252BGrid-Based%252BMethods%26aulast%3DBucher%26aufirst%3DDenis%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D03112017%26date%3D05032018%26date%3D28022018%26volume%3D58%26issue%3D3%26spage%3D692%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A.  Kuttruff</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Tom  Bretschneider</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Sandra  Handschuh</span>, <span class="hlFld-ContribAuthor ">Bernd  Nosse</span>, <span class="hlFld-ContribAuthor ">Helmut  Romig</span>, <span class="hlFld-ContribAuthor ">Paul  Nicklin</span>, and <span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1252-1257. <a href="https://doi.org/10.1021/acsmedchemlett.7b00312" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBI-2545%25253A%252BA%252BNovel%252BAutotaxin%252BInhibitor%252BThat%252BSignificantly%252BReduces%252BLPA%252BLevels%252Bin%252BVivo%26aulast%3DKuttruff%26aufirst%3DChristian%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05082017%26date%3D08112017%26date%3D14112017%26date%3D14122017%26date%3D08112017%26volume%3D8%26issue%3D12%26spage%3D1252%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Partha Pratim  Sen</span>, <span class="hlFld-ContribAuthor ">Vishal Jyoti  Roy</span>, <span class="hlFld-ContribAuthor ">Sudipta  Raha Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free regioselective bromination of imidazo-heteroarenes: the dual role of an organic bromide salt in electrocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2021,</strong> <em>23 </em>
                                    (15)
                                     , 5687-5695. <a href="https://doi.org/10.1039/D1GC01069G" title="DOI URL">https://doi.org/10.1039/D1GC01069G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1GC01069G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1GC01069G%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DMetal-free%252Bregioselective%252Bbromination%252Bof%252Bimidazo-heteroarenes%25253A%252Bthe%252Bdual%252Brole%252Bof%252Ban%252Borganic%252Bbromide%252Bsalt%252Bin%252Belectrocatalysis%26aulast%3DSen%26aufirst%3DPartha%2BPratim%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D15%26spage%3D5687%26epage%3D5695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celia  Dobersalske</span>, <span class="hlFld-ContribAuthor ">Manuel  Grundmann</span>, <span class="hlFld-ContribAuthor ">Andreas  Timmermann</span>, <span class="hlFld-ContribAuthor ">Laura  Theisen</span>, <span class="hlFld-ContribAuthor ">Florian  Kölling</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Harris</span>, <span class="hlFld-ContribAuthor ">Chantal  Fuerstner</span>, <span class="hlFld-ContribAuthor ">Michael S.  Becker</span>, <span class="hlFld-ContribAuthor ">Frank  Wunder</span>. </span><span class="cited-content_cbyCitation_article-title">Establishment of a novel, cell-based autotaxin assay. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2021,</strong> <em>158 </em>, 114322. <a href="https://doi.org/10.1016/j.ab.2021.114322" title="DOI URL">https://doi.org/10.1016/j.ab.2021.114322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2021.114322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2021.114322%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DEstablishment%252Bof%252Ba%252Bnovel%25252C%252Bcell-based%252Bautotaxin%252Bassay%26aulast%3DDobersalske%26aufirst%3DCelia%26date%3D2021%26volume%3D158%26spage%3D114322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehui  Tan</span>, <span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">An updated patent review of autotaxin inhibitors (2017–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 421-434. <a href="https://doi.org/10.1080/13543776.2021.1867106" title="DOI URL">https://doi.org/10.1080/13543776.2021.1867106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1867106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1867106%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAn%252Bupdated%252Bpatent%252Breview%252Bof%252Bautotaxin%252Binhibitors%252B%2525282017%2525E2%252580%252593present%252529%26aulast%3DTan%26aufirst%3DZehui%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D5%26spage%3D421%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Mieczkowski</span>, <span class="hlFld-ContribAuthor ">Tomasz  Frączyk</span>, <span class="hlFld-ContribAuthor ">Mateusz  Psurski</span>, <span class="hlFld-ContribAuthor ">Patrycja  Wińska</span>, <span class="hlFld-ContribAuthor ">Paweł  Siedlecki</span>, <span class="hlFld-ContribAuthor ">Monika  Dziełak</span>, <span class="hlFld-ContribAuthor ">Damian  Trzybiński</span>, <span class="hlFld-ContribAuthor ">Marcin  Wilczek</span>, <span class="hlFld-ContribAuthor ">Maciej  Bagiński</span>, <span class="hlFld-ContribAuthor ">Bartosz  Bieszczad</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Woźniak</span>. </span><span class="cited-content_cbyCitation_article-title">Design and in Vitro Characterization of Tricyclic Benzodiazepine Derivatives as Potent and Selective Antileukemic Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/cbdv.202000733" title="DOI URL">https://doi.org/10.1002/cbdv.202000733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000733%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDesign%252Band%252Bin%252BVitro%252BCharacterization%252Bof%252BTricyclic%252BBenzodiazepine%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BAntileukemic%252BAgents%26aulast%3DMieczkowski%26aufirst%3DAdam%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart  van Beusekom</span>, <span class="hlFld-ContribAuthor ">George  Damaskos</span>, <span class="hlFld-ContribAuthor ">Maarten L.  Hekkelman</span>, <span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Hiruma</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>, <span class="hlFld-ContribAuthor ">Robbie P.  Joosten</span>. </span><span class="cited-content_cbyCitation_article-title">LAHMA
              : structure analysis through local annotation of homology-matched amino acids. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2021,</strong> <em>77 </em>
                                    (1)
                                     , 28-40. <a href="https://doi.org/10.1107/S2059798320014473" title="DOI URL">https://doi.org/10.1107/S2059798320014473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798320014473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798320014473%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DLAHMA%252B%25253A%252Bstructure%252Banalysis%252Bthrough%252Blocal%252Bannotation%252Bof%252Bhomology-matched%252Bamino%252Bacids%26aulast%3Dvan%2BBeusekom%26aufirst%3DBart%26date%3D2021%26date%3D2021%26volume%3D77%26issue%3D1%26spage%3D28%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marley L.  Samways</span>, <span class="hlFld-ContribAuthor ">Richard D.  Taylor</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Bruce Macdonald</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Essex</span>. </span><span class="cited-content_cbyCitation_article-title">Water molecules at protein–drug interfaces: computational prediction and analysis methods. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>326 </em><a href="https://doi.org/10.1039/D0CS00151A" title="DOI URL">https://doi.org/10.1039/D0CS00151A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00151A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00151A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DWater%252Bmolecules%252Bat%252Bprotein%2525E2%252580%252593drug%252Binterfaces%25253A%252Bcomputational%252Bprediction%252Band%252Banalysis%252Bmethods%26aulast%3DSamways%26aufirst%3DMarley%2BL.%26date%3D2021%26date%3D2021%26volume%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Jia</span>, <span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Tong  Li</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Zhi  Cao</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based linker exploration: Discovery of 1-ethyl-1H-indole analogs as novel ATX inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (22)
                                     , 115795. <a href="https://doi.org/10.1016/j.bmc.2020.115795" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115795%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Blinker%252Bexploration%25253A%252BDiscovery%252Bof%252B1-ethyl-1H-indole%252Banalogs%252Bas%252Bnovel%252BATX%252Binhibitors%26aulast%3DJia%26aufirst%3DFang%26date%3D2020%26volume%3D28%26issue%3D22%26spage%3D115795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Changtao  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Jia</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Minglin  Zhu</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure guided design of potent indole-based ATX inhibitors bearing hydrazone moiety with tumor suppression effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112456. <a href="https://doi.org/10.1016/j.ejmech.2020.112456" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112456%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bguided%252Bdesign%252Bof%252Bpotent%252Bindole-based%252BATX%252Binhibitors%252Bbearing%252Bhydrazone%252Bmoiety%252Bwith%252Btumor%252Bsuppression%252Beffects%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2020%26volume%3D201%26spage%3D112456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Xia  Ren</span>, <span class="hlFld-ContribAuthor ">Rui-Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1107. <a href="https://doi.org/10.3390/molecules25051107" title="DOI URL">https://doi.org/10.3390/molecules25051107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051107%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentifying%252BNovel%252BATX%252BInhibitors%252Bvia%252BCombinatory%252BVirtual%252BScreening%252BUsing%252BCrystallography-Derived%252BPharmacophore%252BModelling%25252C%252BDocking%252BStudy%25252C%252Band%252BQSAR%252BAnalysis%26aulast%3DRen%26aufirst%3DJi-Xia%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keisuke  Yanagida</span>, <span class="hlFld-ContribAuthor ">William J.  Valentine</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Lysophospholipid Signaling Pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 137-176. <a href="https://doi.org/10.1007/978-3-030-50621-6_7" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_7%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BLysophospholipid%252BSignaling%252BPathways%26aulast%3DYanagida%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26spage%3D137%26epage%3D176%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Boltjes</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">The Groebke-Blackburn-Bienaymé Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (42)
                                     , 7007-7049. <a href="https://doi.org/10.1002/ejoc.201901124" title="DOI URL">https://doi.org/10.1002/ejoc.201901124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901124%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThe%252BGroebke-Blackburn-Bienaym%2525C3%2525A9%252BReaction%26aulast%3DBoltjes%26aufirst%3DAndr%25C3%25A9%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D42%26spage%3D7007%26epage%3D7049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">The Structural Binding Mode of the Four Autotaxin Inhibitor Types that Differentially Affect Catalytic and Non-Catalytic Functions. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (10)
                                     , 1577. <a href="https://doi.org/10.3390/cancers11101577" title="DOI URL">https://doi.org/10.3390/cancers11101577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11101577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11101577%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BStructural%252BBinding%252BMode%252Bof%252Bthe%252BFour%252BAutotaxin%252BInhibitor%252BTypes%252Bthat%252BDifferentially%252BAffect%252BCatalytic%252Band%252BNon-Catalytic%252BFunctions%26aulast%3DSalgado-Polo%26aufirst%3DFernando%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 976-1013. <a href="https://doi.org/10.1002/med.21551" title="DOI URL">https://doi.org/10.1002/med.21551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21551%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDevelopment%252Band%252Btherapeutic%252Bpotential%252Bof%252Bautotaxin%252Bsmall%252Bmolecule%252Binhibitors%25253A%252BFrom%252Bbench%252Bto%252Badvanced%252Bclinical%252Btrials%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D976%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Salgado-Polo</span>, <span class="hlFld-ContribAuthor ">Alex  Fish</span>, <span class="hlFld-ContribAuthor ">Minos-Timotheos  Matsoukas</span>, <span class="hlFld-ContribAuthor ">Tatjana  Heidebrecht</span>, <span class="hlFld-ContribAuthor ">Willem-Jan  Keune</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (37)
                                     , 14312-14327. <a href="https://doi.org/10.1074/jbc.RA118.004450" title="DOI URL">https://doi.org/10.1074/jbc.RA118.004450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.004450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.004450%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DLysophosphatidic%252Bacid%252Bproduced%252Bby%252Bautotaxin%252Bacts%252Bas%252Ban%252Ballosteric%252Bmodulator%252Bof%252Bits%252Bcatalytic%252Befficiency%26aulast%3DSalgado-Polo%26aufirst%3DFernando%26date%3D2018%26volume%3D293%26issue%3D37%26spage%3D14312%26epage%3D14327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Yu  Meng</span>, <span class="hlFld-ContribAuthor ">Wei-Fen  Kang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ju  Si</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Song</span>, <span class="hlFld-ContribAuthor ">Yan-Jie  Li</span>, <span class="hlFld-ContribAuthor ">Fen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">HKUST-1-Catalyzed Formation of C-C and C-N Bonds: Rapid Assembly of Substituted Pyridines from Propargylamine and Carbonyl Compounds. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (31)
                                     , 8793-8796. <a href="https://doi.org/10.1002/slct.201801799" title="DOI URL">https://doi.org/10.1002/slct.201801799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801799%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DHKUST-1-Catalyzed%252BFormation%252Bof%252BC-C%252Band%252BC-N%252BBonds%25253A%252BRapid%252BAssembly%252Bof%252BSubstituted%252BPyridines%252Bfrom%252BPropargylamine%252Band%252BCarbonyl%252BCompounds%26aulast%3DMeng%26aufirst%3DYan-Yu%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D31%26spage%3D8793%26epage%3D8796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) ATX-mediated conversion of LPC into LPA and summary of cellular events triggered by LPA receptor activation. (B) Examples of abundant LPA species in plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Methods to assess ATX activity <i>in vitro</i> and in plasma samples.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hit series and compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of compound <b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Overall structure of ATX with compound <b>9</b> shown in CPK with green carbon atoms. Somatomedin B-like, catalytic, and nuclease-like domains are shown in blue, green, and pink, respectively. Disulfide bridges are depicted as yellow bars, and the two zinc ions of the catalytic site are shown as magenta spheres. The arrow indicates the viewing angle of panel B and the dashed line the clipping plane for the site surface. (B) Focus on the binding pocket showing details of the binding mode of <b>9</b>. The surface delineating the site is colored by hydrophobicity using in a blue–white–brown spectrum (blue for hydrophilic, brown for hydrophobic). For clarity, the surface was clipped vertically (see panel A). Dashed lines highlight interactions between compound <b>9</b> and ATX, hydrophobic contacts in pink, and hydrogen bonding in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of ATX inhibitors. PDB codes of cocrystal structures with ATX are indicated in brackets (note: reported PDB code for compound <b>64</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5mom">5mom</a>) does not match the intended structure).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic representation of the autotaxin binding pocket and the different inhibitor binding modes reported to date. Type I, II, III, and IV inhibitors are represented in green, purple, cyan, and orange, respectively, on the schema with matching colors for carbon atoms on the exemplified structures. The gray dotted lines represent secondary ligands modeled next to the inhibitor as shown with gray carbons on the illustrations. Some structures lack secondary ligand models but exhibit a positive electron density in the same region (Fo-Fc map at 3 sigma in green, 2Fo-Fc map at 1 sigma in blue). Zinc ions are depicted in magenta. (A) Binding mode of type I inhibitors LPA 22:6 (a), <b>56</b> (b), <b>58</b> (c). (B) Binding mode of type II inhibitors <b>60</b> (d), <b>59</b> (e), and <b>61</b> (f). (C) Binding mode of type III inhibitors <b>63</b> (g) and <b>62</b> (h). (D) Binding mode of type IV inhibitors <b>55</b> (i) and compound <b>9</b> (j).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. WaterMap results in the hydrophobic pocket. (A) Apo map showing the high energy water molecule highlighted by a dashed circle. Water molecules are colored based on their calculated free energy using a blue (negative, stable)–green (neutral)–red (positive, unstable) spectrum. Albeit absent during the calculation, the ligand is shown in sticks with white carbon atoms. (B) Holo map highlighting the high energy vacuum bubble (crosses circled in black) left by compounds (balls and sticks with orange carbon atoms). (C) Model of a compound with a nitrile group on the thiazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of (2-Ethylimidazo[1,2-<i>a</i>]pyridine-3-yl)-4-aryl-<i>N</i>-alkylthiazol-2-amine Derivatives <b>44a</b>–<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) 1,1,3,3-tetramethylbutyl isocyanide, EtCHO, MgCl<sub>2</sub>, <i>n</i>-BuOH, 130 °C, (2) HCOOH 80 °C, 56–78% over 2 steps; (b) (1) MeI, NaH, DMF, rt, (2) HCl, MeOH, rt-reflux, 37–80% over 2 steps; (c) (1) Fmoc-NCS, TEA, DCM, rt then piperidine, rt, (2) bromo- or chloroacetophenone, EtOH, reflux, 27–74% over 2 steps.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) NaOH, MeOH/H<sub>2</sub>O or LiOH, THF/H<sub>2</sub>O, rt, (2) amine, EDC.HCl, TEA, HOBt, DMF, rt, 15–74% over 2 steps (for <b>1</b> and <b>2</b>); (b) (1) LiAlH<sub>4</sub>, THF, rt, (2) MsCl, TEA, DCM, rt, then amine, rt, 25% over 2 steps (for <b>5</b>); (c) pyridine-3-boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 90 °C, 53% (for <b>3</b>); (d) amine, <i>t</i>-BuONa, Pd<sub>2</sub>dba<sub>3</sub>, Xantphos or DavePhos, toluene or dioxane, 90–120 °C, 7–16% (for <b>4</b> and <b>6</b>).</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>7</b>–<b>10</b>, <b>17</b>–<b>20</b>, and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C, quant.; (b) HCl, THF/H<sub>2</sub>O or dioxane/MeOH or MeOH, 0 °C–rt, 71–100%; (c) (1) acetyl chloride, TEA, DCM, rt, 91%, (2) H<sub>2</sub>, Pd/C, EtOH, 60 °C, 34% (for <b>7</b>); (d) H<sub>2</sub>, Pd(OH)<sub>2</sub>, DCM/EtOH, rt, 79%; (e) ethyl 2-bromoacetate, NaH, DMF, rt, 56% (for <b>10</b>); (f) MsCl, TEA, DCM, 0 °C–rt, 17% (for <b>8</b>); (g) R<sub>2</sub>X, K<sub>2</sub>CO<sub>3</sub>, MeCN, 70–100 °C, 40–100% (for <b>17, 18, 19, 22</b>); (h) 2-chloro-1-pyrrolidin-1-yl-ethanone, TEA, MeCN, 190 °C (microwave irradiation), 45% (for <b>20</b>); (i) (1) 3-chloropropane-1-sulfonyl chloride, TEA, DCM, rt, 99%, (2) dimethylamine, NaI, THF, 150 °C (microwave irradiation), 59% over 2 steps (for <b>9</b>); (j) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DCM, 0 °C–rt, 70%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Piperazine Derivatives <b>11</b>–<b>16</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) <i>N</i>-Boc-piperazine, <i>t-</i>BuONa, Pd<sub>2</sub>dba<sub>3</sub>, DavePhos, toluene, 105 °C, (2) HCl, dioxane, rt, 79% over 2 steps; (b) R<sub>1</sub>Cl, TEA, DCM, rt, 22–24% (for <b>13</b>, <b>14</b>); (c) R<sub>1</sub>CHO, NaBH<sub>3</sub>CN, TEA, MeOH, rt, 29–49% (for <b>16</b>, <b>15</b>); (d) ethyl chloroacetate, TEA, MeCN, 0–45 °C, 71% (for <b>11</b>); (e) LiOH, THF/H<sub>2</sub>O, rt, 33% (for <b>12</b>); (f) <b>49</b>, TEA, MeCN, 160 °C (microwave irradiation), 26%; (g) morpholine, TEA, DCM, 0 °C, quant.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>23</b>–<b>25</b>, <b>30</b>, <b>32</b>–<b>36</b>, and <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) MeI, NaH, DMF, rt, (2) 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 85 °C, 80% over 2 steps; (b) (1) H<sub>2</sub>, PtO<sub>2</sub>, THF/MeOH, rt, (2) HCl, dioxane/MeOH, rt, 47% over 2 steps; (c) (1) FmocNCS, TEA, DCM, rt then piperidine, rt, (2) bromoacetophenone derivative, EtOH, reflux, 17–64% over 2 steps (for <b>24</b>, <b>25</b>, <b>30</b>, <b>32</b>–<b>34</b>, <b>36</b>, <b>52</b>, <b>53</b>); (d) 2-bromobenzo[<i>d</i>]thiazole, Pd(OAc)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, 36% (for <b>23</b>); (e) CuCN, pyridine, 150 °C (microwave irradiation), 41% (for <b>35</b>); (f) LiOH, THF/H<sub>2</sub>O, rt to 50 °C, 18% (for <b>39</b>).</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>26</b>–<b>29</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) <i>N</i>-<i>tert</i>-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)boronic acid pinacol ester, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C, 79–94%, (2) HCl, dioxane/MeOH, rt, 90–100%, (b) (1) MsCl, TEA, DCM, rt, 39–88%, (2) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 35–65% (for <b>26, 27, 29</b>); (c) (1) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 70%, (2) MsCl, TEA, DCM, rt, 40% (for <b>31</b>); (d) (1) 1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 100 °C, 99%, (2) H<sub>2</sub>, PtO<sub>2</sub>, MeOH/THF, rt, 27% for 2 steps.</p></p></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/medium/jm-2017-00647q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>37</b>, <b>38</b>, and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00647/20170908/images/large/jm-2017-00647q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00647&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) bromine on polymer support, DCM, rt, quant., (2) CuCN, pyridine, 125 °C (microwave irradiation), 9–41%; (b) conc. H<sub>2</sub>SO<sub>4</sub>, rt, 29%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span> </span><span class="NLM_article-title">Autotaxin-an LPA producing enzyme with diverse functions</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin-an+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0lgECoImNIpGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin-an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span><span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0lgECoImNIpGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bandoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)01827-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2FS0014-5793%2800%2901827-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2000&pages=159-165&author=K.+Bandohauthor=J.+Aokiauthor=A.+Tairaauthor=M.+Tsujimotoauthor=H.+Araiauthor=K.+Inoue&title=Lysophosphatidic+acid+%28LPA%29+receptors+of+the+EDG+family+are+differentially+activated+by+LPA+species&doi=10.1016%2FS0014-5793%2800%2901827-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2901827-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252901827-5%26sid%3Dliteratum%253Aachs%26aulast%3DBandoh%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DTaira%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%2520of%2520the%2520EDG%2520family%2520are%2520differentially%2520activated%2520by%2520LPA%2520species%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D478%26spage%3D159%26epage%3D165%26doi%3D10.1016%2FS0014-5793%2800%2901827-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+Signaling+properties+and+disease+relevance&doi=10.1016%2Fj.prostaglandins.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0lgECoImNIpGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520Signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D130%26epage%3D138%26doi%3D10.1016%2Fj.prostaglandins.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span><span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0lgY3Gob3rCzPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stoddard, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span> <span class="citation_source-journal">Biomol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0lgY3Gob3rCzPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="note"><p class="first last">Reviews:</p></div><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albers, H. M. H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Chemical evolution of autotaxin inhibitors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span><span class="refDoi"> DOI: 10.1021/cr2003213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2003213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=2593-2603&author=H.+M.+H.+G.+Albersauthor=H.+Ovaa&title=Chemical+evolution+of+autotaxin+inhibitors&doi=10.1021%2Fcr2003213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fcr2003213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2003213%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DH.%2BM.%2BH.%2BG.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DChemical%2520evolution%2520of%2520autotaxin%2520inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D2593%26epage%3D2603%26doi%3D10.1021%2Fcr2003213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbayianni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrioti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutevelis-Minakakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokotos, G.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1517/13543776.2013.796364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1517%2F13543776.2013.796364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=23641951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1123-1132&author=E.+Barbayianniauthor=V.+Magriotiauthor=P.+Moutevelis-Minakakisauthor=G.+Kokotos&title=Autotaxin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2013.796364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a patent review</span></div><div class="casAuthors">Barbayianni, Efrosini; Magrioti, Victoria; Moutevelis-Minakakis, Panagiota; Kokotos, George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Autotaxin (ATX) is a lysophospholipase D enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA) and choline.  LPA is a bioactive lipid mediator that activates several transduction pathways, and is involved in migration, proliferation and survival of various cells.  Thus, ATX is an attractive medicinal target.  Areas covered: The aim of this review is to summarize ATX inhibitors, reported in patents from 2006 up to now, describing their discovery and biol. evaluation.  Expert opinion: ATX has been implicated in various pathol. conditions, such as cancer, chronic inflammation, neuropathic pain, fibrotic diseases, etc.  Although there is an intensive effort on the discovery of potent and selective ATX inhibitors in order to identify novel medicinal agents, up to now, no ATX inhibitor has reached clin. trials.  However, the use of ATX inhibitors seems an attractive strategy for the development of novel medicinal agents, for example anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrIPRU28R5LVg90H21EOLACvtfcHk0lgY3Gob3rCzPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OqsL%252FF&md5=517c590694d78587305229ce500e228a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.796364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.796364%26sid%3Dliteratum%253Aachs%26aulast%3DBarbayianni%26aufirst%3DE.%26aulast%3DMagrioti%26aufirst%3DV.%26aulast%3DMoutevelis-Minakakis%26aufirst%3DP.%26aulast%3DKokotos%26aufirst%3DG.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1123%26epage%3D1132%26doi%3D10.1517%2F13543776.2013.796364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Development of autotaxin inhibitors: an overview of the patent and primary literature</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5604</span><span class="NLM_x">–</span> <span class="NLM_lpage">5621</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5604-5621&author=D.+Castagnaauthor=D.+C.+Buddauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Development+of+autotaxin+inhibitors%3A+an+overview+of+the+patent+and+primary+literature&doi=10.1021%2Facs.jmedchem.5b01599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature</span></div><div class="casAuthors">Castagna, Diana; Budd, David C.; MacDonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5604-5621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others.  As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities.  This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clin. trial data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWzWQadusHW7Vg90H21EOLACvtfcHk0ljhBrALQ0CtvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCitg%253D%253D&md5=68ca29436fd3b0a1728a9a52fbaf2cb0</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DDevelopment%2520of%2520autotaxin%2520inhibitors%253A%2520an%2520overview%2520of%2520the%2520patent%2520and%2520primary%2520literature%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5604%26epage%3D5621%26doi%3D10.1021%2Facs.jmedchem.5b01599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ferguson, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigman, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span><span class="refDoi"> DOI: 10.1021/ol060414i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol060414i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2023-2026&author=C.+G.+Fergusonauthor=C.+S.+Bigmanauthor=R.+D.+Richardsonauthor=L.+A.+van+Meeterenauthor=W.+H.+Moolenaarauthor=G.+D.+Prestwich&title=Fluorogenic+phospholipid+substrate+to+detect+lysophospholipase+D%2Fautotaxin+activity&doi=10.1021%2Fol060414i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fol060414i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060414i%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DC.%2BG.%26aulast%3DBigman%26aufirst%3DC.%2BS.%26aulast%3DRichardson%26aufirst%3DR.%2BD.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DFluorogenic%2520phospholipid%2520substrate%2520to%2520detect%2520lysophospholipase%2520D%252Fautotaxin%2520activity%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2023%26epage%3D2026%26doi%3D10.1021%2Fol060414i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Desroy, N.; Heckmann, B.; Brys, R. C. X.; Joncour, A.; Peixoto, C.; Bock, X.</span><span> </span><span class="NLM_article-title">Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders</span>. PCT Int. Appl. WO2014/139882A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Desroy&author=B.+Heckmann&author=R.+C.+X.+Brys&author=A.+Joncour&author=C.+Peixoto&author=X.+Bock&title=Compounds+and+Pharmaceutical+Compositions+Thereof+for+the+Treatment+of+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DCompounds%2520and%2520Pharmaceutical%2520Compositions%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Desroy, N.; Joncour, A.; Bock, X.; Housseman, C.; Peixoto, C.; Bienvenu, N.; Labeguere, V.; Cherel, L.; Annoot, D.; Christophe, T.; Conrath, K.; Triballeau, N.; Mollat, P.; Wohlkonig, A.; Blanque, R.; Cottereaux, C.; Hrvacic, B.; Borgonovi, M.; Monjardet, A.; Van der Aar, E.; Brys, R.; Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of GLPG1690: A first-in-class autotaxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis</span>. Abstracts of Papers, 251st ACS National Meeting & Exposition, San Diego, CA, United States, March 13–17,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-254</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Desroy&author=A.+Joncour&author=X.+Bock&author=C.+Housseman&author=C.+Peixoto&author=N.+Bienvenu&author=V.+Labeguere&author=L.+Cherel&author=D.+Annoot&author=T.+Christophe&author=K.+Conrath&author=N.+Triballeau&author=P.+Mollat&author=A.+Wohlkonig&author=R.+Blanque&author=C.+Cottereaux&author=B.+Hrvacic&author=M.+Borgonovi&author=A.+Monjardet&author=E.+Van+der+Aar&author=R.+Brys&author=B.+Heckmann&title=Discovery+of+GLPG1690%3A+A+first-in-class+autotaxin+inhibitor+in+clinical+development+for+the+treatment+of+idiopathic+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520GLPG1690%253A%2520A%2520first-in-class%2520autotaxin%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520251st%2520ACS%2520National%2520Meeting%2520%2526%2520Exposition%252C%2520San%2520Diego%252C%2520CA%252C%2520United%2520States%252C%2520March%252013%25E2%2580%259317%26date%3D2016%26spage%3DMEDI-254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Desroy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housseman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joncour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienvenu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labeguere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassot, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picolet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annoot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triballeau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjardet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakselman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncoroni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Tallec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanque, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottereaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandervoort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrvacic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oste, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Aar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brys, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckmann, B.</span><span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxo-ethyl]piperazin-1-yl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-methyl-amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3580</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=A.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.-M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxo-ethyl%5Dpiperazin-1-yl%5D-8-methyl-imidazo%5B1%2C2-a%5Dpyridin-3-yl%5D-methyl-amino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DA.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.-M.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxo-ethyl%255Dpiperazin-1-yl%255D-8-methyl-imidazo%255B1%252C2-a%255Dpyridin-3-yl%255D-methyl-amino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">A similar observation where the activity of ATX inhibitors is influenced by the assay substrate was also observed by other groups:</p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potjewyd, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado-Polo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel García, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semaan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=722-748&author=L.+M.+Millerauthor=W.+J.+Keuneauthor=D.+Castagnaauthor=L.+C.+Youngauthor=E.+L.+Duffyauthor=F.+Potjewydauthor=F.+Salgado-Poloauthor=P.+Engel+Garc%C3%ADaauthor=D.+Semaanauthor=J.+M.+Pritchardauthor=A.+Perrakisauthor=S.+J.+Macdonaldauthor=C.+Jamiesonauthor=A.+J.+Watson&title=Structure-activity+relationships+of+small+molecule+autotaxin+inhibitors+with+a+discrete+binding+mode&doi=10.1021%2Facs.jmedchem.6b01597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode</span></div><div class="casAuthors">Miller, Lisa M.; Keune, Willem-Jan; Castagna, Diana; Young, Louise C.; Duffy, Emma L.; Potjewyd, Frances; Salgado-Polo, Fernando; Engel Garcia, Paloma; Semaan, Dima; Pritchard, John M.; Perrakis, Anastassis; Macdonald, Simon J. F.; Jamieson, Craig; Watson, Allan J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">722-748</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline.  The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a no. of diseases including fibrotic diseases, cancer, and inflammation, amongst others.  Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small no. of inhibitors have been described that deviate from this common scaffold.  Herein, the authors report the structure-activity relationships (SAR) of a previously reported small mol. ATX inhibitor.  The authors show through enzyme kinetics studies that analogs of this chemotype are noncompetitive inhibitors, and using a crystal structure with ATX the authors confirm the discrete binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiaOETATMDbVg90H21EOLACvtfcHk0lj67DGyyk2PEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsrrO&md5=514df4aae4a6d362812d4461494c5c4a</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01597%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BM.%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DCastagna%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DDuffy%26aufirst%3DE.%2BL.%26aulast%3DPotjewyd%26aufirst%3DF.%26aulast%3DSalgado-Polo%26aufirst%3DF.%26aulast%3DEngel%2BGarc%25C3%25ADa%26aufirst%3DP.%26aulast%3DSemaan%26aufirst%3DD.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520of%2520small%2520molecule%2520autotaxin%2520inhibitors%2520with%2520a%2520discrete%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D722%26epage%3D748%26doi%3D10.1021%2Facs.jmedchem.6b01597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also references <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a> and <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+also+references+18+and+20."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a discussion on substrate-specific kinetics of ATX, see:</p></div><span class="NLM_contrib-group">Saunders, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De La Cruz, E. M.</span><span> </span><span class="NLM_article-title">Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">30130</span><span class="NLM_x">–</span> <span class="NLM_lpage">30141</span><span class="refDoi"> DOI: 10.1074/jbc.M111.246884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1074%2Fjbc.M111.246884" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=30130-30141&author=L.+P.+Saundersauthor=W.+Caoauthor=W.+C.+Changauthor=R.+A.+Albrightauthor=D.+T.+Braddockauthor=E.+M.+De+La+Cruz&title=Kinetic+analysis+of+autotaxin+reveals+substrate-specific+catalytic+pathways+and+a+mechanism+for+lysophosphatidic+acid+distribution&doi=10.1074%2Fjbc.M111.246884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.246884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.246884%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DL.%2BP.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DW.%2BC.%26aulast%3DAlbright%26aufirst%3DR.%2BA.%26aulast%3DBraddock%26aufirst%3DD.%2BT.%26aulast%3DDe%2BLa%2BCruz%26aufirst%3DE.%2BM.%26atitle%3DKinetic%2520analysis%2520of%2520autotaxin%2520reveals%2520substrate-specific%2520catalytic%2520pathways%2520and%2520a%2520mechanism%2520for%2520lysophosphatidic%2520acid%2520distribution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D30130%26epage%3D30141%26doi%3D10.1074%2Fjbc.M111.246884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiosaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.</span><span> </span><span class="NLM_article-title">Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3635</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span><span class="refDoi"> DOI: 10.1016/S0040-4039(98)00653-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2FS0040-4039%2898%2900653-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlWrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3635-3638&author=C.+Blackburnauthor=B.+Guanauthor=P.+Flemingauthor=K.+Shiosakiauthor=S.+Tsai&title=Parallel+synthesis+of+3-aminoimidazo%5B1%2C2-a%5Dpyridines+and+pyrazines+by+a+new+three-component+condensation&doi=10.1016%2FS0040-4039%2898%2900653-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation</span></div><div class="casAuthors">Blackburn, Christopher; Guan, Bing; Fleming, Paul; Shiosaki, Kazumi; Tsai, Shirling</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3635-3638</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A three-component condensation reaction between 2-aminopyridine, an aldehyde and an isonitrile catalyzed by scandium triflate affords derivs. of 3-aminoimidazo[1,2-a]pyridine; aminopyrazine reacts similarly.  A library of heterocycles, prepd. in high yield by parallel synthesis and purifn. on an ion-exchange resin, was subjected to further reaction at the amino group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrndWK-azaOEbVg90H21EOLACvtfcHk0lj67DGyyk2PEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlWrtLs%253D&md5=dfdddf23bcb1051d2ff6375f9f2616f5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900653-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900653-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DShiosaki%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DS.%26atitle%3DParallel%2520synthesis%2520of%25203-aminoimidazo%255B1%252C2-a%255Dpyridines%2520and%2520pyrazines%2520by%2520a%2520new%2520three-component%2520condensation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3635%26epage%3D3638%26doi%3D10.1016%2FS0040-4039%2898%2900653-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Groebke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlin, F.</span><span> </span><span class="NLM_article-title">Synthesis of imidazo[1,2-a] annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1055/s-1998-1721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1055%2Fs-1998-1721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1998&publication_year=1998&pages=661-663&author=K.+Groebkeauthor=L.+Weberauthor=F.+Mehlin&title=Synthesis+of+imidazo%5B1%2C2-a%5D+annulated+pyridines%2C+pyrazines+and+pyrimidines+by+a+novel+three-component+condensation&doi=10.1055%2Fs-1998-1721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-1721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-1721%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DL.%26aulast%3DMehlin%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520imidazo%255B1%252C2-a%255D%2520annulated%2520pyridines%252C%2520pyrazines%2520and%2520pyrimidines%2520by%2520a%2520novel%2520three-component%2520condensation%26jtitle%3DSynlett%26date%3D1998%26volume%3D1998%26spage%3D661%26epage%3D663%26doi%3D10.1055%2Fs-1998-1721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bienaymé, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzid, K.</span><span> </span><span class="NLM_article-title">A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2234</span><span class="NLM_x">–</span> <span class="NLM_lpage">2237</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1Crt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2234-2237&author=H.+Bienaym%C3%A9author=K.+Bouzid&title=A+new+heterocyclic+multicomponent+reaction+for+the+combinatorial+synthesis+of+fused+3-aminoimidazoles&doi=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles</span></div><div class="casAuthors">Bienayme, Hugues; Bouzid, Kamel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2234-2237</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Reaction of heteroarom. amidines, aldehydes, and isonitriles in the presence of a catalytic amt. of protic acids gave fused 3-aminoimidazoles.  E.g., HClO4-catalyzed reaction of 2-aminopyrimidine, PhCHO, and Me3CNC gave 82% imidazopyrimidine I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1LwDCSCFs_rVg90H21EOLACvtfcHk0lj67DGyyk2PEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1Crt7Y%253D&md5=6c11f8f883d1699e9a3def969b5f3e04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819980904%252937%253A16%253C2234%253A%253AAID-ANIE2234%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DBienaym%25C3%25A9%26aufirst%3DH.%26aulast%3DBouzid%26aufirst%3DK.%26atitle%3DA%2520new%2520heterocyclic%2520multicomponent%2520reaction%2520for%2520the%2520combinatorial%2520synthesis%2520of%2520fused%25203-aminoimidazoles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2234%26epage%3D2237%26doi%3D10.1002%2F%28SICI%291521-3773%2819980904%2937%3A16%3C2234%3A%3AAID-ANIE2234%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, G. E.</span><span> </span><span class="NLM_article-title">Lithium Aldimines. A new synthetic intermediate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">7778</span><span class="NLM_x">–</span> <span class="NLM_lpage">7778</span><span class="refDoi"> DOI: 10.1021/ja50001a064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja50001a064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1969&pages=7778-7778&author=H.+M.+Walborskyauthor=G.+E.+Niznik&title=Lithium+Aldimines.+A+new+synthetic+intermediate&doi=10.1021%2Fja50001a064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fja50001a064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja50001a064%26sid%3Dliteratum%253Aachs%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26aulast%3DNiznik%26aufirst%3DG.%2BE.%26atitle%3DLithium%2520Aldimines.%2520A%2520new%2520synthetic%2520intermediate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1969%26volume%3D91%26spage%3D7778%26epage%3D7778%26doi%3D10.1021%2Fja50001a064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, G. E.</span><span> </span><span class="NLM_article-title">Synthesis of isonitriles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1021/jo00967a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00967a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1972&pages=187-191&author=H.+M.+Walborskyauthor=G.+E.+Niznik&title=Synthesis+of+isonitriles&doi=10.1021%2Fjo00967a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjo00967a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00967a005%26sid%3Dliteratum%253Aachs%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26aulast%3DNiznik%26aufirst%3DG.%2BE.%26atitle%3DSynthesis%2520of%2520isonitriles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1972%26volume%3D37%26spage%3D187%26epage%3D191%26doi%3D10.1021%2Fjo00967a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christodoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulkerson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meeteren, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeijl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasiem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Structural basis of substrate discrimination and integrin binding by autotaxin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nsmb.1980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21240271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=198-204&author=J.+Hausmannauthor=S.+Kamtekarauthor=E.+Christodoulouauthor=J.+E.+Dayauthor=T.+Wuauthor=Z.+Fulkersonauthor=H.+M.+Albersauthor=L.+A.+van+Meeterenauthor=A.+J.+Houbenauthor=L.+van+Zeijlauthor=S.+Jansenauthor=M.+Andriesauthor=T.+Hallauthor=L.+E.+Peggauthor=T.+E.+Bensonauthor=M.+Kasiemauthor=K.+Harlosauthor=C.+W.+Kooiauthor=S.+S.+Smythauthor=H.+Ovaaauthor=M.+Bollenauthor=A.+J.+Morrisauthor=W.+H.+Moolenaarauthor=A.+Perrakis&title=Structural+basis+of+substrate+discrimination+and+integrin+binding+by+autotaxin&doi=10.1038%2Fnsmb.1980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of substrate discrimination and integrin binding by autotaxin</span></div><div class="casAuthors">Hausmann, Jens; Kamtekar, Satwik; Christodoulou, Evangelos; Day, Jacqueline E.; Wu, Tao; Fulkerson, Zachary; Albers, Harald M. H. G.; van Meeteren, Laurens A.; Houben, Anna J. S.; van Zeijl, Leonie; Jansen, Silvia; Andries, Maria; Hall, Troii; Pegg, Lyle E.; Benson, Timothy E.; Kasiem, Mobien; Harlos, Karl; Vander Kooi, Craig W.; Smyth, Susan S.; Ovaa, Huib; Bollen, Mathieu; Morris, Andrew J.; Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types.  ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation.  However, the mol. basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear.  Here, we present the crystal structure of ATX, alone and in complex with a small-mol. inhibitor.  We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates.  We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B-like domains, using an atypical mechanism.  Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-mol. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fkNlSRtsTbVg90H21EOLACvtfcHk0ljiRTJNBvH7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCmsA%253D%253D&md5=bc2ab613ace29ee008825cec69d65fce</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1980%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DChristodoulou%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DFulkerson%26aufirst%3DZ.%26aulast%3DAlbers%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DHouben%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BZeijl%26aufirst%3DL.%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DPegg%26aufirst%3DL.%2BE.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKasiem%26aufirst%3DM.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DKooi%26aufirst%3DC.%2BW.%26aulast%3DSmyth%26aufirst%3DS.%2BS.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520discrimination%2520and%2520integrin%2520binding%2520by%2520autotaxin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D198%26epage%3D204%26doi%3D10.1038%2Fnsmb.1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohmae, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Crystal structure of autotaxin an insight into GPCR activation by lipid mediators</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nsmb.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21240269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=205-213&author=H.+Nishimasuauthor=S.+Okudairaauthor=K.+Hamaauthor=E.+Miharaauthor=N.+Dohmaeauthor=A.+Inoueauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+structure+of+autotaxin+an+insight+into+GPCR+activation+by+lipid+mediators&doi=10.1038%2Fnsmb.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of autotaxin and insight into GPCR activation by lipid mediators</span></div><div class="casAuthors">Nishimasu, Hiroshi; Okudaira, Shinichi; Hama, Kotaro; Mihara, Emiko; Dohmae, Naoshi; Inoue, Asuka; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses.  Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations.  These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the resp. LPA mols. in distinct conformations.  They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes.  Furthermore, along with biochem. and biol. data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9dHNmB6yTbVg90H21EOLACvtfcHk0ljiRTJNBvH7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsQ%253D%253D&md5=f2f9ccaadf5c7de7bfd8431e5f954b2a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1998%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DDohmae%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520structure%2520of%2520autotaxin%2520an%2520insight%2520into%2520GPCR%2520activation%2520by%2520lipid%2520mediators%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D205%26epage%3D213%26doi%3D10.1038%2Fnsmb.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">A 3D view of autotaxin</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1016/j.tips.2011.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.tips.2011.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=22277299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=138-145&author=H.+Nishimasuauthor=R.+Ishitaniauthor=J.+Aokiauthor=O.+Nureki&title=A+3D+view+of+autotaxin&doi=10.1016%2Fj.tips.2011.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A 3D view of autotaxin</span></div><div class="casAuthors">Nishimasu, Hiroshi; Ishitani, Ryuichiro; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (Enpp2), is a secreted lysophospholipase D (lysoPLD) that generates the lipid mediator lysophosphatidic acid (LPA), which in turn activates G protein-coupled receptors to evoke various cellular responses.  ATX is essential for normal development, is implicated in various physiol. processes, and is also assocd. with pathol. conditions such as cancer, pain and fibrosis.  Despite its importance, the mol. mechanism of ATX-catalyzed LPA prodn. has long been elusive.  Recent structural analyses have provided new insights into the mechanisms of localized and regulated LPA prodn. by ATX.  This structural information will pave the way for further biochem., biol. and medical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxar9dg5wsrVg90H21EOLACvtfcHk0lgIPgAi87KDwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOgsLc%253D&md5=9bbf198e24aa8cb4f9e7da2525e1e60c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DA%25203D%2520view%2520of%2520autotaxin%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D138%26epage%3D145%26doi%3D10.1016%2Fj.tips.2011.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Insights into autotaxin: how to produce and present a lipid mediator</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1038/nrm3188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnrm3188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21915140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=674-679&author=W.+H.+Moolenaarauthor=A.+Perrakis&title=Insights+into+autotaxin%3A+how+to+produce+and+present+a+lipid+mediator&doi=10.1038%2Fnrm3188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into autotaxin: how to produce and present a lipid mediator</span></div><div class="casAuthors">Moolenaar, Wouter H.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA).  LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types.  ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumor progression.  However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved.  Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm3UHhjy0QP7Vg90H21EOLACvtfcHk0lgIPgAi87KDwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsb%252FJ&md5=96ab96a9e7f6cd70f5dcc1be0363d298</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrm3188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3188%26sid%3Dliteratum%253Aachs%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DInsights%2520into%2520autotaxin%253A%2520how%2520to%2520produce%2520and%2520present%2520a%2520lipid%2520mediator%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D674%26epage%3D679%26doi%3D10.1038%2Fnrm3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tabchy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1038/nsmb0211-117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb0211-117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=21289650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVynsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=117-118&author=A.+Tabchyauthor=G.+Tigyiauthor=G.+B.+Mills&title=Location%2C+location%2C+location%3A+a+crystal-clear+view+of+autotaxin+saturating+LPA+receptors&doi=10.1038%2Fnsmb0211-117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Location, location, location: A crystal-clear view of autotaxin saturating LPA receptors</span></div><div class="casAuthors">Tabchy, Adel; Tigyi, Gabor; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-118</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The interaction of autotaxin with its substrates leads to the prodn. of lysophosphatidic acids (LPA), bioactive lipids with an emerging prominent role in inflammation and cancer.  Two papers in this issue tell the previously unknown story of autotaxin, from substrate discrimination to highly efficient local delivery of LPA to target receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kKn6fh2B1LVg90H21EOLACvtfcHk0lh53PDCgzu0sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVynsr0%253D&md5=2518bc0067b00bd07d1872dbb83619fb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnsmb0211-117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb0211-117%26sid%3Dliteratum%253Aachs%26aulast%3DTabchy%26aufirst%3DA.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DLocation%252C%2520location%252C%2520location%253A%2520a%2520crystal-clear%2520view%2520of%2520autotaxin%2520saturating%2520LPA%2520receptors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D117%26epage%3D118%26doi%3D10.1038%2Fnsmb0211-117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolenaars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunkara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matas-Rico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Elferink, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11248</span><span class="refDoi"> DOI: 10.1038/ncomms11248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fncomms11248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27075612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11248&author=W.+J.+Keuneauthor=J.+Hausmannauthor=R.+Bolierauthor=D.+Tolenaarsauthor=A.+Kremerauthor=T.+Heidebrechtauthor=R.+P.+Joostenauthor=M.+Sunkaraauthor=A.+J.+Morrisauthor=E.+Matas-Ricoauthor=W.+H.+Moolenaarauthor=R.+P.+Oude+Elferinkauthor=A.+Perrakis&title=Steroid+binding+to+Autotaxin+links+bile+salts+and+lysophosphatidic+acid+signalling&doi=10.1038%2Fncomms11248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling</span></div><div class="casAuthors">Keune, Willem-Jan; Hausmann, Jens; Bolier, Ruth; Tolenaars, Dagmar; Kremer, Andreas; Heidebrecht, Tatjana; Joosten, Robbie P.; Sunkara, Manjula; Morris, Andrew J.; Matas-Rico, Elisa; Moolenaar, Wouter H.; Oude Elferink, Ronald P.; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11248</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autotaxin (ATX) generates the lipid mediator lysophosphatidic acid (LPA).  ATX-LPA signalling is involved in multiple biol. and pathophysiol. processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumor progression.  ATX has a tripartite active site, combining a hydrophilic groove, a hydrophobic lipid-binding pocket and a tunnel of unclear function.  We present crystal structures of rat ATX bound to 7α-hydroxycholesterol and the bile salt tauroursodeoxycholate (TUDCA), showing how the tunnel selectively binds steroids.  A structure of ATX simultaneously harbouring TUDCA in the tunnel and LPA in the pocket, together with kinetic anal., reveals that bile salts act as partial non-competitive inhibitors of ATX, thereby attenuating LPA receptor activation.  This unexpected interplay between ATX-LPA signalling and select steroids, notably natural bile salts, provides a mol. basis for the emerging assocn. of ATX with disorders assocd. with increased circulating levels of bile salts.  Furthermore, our findings suggest potential clin. implications in the use of steroid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3bO2RWT8ZrVg90H21EOLACvtfcHk0lh53PDCgzu0sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Sisb4%253D&md5=29178b1c529c8c72ea6890fe32a66372</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncomms11248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11248%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DHausmann%26aufirst%3DJ.%26aulast%3DBolier%26aufirst%3DR.%26aulast%3DTolenaars%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DSunkara%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DMatas-Rico%26aufirst%3DE.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DOude%2BElferink%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DSteroid%2520binding%2520to%2520Autotaxin%2520links%2520bile%2520salts%2520and%2520lysophosphatidic%2520acid%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11248%26doi%3D10.1038%2Fncomms11248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jones, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirunavukkarasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0lh53PDCgzu0sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span><span class="refDoi"> DOI: 10.1124/mol.115.100404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1124%2Fmol.115.100404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=26371182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=982-992&author=A.+J.+Steinauthor=G.+Bainauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=N.+M.+Stelzerauthor=R.+S.+Sidhuauthor=J.+Schaubauthor=L.+Gouletauthor=D.+Lonerganauthor=I.+Calderonauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Structural+basis+for+inhibition+of+human+autotaxin+by+four+potent+compounds+with+distinct+modes+of+binding&doi=10.1124%2Fmol.115.100404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding</span></div><div class="casAuthors">Stein, Adam J.; Bain, Gretchen; Prodanovich, Pat; Santini, Angelina M.; Darlington, Janice; Stelzer, Nina M. P.; Sidhu, Ranjinder S.; Schaub, Jeffrey; Goulet, Lance; Lonergan, Dave; Calderon, Imelda; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA).  LPA is a bioactive phospholipid that regulates diverse biol. processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of Gprotein-coupled receptors.  The ATXLPA pathway has been implicated in many pathol. conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain.  Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases.  Mouse and rat ATX have been crystd. previously with LPA or small-mol. inhibitors bound.  Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors.  We demonstrate that the mechanism of inhibition of each compd. reflects its unique interactions with human ATX.  Our studies may provide a basis for the rational design of novel ATX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8334n30PQrLVg90H21EOLACvtfcHk0ljv6a44e5yyng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisF2ns7g%253D&md5=f847e18cf228207349d21c449abdb039</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100404%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DStelzer%26aufirst%3DN.%2BM.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26aulast%3DSchaub%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520human%2520autotaxin%2520by%2520four%2520potent%2520compounds%2520with%2520distinct%2520modes%2520of%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D982%26epage%3D992%26doi%3D10.1124%2Fmol.115.100404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheasty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farooq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeete, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of the lysophospholipase autotaxin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5403</span><span class="NLM_x">–</span> <span class="NLM_lpage">5410</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1016%2Fj.bmcl.2016.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5403-5410&author=P.+Shahauthor=A.+Cheastyauthor=C.+Foxtonauthor=T.+Raynhamauthor=M.+Farooqauthor=I.+F.+Gutierrezauthor=A.+Lejeuneauthor=M.+Pritchardauthor=A.+Turnbullauthor=L.+Pangauthor=P.+Owenauthor=S.+Boydauthor=A.+Stowellauthor=A.+Jordanauthor=N.+M.+Hamiltonauthor=J.+R.+Hitchinauthor=M.+Stockleyauthor=E.+MacDonaldauthor=M.+J.+Quesadaauthor=E.+Trivierauthor=J.+Skeeteauthor=H.+Ovaaauthor=W.+H.+Moolenaarauthor=H.+Ryder&title=Discovery+of+potent+inhibitors+of+the+lysophospholipase+autotaxin&doi=10.1016%2Fj.bmcl.2016.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DCheasty%26aufirst%3DA.%26aulast%3DFoxton%26aufirst%3DC.%26aulast%3DRaynham%26aufirst%3DT.%26aulast%3DFarooq%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DI.%2BF.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DPritchard%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DOwen%26aufirst%3DP.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DStowell%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DN.%2BM.%26aulast%3DHitchin%26aufirst%3DJ.%2BR.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DTrivier%26aufirst%3DE.%26aulast%3DSkeete%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DRyder%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520lysophospholipase%2520autotaxin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5403%26epage%3D5410%26doi%3D10.1016%2Fj.bmcl.2016.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonergan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1124/jpet.116.237156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1124%2Fjpet.116.237156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27754931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=1-13&author=G.+Bainauthor=K.+E.+Shannonauthor=F.+Huangauthor=J.+Darlingtonauthor=L.+Gouletauthor=P.+Prodanovichauthor=G.+L.+Maauthor=A.+M.+Santiniauthor=A.+J.+Steinauthor=D.+Lonerganauthor=C.+D.+Kingauthor=I.+Calderonauthor=A.+Laiauthor=J.+H.+Hutchinsonauthor=J.+F.+Evans&title=Selective+inhibition+of+autotaxin+is+efficacious+in+mouse+models+of+liver+fibrosis&doi=10.1124%2Fjpet.116.237156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis</span></div><div class="casAuthors">Bain Gretchen; Shannon Kristen E; Huang Fei; Darlington Janice; Goulet Lance; Prodanovich Patricia; Ma Gina L; Santini Angelina M; Stein Adam J; Lonergan Dave; King Christopher D; Calderon Imelda; Lai Andiliy; Hutchinson John H; Evans Jilly F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autotaxin (ATX) is a secreted glycoprotein that converts lysophosphatidylcholine (LPC) to the bioactive phospholipid lysophosphatidic acid (LPA) and is the major enzyme generating circulating LPA.  Inhibition of LPA signaling has profound antifibrotic effects in multiple organ systems, including lung, kidney, skin, and peritoneum.  However, other LPA-generating pathways exist, and the role of ATX in localized tissue LPA production and fibrosis remains unclear and controversial.  In this study, we describe the preclinical pharmacologic, pharmacokinetic, and pharmacodynamic properties of a novel small-molecule ATX inhibitor, PAT-505 [3-((6-chloro-2-cyclopropyl-1-(1-ethyl-1H-pyrazol-4-yl)-7-fluoro-1H-indol-3-yl) thio)-2-fluorobenzoic acid sodium salt].  PAT-505 is a potent, selective, noncompetitive inhibitor that displays significant inhibition of ATX activity in plasma and liver tissue after oral administration.  When dosed therapeutically in a Stelic Mouse Animal Model of nonalcoholic steatohepatitis (NASH), PAT-505 treatment resulted in a small but significant improvement in fibrosis with only minor improvements in hepatocellular ballooning and hepatic inflammation.  In a choline-deficient, high-fat diet model of NASH, therapeutic treatment with PAT-505 robustly reduced liver fibrosis with no significant effect on steatosis, hepatocellular ballooning, or inflammation.  These data demonstrate that inhibiting autotaxin is antifibrotic and may represent a novel therapeutic approach for the treatment of multiple fibrotic liver diseases, including NASH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL-FO7LhxeeTjk2McQZ6XmfW6udTcc2eY8Bz6EZcrz27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhvVequg%253D%253D&md5=0ecd238167807657b30f436c05180dce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237156%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DG.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DStein%26aufirst%3DA.%2BJ.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DSelective%2520inhibition%2520of%2520autotaxin%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520liver%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D360%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.116.237156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Keune, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potjewyd, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidebrecht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado-Polo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelvarajan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Latif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrakis, A.</span><span> </span><span class="NLM_article-title">Rational design of autotaxin inhibitors by structural evolution of endogenous modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2017</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01743</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01743" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2006-2017&author=W.+J.+Keuneauthor=F.+Potjewydauthor=T.+Heidebrechtauthor=F.+Salgado-Poloauthor=S.+J.+Macdonaldauthor=L.+Chelvarajanauthor=A.+Abdel+Latifauthor=S.+Somanauthor=A.+J.+Morrisauthor=A.+J.+Watsonauthor=C.+Jamiesonauthor=A.+Perrakis&title=Rational+design+of+autotaxin+inhibitors+by+structural+evolution+of+endogenous+modulators&doi=10.1021%2Facs.jmedchem.6b01743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators</span></div><div class="casAuthors">Keune, Willem-Jan; Potjewyd, Frances; Heidebrecht, Tatjana; Salgado-Polo, Fernando; Macdonald, Simon J. F.; Chelvarajan, Lakshman; Abdel Latif, Ahmed; Soman, Sony; Morris, Andrew J.; Watson, Allan J. B.; Jamieson, Craig; Perrakis, Anastassis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2006-2017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin produces the bioactive lipid lysophosphatidic acid (LPA), and is a drug target of considerable interest for numerous pathologies.  The authors report the expedient, structure-guided evolution of weak physiol. allosteric inhibitors (bile salts) into potent competitive Autotaxin inhibitors that do not interact with the catalytic site.  Functional data confirms that the authors' lead compd. attenuates LPA mediated signaling in cells, and reduces LPA synthesis in vivo, providing a promising natural product derived scaffold for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot4QXxEeWhtrVg90H21EOLACvtfcHk0ljv6a44e5yyng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWgsrk%253D&md5=b6409fd76eda5042a983800a43723922</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01743%26sid%3Dliteratum%253Aachs%26aulast%3DKeune%26aufirst%3DW.%2BJ.%26aulast%3DPotjewyd%26aufirst%3DF.%26aulast%3DHeidebrecht%26aufirst%3DT.%26aulast%3DSalgado-Polo%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DChelvarajan%26aufirst%3DL.%26aulast%3DAbdel%2BLatif%26aufirst%3DA.%26aulast%3DSoman%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DA.%2BJ.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DPerrakis%26aufirst%3DA.%26atitle%3DRational%2520design%2520of%2520autotaxin%2520inhibitors%2520by%2520structural%2520evolution%2520of%2520endogenous%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2006%26epage%3D2017%26doi%3D10.1021%2Facs.jmedchem.6b01743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">For example, the following articles describe the activity of ATX inhibitors in a bleomycin-induced pulmonary fibrosis mice model; differences in their pharmacological activity might be linked, in part, to differences in their binding modes:</p></div><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okudaira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimasu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nureki, O.</span><span> </span><span class="NLM_article-title">Structural basis for specific inhibition of autotaxin by a DNA aptamer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/nsmb.3200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1038%2Fnsmb.3200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=27043297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=395-401&author=K.+Katoauthor=H.+Ikedaauthor=S.+Miyakawaauthor=S.+Futakawaauthor=Y.+Nonakaauthor=M.+Fujiwaraauthor=S.+Okudairaauthor=K.+Kanoauthor=J.+Aokiauthor=J.+Moritaauthor=R.+Ishitaniauthor=H.+Nishimasuauthor=Y.+Nakamuraauthor=O.+Nureki&title=Structural+basis+for+specific+inhibition+of+autotaxin+by+a+DNA+aptamer&doi=10.1038%2Fnsmb.3200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for specific inhibition of Autotaxin by a DNA aptamer</span></div><div class="casAuthors">Kato, Kazuki; Ikeda, Hisako; Miyakawa, Shin; Futakawa, Satoshi; Nonaka, Yosuke; Fujiwara, Masatoshi; Okudaira, Shinichi; Kano, Kuniyuki; Aoki, Junken; Morita, Junko; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nakamura, Yoshikazu; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ATX is a plasma lysophospholipase D that hydrolyzes lysophosphatidylcholine (LPC) and produces lysophosphatidic acid.  To date, no ATX-inhibition-mediated treatment strategies for human diseases have been established.  Here, we report anti-ATX DNA aptamers that inhibit ATX with high specificity and efficacy.  We solved the crystal structure of ATX in complex with the anti-ATX aptamer RB011, at 2.0-Å resoln.  RB011 binds in the vicinity of the active site through base-specific interactions, thus preventing the access of the choline moiety of LPC substrates.  Using the structural information, we developed the modified anti-ATX DNA aptamer RB014, which exhibited in vivo efficacy in a bleomycin-induced pulmonary fibrosis mouse model.  Our findings reveal the structural basis for the specific inhibition of ATX by the anti-ATX aptamer and highlight the therapeutic potential of anti-ATX aptamers for the treatment of human diseases, such as pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NHdAXL4UqLVg90H21EOLACvtfcHk0ljKH0KsPyydrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVajtLk%253D&md5=aca4be211ddf67faad6a2decadd73a12</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3200%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DMiyakawa%26aufirst%3DS.%26aulast%3DFutakawa%26aufirst%3DS.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DKano%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DMorita%26aufirst%3DJ.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520basis%2520for%2520specific%2520inhibition%2520of%2520autotaxin%2520by%2520a%2520DNA%2520aptamer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D395%26epage%3D401%26doi%3D10.1038%2Fnsmb.3200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdyshev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagares, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahluwalia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1096/fj.201500197R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1096%2Ffj.201500197R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2435-2450&author=K.+E.+Blackauthor=E.+Berdyshevauthor=G.+Bainauthor=F.+V.+Castelinoauthor=B.+S.+Sheaauthor=C.+K.+Probstauthor=B.+A.+Fontaineauthor=I.+Bronovaauthor=L.+Gouletauthor=D.+Lagaresauthor=N.+Ahluwaliaauthor=R.+S.+Knipeauthor=V.+Natarajanauthor=A.+M.+Tager&title=Autotaxin+activity+increases+locally+following+lung+injury%2C+but+is+not+required+for+pulmonary+lysophosphatidic+acid+production+or+fibrosis&doi=10.1096%2Ffj.201500197R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1096%2Ffj.201500197R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201500197R%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DBerdyshev%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DProbst%26aufirst%3DC.%2BK.%26aulast%3DFontaine%26aufirst%3DB.%2BA.%26aulast%3DBronova%26aufirst%3DI.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DLagares%26aufirst%3DD.%26aulast%3DAhluwalia%26aufirst%3DN.%26aulast%3DKnipe%26aufirst%3DR.%2BS.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAutotaxin%2520activity%2520increases%2520locally%2520following%2520lung%2520injury%252C%2520but%2520is%2520not%2520required%2520for%2520pulmonary%2520lysophosphatidic%2520acid%2520production%2520or%2520fibrosis%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D2435%26epage%3D2450%26doi%3D10.1096%2Ffj.201500197R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">WaterMap (Schrödinger, LLC, New York, NY, 2017).</p></div><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+molecular+recognition+exploiting+hydrophobic+enclosure+in+protein-ligand+binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0ljKH0KsPyydrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520molecular%2520recognition%2520exploiting%2520hydrophobic%2520enclosure%2520in%2520protein-ligand%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Role of the active-site solvent in the thermodynamics of factor Xa ligand binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+active-site+solvent+in+the+thermodynamics+of+factor+Xa+ligand+binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0lhdCJ-QV3AYLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520active-site%2520solvent%2520in%2520the%2520thermodynamics%2520of%2520factor%2520Xa%2520ligand%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5mom" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5mom','PDB','5mom'); return false;">PDB: 5mom</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M7M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M7M','PDB','5M7M'); return false;">PDB: 5M7M</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i117"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00647">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72870"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00647">10.1021/acs.jmedchem.7b00647</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Preparation, characterization of ATX protein, and cocrystallization protocol (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_001.pdf">jm7b00647_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00647/suppl_file/jm7b00647_si_002.csv">jm7b00647_si_002.csv (4.7 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structure of compound <b>9</b> with ATX: PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M7M">5M7M</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00647%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00647" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c1041a353d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
